Presentations

Welcome to the SITC Annual Meeting & Associated Program presentations archive.

Since its inception in 1986, the SITC Annual Meeting & Associated Programs have been the premier destination for scientific exchange, education and networking for those who are dedicated to increasing their knowledge of cancer immunology and improving patient outcomes through immunotherapy. In this section of our website, you'll find many of the presentations given at the SITC Annual Meeting & Associated Programs over the past several years, along with presentations given at other SITC programs. You can browse by year or by program.

Browse by meeting:


You can also simply enter either the author, the presentation title or the presentation topic into the search field. The catalog will display the most relevant items first.

2015 ACI

Princeton, NJ

Immunology 101 for the Non-Immunologist
Derek B. Sant’Angelo, PhD - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=0810 SantAngelo-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Richard D. Carvajal, MD - Columbia University
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=0835 Carvajal-SECURE.pdf
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
Jedd D. Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=0940 Wolchok-SECURE.pdf
Oncolytic Viruses as Tumor Immunotherapy Agents
Howard L. Kaufman, MD, FACS - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=1005 Kaufman-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Salma K. Jabbour, MD - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=1030 Jabbour Revised-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond
Sanjiv S. Agarwala, MD - St. Luke's Cancer Center and Temple University
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=1300 Agarwala-SECURE.pdf
Immunotherapy for the Treatment of GU Malignancies
Eric Singer, MD - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=1325 Singer-SECURE.pdf
Immunotherapy for the Treatment of Melanoma
Janice M. Mehnert, MD - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=1350 Mehnert-SECURE.pdf
Immunotherapy for the Treatment of Brain Metastases
Ann W. Silk, MD, MS - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci15nj/presentations/index.php?filename=1455 Silk Revised-SECURE.pdf

Chicago, IL

Immunology 101 for the Non-Immunologist
Leisha A. Emens, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/aci15il/presentations/index.php?filename=0810 Emens-SECURE.pdf
Basic Mechanisms of Tumor Immune Suppression
Brent A. Hanks, MD, PhD - Duke University Medical Center
www.sitcancer.org/meetings/aci15il/presentations/index.php?filename=0835 Hanks-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Charles G. Drake, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/aci15il/presentations/index.php?filename=0900 Drake-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond
Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci15il/presentations/index.php?filename=0940 Curti-SECURE.pdf
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
John D. Powderly II, MD, CPI - Carolina BioOncology Institute, PLLC
www.sitcancer.org/meetings/aci15il/presentations/index.php?filename=1005 Powderly REVISED-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Sandra Demaria, MD - New York University
www.sitcancer.org/meetings/aci15il/presentations/index.php?filename=1030 Demaria-SECURE.pdf
Oncolytic Viruses as Tumor Immunotherapy Agents
Howard L. Kaufman, MD, FACS - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci15il/presentations/index.php?filename=1055 Kaufman-SECURE.pdf

Houston, TX

Immunology 101 for the Non-Immunologist
Kimberly S. Schluns, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=0810 Schluns-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Michael A. Curran, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=0835 Curran-SECURE.pdf
Basic Mechanisms of Tumor Immune Suppression
Dean A. Lee, MD, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=0900 Lee-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond
Stephanie S. Watowich, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=0940 Watowich-SECURE.pdf
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
Michael A. Curran, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1005 Curran-SECURE.pdf
Active Immunization Approaches
Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1030 Overwijk-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Chad Tang, MD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1120 Tang-SECURE.pdf
Immunotherapy for the Treatment of Melanoma
Patrick Hwu, MD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1320 Hwu-SECURE.pdf
Immunotherapy for the Treatment of GU Malignancies
Sumit K. Subudhi, MD, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1340 Subudhi-SECURE.pdf
Immunotherapy for the Treatment of Hematologic Malignancies
Gheath Alatrash, DO, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1435 Alatrash-SECURE.pdf
Immunotherapy for the Treatment of Brain Malignancies
Amy B. Heimberger, MD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1455 Heimberger-SECURE.pdf
Immunotherapy for the Treatment of Breast Cancer
Elizabeth A. Mittendorf, MD, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/aci15tx/presentations/index.php?filename=1515 Mittendorf-SECURE.pdf

Los Angeles, CA

Immunology 101 for the Non-Immunologist
Stephen L. Shiao, MD, PhD - Cedars-Sinai Medical Center
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=0810 Shiao-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Satiro N. De Oliveira, MD - Mattel Children's Hospital at the University of California Los Angeles
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=0835 De Oliveira-SECURE.pdf
Basic Mechanisms of Tumor Immune Suppression
Bernard A. Fox, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=0900 Fox-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond (Non CME/CNE)
Bernard A. Fox, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=0940 Fox-SECURE.pdf
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
Gregory A. Daniels, MD, PhD - University of California San Diego Moores Cancer Center
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1005 Daniels-SECURE.pdf
Active Immunization Approaches
Richard Essner, MD, FACS - Cedars-Sinai Medical Center and University of California Los Angeles
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1030 Essner-SECURE.pdf
Current Status of Chimeric and Adoptive T Cell Therapy
Mark Faries, MD - The John Wayne Cancer Institute
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1055 Faries-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Stephen L. Shiao, MD, PhD - Cedars-Sinai Medical Center
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1120 Shiao-SECURE.pdf
Immune-Related Adverse Events
Brianna W. Hoffner, BA, RN, MSN - The Angeles Clinic and Research Institute
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1300 Hoffner-SECURE.pdf
Immunotherapy for the Treatment of Melanoma
Omid Hamid, MD - The Angeles Clinic and Research Institute
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1320 - Hamid-SECURE.pdf
Immunotherapy for the Treatment of GU Malignancies
Edwin M. Posadas, MD, FACP - Cedars-Sinai Medical Center
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1340 - Posadas-SECURE.pdf
Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma
Ani Balmanoukian, MD - The Angeles Clinic and Research Institute
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1400 Balmanoukian-SECURE.pdf
Immunotherapy for the Treatment of Hematologic Malignancies
Omid Hamid, MD - The Angeles Clinic and Research Institute
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1435 - Hamid-SECURE.pdf
Immunotherapy for the Treatment of Brain Metastases
Chirag G. Patil, DMD, MD - Cedars-Sinai Medical Center
www.sitcancer.org/meetings/aci15cala/presentations/index.php?filename=1455 Patil-SECURE.pdf

Dearborn, MI

Immunology 101 for the Non-Immunologist
Abhinav Deol, MD - Karmanos Cancer Institute
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=0810 Deol-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Jessica B. Back, PhD - Wayne State University
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=0835 Back-SECURE.pdf
Basic Mechanisms of Tumor Immune Suppression
Wei-Zen Wei, PhD - Wayne State University
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=0900 Wei-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond
Amy Weise, DO - Karmanos Cancer Institute
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=0940 Weise-SECURE.pdf
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
Shirish Gadgeel, MD - Karmanos Cancer Institute
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1005 Gadgeel-SECURE.pdf
Oncolytic Viruses as Tumor Immunotherapy Agents
Ding Wang, MD - Josephine Ford Cancer Center
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1030 Wang-SECURE.pdf
Current Status of Chimeric and Adoptive T Cell Therapy
Lawrence G. Lum, MD, DSc - Karmanos Cancer Institute
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1055 Lum-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Gilda G. Hillman, PhD - Karmanos Cancer Institute and Wayne State University
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1120 Hillman-SECURE.pdf
Immune-Related Adverse Events
Amy Weise, DO - Karmanos Cancer Institute
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1300 Weise-SECURE.pdf
Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma
Bernard A. Fox, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1400 Fox-SECURE.pdf
Immunotherapy for the Treatment of Hematologic Malignancies
Abhinav Deol, MD - Karmanos Cancer Institute
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1435 Deol-SECURE.pdf
Immunotherapy for the Treatment of Brain Metastases and Breast Cancer
Lawrence G. Lum, MD, DSc - Karmanos Cancer Institute
www.sitcancer.org/meetings/aci15mi/presentations/index.php?filename=1455 Lum-SECURE.pdf

Pittsburgh, Pennsylvania

Immunology 101 for the Non-Immunologist
Lisa Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=0810 Butterfield-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Greg M. Delgoffe, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=0835 Delgoffe-SECURE.pdf
Basic Mechanisms of Tumor Immune Suppression
Dario A. Vignali, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=0900 Vignali-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond
Theresa L. Whiteside, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=0935 Whiteside-SECURE.pdf
Active Immunization and Oncolytic Viruses
David Bartlett, MD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1025 Bartlett-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Sandra Demaria, MD - New York University
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1115 Demaria-SECURE.pdf
Immune-Related Adverse Events
Julie E. Bauman, MD, MPH - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1240 Bauman-SECURE.pdf
Immunotherapy for the Treatment of Disseminated and Operable Melanoma
John M. Kirkwood, MD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1300 Kirkwood-SECURE.pdf
Immunotherapy for the Treatment of GU Malignancies
Leonard J. Appleman, MD, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1325 Appleman-SECURE.pdf
Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma
Liza C. Villaruz, MD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1350 Villaruz-SECURE.pdf
Immunotherapy for the Treatment of Hematologic Malignancies
Annie Im, MD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1425 Im-SECURE.pdf
Immunotherapy for the Treatment of Brain Metastases
Hussein Abdul-Hassan Tawbi, MD, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1445 Tawbi-SECURE.pdf
Immunotherapy for the Treatment of Head and Neck
Robert L. Ferris, MD, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci15pa/presentations/index.php?filename=1505 Ferris-SECURE.pdf

Washington, DC

Immunology 101 for the Non-Immunologist
Louis M. Weiner, MD - Georgetown University Medical Center
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=0810 Weiner-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond
Michael B. Atkins, MD - Georgetown-Lombardi Comprehensive Cancer Center
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=0930 Atkins-SECURE.pdf
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
Mario Sznol, MD - Yale University School of Medicine
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=0955 Sznol-SECURE.pdf
Current Status of Chimeric and Adoptive T Cell Therapy
James C. Yang, MD - National Cancer Institute Surgery Branch
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=1115 Yang-SECURE.pdf
Is There a Role for Combination Radiation Therapy and Immunotherapy?
Michael Postow, MD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=1140 Postow-SECURE.pdf
Immunotherapy for the Treatment of Melanoma 
Geoffrey T. Gibney, MD - Georgetown-Lombardi Comprehensive Cancer Center
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=1340 Gibney-SECURE.pdf
Immunotherapy for the Treatment of GU Malignancies
Michael B. Atkins, MD - Georgetown-Lombardi Comprehensive Cancer Center
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=1400 Atkins-SECURE.pdf
Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma
Julie R. Brahmer, MD - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=1420 Brahmer-SECURE.pdf
Immunotherapy for the Treatment of Brain Metastases  
Geoffrey T. Gibney, MD - Georgetown-Lombardi Comprehensive Cancer Center
www.sitcancer.org/meetings/aci15dc/presentations/index.php?filename=1455 Gibney-SECURE.pdf

Chicago, IL

Immunology 101 for the Non-Immunologist
Justin P. Kline, MD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=0810 Kline-SECURE.pdf
Principles of Targeting Regulatory Checkpoints in Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=0835 Gajewski-SECURE.pdf
Melanoma: the Poster Child for Immunotherapy (Cytokines, Checkpoint Inhibitors, Oncolytic Viruses)
Jason J. Luke, MD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=0900 Luke-SECURE.pdf
Head and Neck Cancer, Mesothelioma, and Lung Cancer
Tanguy Seiwert, MD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=940 Seiwert-SECURE.pdf
GI Malignancies
Manish Sharma, MD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=1005 Sharma-SECURE.pdf
Breast Cancer
Rita Nanda, MD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=1030 Nanda-SECURE.pdf
Immunotherapy for GU Malignancies (Prostate, RCC, Bladder)
Walter Stadler, MD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=1055 Stadler-SECURE.pdf
Hematologic Malignancies (CAR-T cells, Vaccines, Checkpoint Inhibitors)
Hongtao Liu, MD, PhD - University of Chicago
www.sitcancer.org/meetings/aci15il2/presentations/index.php?filename=1120 Liu-SECURE.pdf

Augusta, GA

Immunology 101 for the Non-Immunologist
Esteban Celis, MD, PhD - Georgia Regents University Center
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=0810 Celis-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Samir N. Khleif, MD - Georgia Regents University Cancer Center
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=0835 Khleif-SECURE.pdf
Basic Mechanisms of Tumor Immune Suppression
Zihai Li, MD, PhD - Medical University of South Carolina
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=0900 Li-SECURE.pdf
Active Immunization Approaches
Yukai He, PhD - Georgia Regents University
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1030 He-SECURE.pdf
Current Status of Chimeric and Adoptive T Cell Therapy
Chrystal Paulos, PhD - Medical University of South Carolina
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1055 Paulos-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Lewis Cooper, MD - Medical University of South Carolina
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1120 Cooper-SECURE.pdf
Immune-Related Adverse Events
Asha Nayak-Kapoor, MD - Georgia Regents University
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1300 Nayak-SECURE.pdf
Immunotherapy for the Treatment of Hematologic Malignancies
Xue-Zhong Yu, MD - Medical University of South Carolina
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1340 Yu-SECURE.pdf
Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma
Zhonglin Hao, MD, PhD - Georgia Regents University
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1400 Hao-SECURE.pdf
Immunotherapy for the Treatment of GU Malignancies
Jennifer Wu, PhD - Medical University of South Carolina
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1435 Wu-SECURE.pdf
Immunotherapy for the Treatment of Brain Malignancies
Theodore Johnson, MD, PhD - Georgia Regents University
www.sitcancer.org/meetings/aci15ga/presentations/index.php?filename=1455 Johnson-SECURE.pdf

Nashville, TN

Immunology 101 for the Non-Immunologist
Jeffrey A. Sosman, MD - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=0810 Sosman-SECURE.pdf
Basic Principles of Tumor Immunotherapy
Anil Shanker, PhD - Meherry Medical College/Vanderbilt Ingram Cancer Center
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=0835 Shankar-SECURE.pdf
Basic Mechanisms of Tumor Immune Suppression
Jeffrey A. Sosman, MD - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=0900 Sosman-SECURE.pdf
Cytokines: Interferons, Interleukins and Beyond
Venkataswarup Tiriveedhi, MD, PhD - Tennessee State University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=0940 Tiriveedhi-SECURE.pdf
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
Jeffrey A. Sosman, MD - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1005 Sosman-SECURE.pdf
Active Immunization Approaches
Anil Shanker, PhD - Meherry Medical College/Vanderbilt-Ingram Cancer Center
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1030 Shankar-SECURE.pdf
Current Status of Chimeric and Adoptive T Cell Therapy
Marco L Davila, MD, PhD - H. Lee Moffitt Cancer Center
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1055 Davila-SECURE.pdf
Is there a Role for Radiation Therapy and Immunotherapy?
Eric T Shinohara, MD, MSCI - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1120 Shinohara-SECURE.pdf
Immunotherapy for the Treatment of Hematologic Malignancies
Michael R Savona, MD - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1300 Savona-SECURE.pdf
Immunotherapy for the Treatment of Non-Small Cell Lung Carcinoma
Leora Horn, MD - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1320 Horn-SECURE.pdf
Immunotherapy for the Treatment of GU Malignancies
Igor Puzanov, MD, MSCI, FACP - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1340 Puzanov-SECURE.pdf
Immunotherapy for the Treatment of Melanoma
Douglas B Johnson, MD, MSCI - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1400 Johnson-SECURE.pdf
Immunotherapy for the Treatment of Brain Metastases
Igor Puzanov, MD, MSCI, FACP - Vanderbilt University
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1435 Puzanov-SECURE.pdf
Immune-Related Adverse Events
Melissa Johnson, MD - Sarah Cannon Research Institute
www.sitcancer.org/meetings/aci15tn/presentations/index.php?filename=1455 Johnson-SECURE.pdf

San Francisco, CA

Immunology 101 for the Practicing Oncologist
Aaron Logan, MD, PhD - University of California San Francisco
www.sitcancer.org/meetings/aci15casf/presentations/index.php?filename=1310 Logan-SECURE.pdf
Applying Basic Immunology to Treat Cancer
Lawrence Fong, MD - University of California San Francisco
www.sitcancer.org/meetings/aci15casf/presentations/index.php?filename=1335 Fong-SECURE.pdf
The Immune Suppressive Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/aci15casf/presentations/index.php?filename=1400 Gajewski-SECURE.pdf
Checkpoint Inhibitor Therapy
Antoni Ribas, MD, PhD - University of California Los Angeles
www.sitcancer.org/meetings/aci15casf/presentations/index.php?filename=1505 Ribas-SECURE.pdf
Treatments to Perturb the Tumor Microenvironment (TLR, IDO, Oncolytic)
Siwen Hu-Lieskovan, MD, PhD - University of California Los Angeles
www.sitcancer.org/meetings/aci15casf/presentations/index.php?filename=1555 Hu-Lieskovan-SECURE.pdf
Current Status of Chimeric and Adoptive T Cell Therapy
Stephen J Forman, MD - City of Hope National Medical Center
www.sitcancer.org/meetings/aci15casf/presentations/index.php?filename=1620 Forman-SECURE.pdf

New Orleans, Louisiana

Immunology 101 for the Non-Immunologist
Arnold H. Zea, PhD - Louisiana State University Health Sciences Center
www.sitcancer.org/meetings/aci15la/presentations/index.php?filename=0815 Zea-SECURE.pdf
Clinical Development of Cytokines and New Developments in Immunotherapy of GU Malignancies
Richard W. Joseph, MD - Mayo Clinic
www.sitcancer.org/meetings/aci15la/presentations/index.php?filename=1000 Joseph-SECURE.pdf
Understanding Checkpoint Inhibitors: Mechanisms, Combination Strategies and the Treatment of Non-Small Cell Lung Carcinoma
Scott Antonia, MD, PhD - Moffitt Cancer Center & Research Institute
www.sitcancer.org/meetings/aci15la/presentations/index.php?filename=1045 Antonia-SECURE.pdf
Active Immunization Approaches and Immunotherapy for the Treatment of Melanoma
Adam Riker, MD, FACS - Louisiana State University Health Sciences Center
www.sitcancer.org/meetings/aci15la/presentations/index.php?filename=1130 Riker-SECURE.pdf
Current Status of Chimeric and Adoptive T Cell Therapy and Immunotherapy for Brain Metastases
Nabil Ahmed, MD, MPH - Baylor College of Medicine
www.sitcancer.org/meetings/aci15la/presentations/index.php?filename=1330 Ahmed-SECURE.pdf
Is There a Role for Radiation Therapy and Immunotherapy?
Eric T. Shinohara, MD - Vanderbilt-Ingram Cancer Center
www.sitcancer.org/meetings/aci15la/presentations/index.php?filename=1415 Shinohara-SECURE.pdf
Immunotherapy for the Treatment of Hematologic Malignancies
Nabil Ahmed, MD, MPH - Baylor College of Medicine
www.sitcancer.org/meetings/aci15la/presentations/index.php?filename=1455 Ahmed-SECURE.pdf

2015 Global Regulatory Summit

Evolution and Future Predictions Part I
Ke Liu, MD, PhD - U.S. Food and Drug Administration
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=0815 Ke Liu-SECURE.pdf
Evolution and Future Predictions Part I
Ke Liu, MD, PhD - U.S. Food and Drug Administration
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=98d211973d06496ebe34e61315e0dd7e1d
Evolution and Future Predictions Part II
Björn Carlsson, PhD - Medical Products Agency- Sweden
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=0845 Carlsson-SECURE.pdf
Evolution and Future Predictions Part II
Björn Carlsson, PhD - Medical Products Agency- Sweden
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=51ca1320a5a54e5abb9c2dfbe1df59521d
European Medicines Agency Perspectives
Patrick Celis, PhD - European Medicines Agency
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=0945 Celis-SECURE.pdf
European Medicines Agency Perspectives
Patrick Celis, PhD - European Medicines Agency
www.sitcancer.org/meetings/am15grs/presentations/index.php?dd82b493efae4c828fa4ab53f5a17a531d
Japan Perspective
Sumimasa Nagai, MD, PhD - Pharmaceuticals and Medical Devices Agency
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=1030 Nagai-SECURE.pdf
Japan Perspective
Sumimasa Nagai, MD, PhD - Pharmaceuticals and Medical Devices Agency
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=e95936dad66e4adb9bce28fcb6fa129b1d
India Perspectives
Geeta Jotwani, PhD - Indian Council of Medical Research
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=1045 Jotwani-SECURE.pdf
Korea Perspectives
Gi Hyun Kim, PharmD - Ministry of Food and Drug Safety
www.sitcancer.org/meetings/am15grs/presentations/index.php?filename=363d146aa288471a9ba975ed075b68561d

2015 International Symposium

Toward Personalized Immunotherapy for Lymphoma: Identification of Common Driver Mutations Recognized by Patient T Cells
Julie Nielsen, PhD - Canadian Cancer Immunotherapy Consortium (CCIC
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1405 Nielsen-SECURE.pdf
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen Encoded by an Alternative ITGB2 Transcript
Margot J. Pont, MSc - Dutch Tumor Immunology Working Party (DTIWP)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1427 Pont-SECURE.pdf
Diagnostic Solution Improvement by Immunohistochemistry Analysis of Metastatic Melanoma Liver Core Biopsies, Selected by Magnetic Resonance Imaging
Gyorgy Naszados, MD - National Institute of Oncology, Budapest, Hungary
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1445 Naszados edited-SECURE.pdf
Role of the Calcium Binding GPRC6a Receptor in Chemotherapy Mediated Immunogenic Cell Death Induced Tumor Control
rer. Nat Dagmar Quandt, PhD - AKTuI - Arbeitskreis Tumorimmunologie (German Cancer Immunology group in the German Immunology Society) with Tumor Immunology Meets Oncology (TIMO)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1505 Quandt-SECURE.pdf
Role of the Calcium Binding GPRC6a Receptor in Chemotherapy Mediated Immunogenic Cell Death Induced Tumor Control
rer. Nat Dagmar Quandt, PhD - AKTuI - Arbeitskreis Tumorimmunologie (German Cancer Immunology group in the German Immunology Society) with Tumor Immunology Meets Oncology (TIMO)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=f363afeb0d864211a482c486bec948811d
Role of Melanoma Exosomes in Pro-Tumor Conversion of Immune Cells
Chiara Camisaschi, PhD - Cancer Drug Development Forum (CDDF)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1535 Camisaschi-SECURE.pdf
T Cell Exhaustion in Leukemia relapse Post Allogeneic Stem Cell Transplantation
Hong Zheng, MD, PhD - Chinese American Hematologist and Oncologist Network (CAHON)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1555 Zheng-SECURE.pdf
T Cell Exhaustion in Leukemia relapse Post Allogeneic Stem Cell Transplantation
Hong Zheng, MD, PhD - Chinese American Hematologist and Oncologist Network (CAHON)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=2157eb515d0f496882bfd85a00ca5f641d
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Amir A. Al-Khami, PhD - Tumor Vaccine and Cell Therapy Working Group (TVACT)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1635 Al-Khami-SECURE.pdf
Dynamic Changes of CD127 Expressing CD8+ Effector Memory and Terminal Effector Subsets in Head and Neck Squamous Cell Carcinoma
Hsiang-Fong Kao, MD - The Chinese Oncology Society (COS)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1740 Kao-SECURE.pdf
Dynamic Changes of CD127 Expressing CD8+ Effector Memory and Terminal Effector Subsets in Head and Neck Squamous Cell Carcinoma
Hsiang-Fong Kao, MD - The Chinese Oncology Society (COS)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=cf5076dc6eda4b46a16af2381431b5a61d
The Predictive Value of Centre Tumour CD8+ T Cells in Patients with Hepatocellular Carcinoma: Comparison with Immunoscore
Cheng Sun, MD, PhD - Committee for Tumor Immunology and Bio-Therapy, Chinese Society of Immunology (TIBIT, CSI)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1800 Sun-SECURE.pdf
The Predictive Value of Centre Tumour CD8+ T Cells in Patients with Hepatocellular Carcinoma: Comparison with Immunoscore
Cheng Sun, MD, PhD - Committee for Tumor Immunology and Bio-Therapy, Chinese Society of Immunology (TIBIT, CSI)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=2f2a91cd690542b79cbb74e7d43c582a1d
Relationship between the Peripheral Immune Profile and Tumour Antigen T Cell Responses in Breast Cancer Patients
Christopher Shipp, PhD - Progress in Vaccination against Cancer (PIVAC)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1820 Shipp-SECURE.pdf
Relationship between the Peripheral Immune Profile and Tumour Antigen T Cell Responses in Breast Cancer Patients
Christopher Shipp, PhD - Progress in Vaccination against Cancer (PIVAC)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=2d2ce56aba664a02a7a505b82ebc7f621d
Immunoscore/Immunoprofiling in Melanoma
Gabriele Madonna, PhD - Società
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1840 Madonna-SECURE.pdf
Immunoscore/Immunoprofiling in Melanoma
Gabriele Madonna, PhD - Società
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=2b2a7c6fe8cc497eb9e7b6ef42830a571d
Chimeric Antigen Receptor T Cells for Hematological Tumors: Beyond CART-19
Marco Ruella, MD - The Society for Immunotherapy of Cancer
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=fa32004b28054c609dfaaf13dffc5dcb1d
Prognostic Significance of Peripheral Blood Cell Counts in Melanoma Patients
Chiara Martinoli, PhD – European Institute of Oncology
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=1950 Martinoli-SECURES.pdf
Ipilimumab Treatment Results in CD4 T Cell Activation that is Concomitant with a Reduction in Tregs and MDSCs
Yago Pico de Coana, PhD - Scandinavian Network for Immunotherapy of Cancer (SNIC)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=2010 Pico de Coana-SECURE.pdf
Ipilimumab Treatment Results in CD4 T Cell Activation that is Concomitant with a Reduction in Tregs and MDSCs
Yago Pico de Coana, PhD - Scandinavian Network for Immunotherapy of Cancer (SNIC)
www.sitcancer.org/meetings/am15wic/presentations/index.php?filename=bc94dc31cb654a5185b6b8ff73e0d5841d

2015 Patient Forum

What is Immunotherapy & Its Mechanisms of Action
James Gulley, MD, PhD - National Cancer Institute
www.sitcancer.org/UserFiles/pf15presentations/810 Gulley-B.pdf
What is Immunotherapy & Its Mechanisms of Action
James Gulley, MD, PhD - National Cancer Institute
www.sitcancer.orghttps://vimeo.com/nsci/review/147615566/cc1b94e96b
Current Role of Immunotherapy
Michael Atkins, MD - Georgetown-Lombardi Comprehensive Cancer Center
www.sitcancer.org/UserFiles/pf15presentations/840 Atkins-B.pdf
Current Role of Immunotherapy
Michael Atkins, MD - Georgetown-Lombardi Comprehensive Cancer Center
www.sitcancer.orghttps://vimeo.com/nsci/review/147615541/e692c8b606
Managing Immunotherapy Side Effects
Evan J. Lipson, MD - John Hopkins University
www.sitcancer.org/UserFiles/pf15presentations/905 Lipson-B.pdf
Managing Immunotherapy Side Effects
Evan J. Lipson, MD - John Hopkins University
www.sitcancer.orghttps://vimeo.com/nsci/review/147615496/a88e316d70
Biomarkers and Patient Selection
Julie Brahmer, MD - John Hopkins University
www.sitcancer.org/UserFiles/pf15presentations/1135 Brahmer-B.pdf
New Approaches to Immunotherapy
Craig L. Slingluff, MD - University of Virginia
www.sitcancer.org/UserFiles/pf15presentations/1215 Slingluff-B.pdf
New Approaches to Immunotherapy
Craig L. Slingluff, MD - University of Virginia
www.sitcancer.orghttps://vimeo.com/nsci/review/146955067/a7a02b0aff
The Patient Perspective
Terrie Schmith
www.sitcancer.orghttps://vimeo.com/nsci/review/147615441/02d741c3ec
Lung
Julie Brahmer, MD - John Hopkins University
www.sitcancer.orghttps://vimeo.com/nsci/review/147603828/f38d96a27a
Genitourinary
James Gulley, MD, PhD - National Cancer Institute
www.sitcancer.orghttps://vimeo.com/nsci/review/147615415/e8d851533a

2015 Biomarkers

Science of Biomarkers
Daniel S. Chen, MD, PhD - Genentech 
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=0935 Chen-SECURE.pdf
Science of Biomarkers
Daniel S. Chen, MD, PhD - Genentech 
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=8faa820b8cd4441482b036e1dae9b0e01d
Biomarkers for Cancer Immunotherapy Debate
Pro: Daniel S. Chen, MD, PhD - Genentech
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=0945 Averbuch-SECURE.pdf
Biomarkers for Cancer Immunotherapy Debate
Pro: Daniel S. Chen, MD, PhD - Genentech
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=afdea133f10b4c14826a55197fa768091d
Panel Discussion with Open Audience Questions
Steve Averbuch, MD - Bristol-Myers Squibb
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=a71ae2d0a8bc4b26acb2b34419b231311d
Other Topics in Biomarkers Discussion
Blood-Based:  Michael D. Kalos, PhD - Eli Lilly and Company
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=1105 Kalos-SECURE.pdf
Future Biomarkers Panel Discussion
Naiyer Rizvi, MD - Columbia University Medical Center
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=14cc9042f32643648634fd28ea39fb151d
Future Biomarkers Panel Discussion
Naiyer Rizvi, MD - Columbia University Medical Center
www.sitcancer.org/meetings/bmws16/presentations/index.php?filename=1105 Rizvi-SECURE.pdf

2015 BRECIS

QNRF funding in medical research
Thenaa Said - Program Manager, Biomedical and Health Sciences, Qatar National Research Fund, Qatar
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 0945 Said-SECURE.pdf
Expression profiling of inflammatory breast cancer
Francois Bertucci
- Professor, Institut Paoli-Calmettes, Université de la Méditerranée, France
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 1050 Bertucci - REVISED-SECURE.pdf
Dendritic cells and breast cancer
Karolina Palucka - Professor and associate director of cancer immunology, The Jackson Laboratory, USA
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 1140 Palucka-SECURE.pdf
Foxp3 expression in breast cancer patient from Qatar: Survival analysis
Mahmoud Mohamed - Weill Cornell Medical College-Qatar, Qatar
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 1310 Mohamed APPROVED-SECURE.pdf
Clinico-pathological and transcriptomic determinants of SLFN11 expression in invasive breast carcinoma
Gabriele Zoppoli - Department of Internal Medicine (DiMI), University of Genova, Italy
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 1337 Zoppoli - REVISED-SECURE.pdf
The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
Andrea Aloia - Institute for Molecular Health Sciences, ETH Zurich, Switzerland /Miltenyi Biotec GmbH, Germany
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 1340 Aloia-SECURE.pdf
Prognostic and predictive role of tumour-infiltrating lymphocytes in breast cancer
Carsten Denkert - Head, Translational Cancer Research Group at the Institute of Pathology, Charite University, Germany
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 1405 Denkert APPROVED-SECURE.pdf
Breast cancer immune-subtypes and prognostic implications
Lance Miller - Core Director, Comprehensive Cancer Center, Wake Forest School of Medicine, USA
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Mon - 1550 Miller - REVISED-SECURE.pdf
Generating immunity to breast cancer
Nora Disis - Professor, Department of Medicine, University of Washington, USA
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 0835 Disis - REVISED-SECURE.pdf
The PD-1 pathway: A therapeutic target in breast cancer
Leisha Emens - Associate Professor of Oncology, John Hopkins Medicine, USA
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 0900 Emens APPROVED-SECURE.pdf
Clinical development of HER2-derived peptide vaccines
Elizabeth Mittendorf - Associate Professor, Department of Surgical OncologyThe University of Texas MD Anderson Cancer Center, USA
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 0925 Mittendorf-SECURE.pdf
Immuno-Oncology clinical studies: The model of breast cancer
Giuseppe Curigliano - Co-Chair of the Division of Medical Oncology, European Institute of Oncology, Italy
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 0950 Curigliano - REVISED-SECURE.pdf
Innate immunotherapy to enhance the efficacy of tumor targeting antibodies including trastruzumab for HER2+ breast cancer
Holbrook Kohrt - Assistant Professor, Stanford School of Medicine, USA
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 1055 Kohrt - REVISED-SECURE.pdf
Adoptive T-cell transfer in breast cancer patients - experiences from a phase 1/2 trial
Florian Schuetz - Deputy Director, Women´s Hospital, Heidelberg University, Germany
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 1100 Schuetz-SECURE.pdf
CTLA-4 checkpoint blockade in breast cancer: A case in point report
Chiara Dellepiane - IRCCS San Martino Institute, Genoa University, Italy
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 1125 Dellepiane-SECURE.pdf
Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
David Page - Memorial Sloan Kettering Cancer Center, USA
www.sitcancer.org/meetings/aci15sidra/presentations/index.php?filename=Tue - 1140 Page-SECURE.pdf

2014 ACI

Chicago, IL

The Basics of the Immune System: Our Friends and Foes
Mary L. Disis, MD, FACP - of Washington
www.sitcancer.org/meetings/aci14il/presentations/index.php?filename=1 - Disis.pdf
T-Cells: How do they Work and How Can We Use Them to Combat Cancer?
Jeffrey S. Weber, MD, PhD - Cancer Center
www.sitcancer.org/meetings/aci14il/presentations/index.php?filename=2 - Weber.pdf
B-Cells: How do they Work and How Can We Use Them to Combat Cancer?
Edmund K. Waller, MD, PhD, FACP - University
www.sitcancer.org/meetings/aci14il/presentations/index.php?filename=3 - Waller edited.pdf
What is Innate Immunity and How Does It Work to Combat Cancer?
Justin P. Kline, MD - University of Chicago
www.sitcancer.org/meetings/aci14il/presentations/index.php?filename=4 - Kline.pdf
Is There a Role for Combining Chemotherapy and Immunotherapy?
Leisha A. Emens, MD, PhD - Hopkins University
www.sitcancer.org/meetings/aci14il/presentations/index.php?filename=5 - Emens edited.pdf
Is There a Role for Combining Radiation Therapy and Immunotherapy?
Sandra Demaria, MD - University
www.sitcancer.org/meetings/aci14il/presentations/index.php?filename=6 - Demaria.pdf
Combination Immunotherapy: Can 1 + 1 Equal 4?
Howard L. Kaufman, MD, FACS - Rutgers Cancer Institute of New Jersey
www.sitcancer.org/meetings/aci14il/presentations/index.php?filename=7 - Kaufman.pdf

La Jolla, CA

Inflammation and Tumor Development
Gregory A. Daniels, MD, PhD - University of California San Diego Cancer Center
www.sitcancer.orghttp://www.sitcancer.org/meetings/aci14ca/presentations/index.php?filename=0850%20Daniels%203.pdf
Immune Changes Associated with Tumor Growth and Regression
Jack D. Bui, MD, PhD - University of California, San Diego
www.sitcancer.orghttp://www.sitcancer.org/meetings/aci14ca/presentations/index.php?filename=0920%20Bui%203.pdf
Oncolytic Virus Therapy in Cancer Immunotherapy
Robert Hans Ingemar Andtbacka, MD, CM, FACS, FRCSC - University of Utah
www.sitcancer.orghttp://www.sitcancer.org/meetings/aci14ca/presentations/index.php?filename=1105%20Andtbacka%203.pdf
Cell Therapy
Mark Faries, MD - The John Wayne Cancer Institute
www.sitcancer.orghttp://www.sitcancer.org/meetings/aci14ca/presentations/index.php?filename=1135%20Faries%203.pdf
Combination Therapy
Bartosz Chmielowski, MD, PhD - University of California, Los Angeles
www.sitcancer.orghttp://www.sitcancer.org/meetings/aci14ca/presentations/index.php?filename=1320%20Chmielowski%203.pdf
Radiation and Immune Therapy
Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.orghttp://www.sitcancer.org/meetings/aci14ca/presentations/index.php?filename=1350%20CURTI%203.pdf
Biomarkers: How to Select the Correct Patient for Which Therapy
Gregory A. Daniels, MD, PhD - University of California San Diego Cancer Center
www.sitcancer.orghttp://www.sitcancer.org/meetings/aci14ca/presentations/index.php?filename=1420%20Daniels%203.pdf

Portland, OR

Immunology 101
Amy E. Moran, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=0810 Moran-v2.pdf
Regulation of the Immune Response
Michael J. Gough, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=0905 Gough-v2.pdf
Principles of Immunotherapy
Bernard A. Fox, PhD - Earle A. Chiles Research Institute / Providence Cancer Center
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=0935 Fox-v2.pdf
CTLA-4 Blockade: Indications and Clinical Management
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=1035 Urba-v2.pdf
Blockade of the PD-1/PDL-1 Axis Inhibition
Omid Hamid, MD - The Angeles Clinic and Research Institute
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=1105 Hamid-v2.pdf
Combinations and Other Immune Checkpoint Inhibitors/Agonists
Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=1135 Curti Combination-v2.pdf
Radiation and Immunotherapy
Marka R. Crittenden, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=1205 Crittenden-v2.pdf
Cytokines (IL-2 and IFN) Indications and Clinical Management
Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=1330 Curti IL-2-v2.pdf
Adoptive T Cell Therapy with Variations
Mark Faries, MD - The John Wayne Cancer Institute
www.sitcancer.org/meetings/aci14or/presentations/index.php?filename=1400 Faries-v2.pdf

Charlotte, NC

Antigen Presentation
John H. Stewart IV, MD, MBA, FACS - Wake Forest University School of Medicine
www.sitcancer.org/meetings/aci14nc/presentations/index.php?filename=0840 Stewart approved v2.pdf
Modulation of the Immune Response
Brent A. Hanks, MD, PhD - Duke University Medical Center
www.sitcancer.org/meetings/aci14nc/presentations/index.php?filename=0910 Hanks v2.pdf
CTLA-4 Blockade: Indications and Clinical Management
Asim Amin, MD, PhD - Levine Cancer Institute Carolinas Medical Center
www.sitcancer.org/meetings/aci14nc/presentations/index.php?filename=1035 Amin v2.pdf
PD-1 Inhibition
John D. Powderly II, MD, CPI - Carolina BioOncology Institute, PLLC
www.sitcancer.org/meetings/aci14nc/presentations/index.php?filename=1115 Powderly approved v2.pdf
Cytokines (IL-2 and IFN) Indications and Clinical Management
Richard L. White, Jr., MD, FACS - Levine Cancer Institute / Carolinas Medical Center
www.sitcancer.org/meetings/aci14nc/presentations/index.php?filename=1300 White v2.pdf
Vaccines
Michael A. Morse, MD, MHS - Duke University Medical Center
www.sitcancer.org/meetings/aci14nc/presentations/index.php?filename=1400 Morse revised v2.pdf

Tampa, FL

Immunology 101 for the Non-Immunologist
Shari A. Pilon-Thomas, PhD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci14fl/presentations/index.php?filename=0810 PilonThomas revised-v2.pdf
Dual Role of the Immune System in Protection and Pathogenesis
Keith L. Knutson, PhD - Vaccine & Gene Therapy Institute of Florida
www.sitcancer.org/meetings/aci14fl/presentations/index.php?filename=0835 Knutson-v2.pdf
Immune Escape – Targeting Immune Suppression as a Therapeutic Option
Sergei Kusmartsev, PhD - University of Florida
www.sitcancer.org/meetings/aci14fl/presentations/index.php?filename=0900 Kusmartsev approved-v2.pdf
Adjuvant Immunotherapy for High-Risk Melanoma:  Where Have We Been and Where Are We Going?
Vernon K. Sondak, MD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci14fl/presentations/index.php?filename=0940 Sondak-v2.pdf
Combination Immunotherapies for Metastatic Melanoma:  What Agents and When?
Geoffrey T. Gibney, MD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci14fl/presentations/index.php?filename=1055 Gibney-v2.pdf
Adoptive T Cell Immunotherapy for Metastatic Melanoma
Amod A. Sarnaik, MD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci14fl/presentations/index.php?filename=1120 Sarnaik-v2.pdf

2014 Early Career Scientist and Young Investigator Professional Development

Keynote: Preparing for Transition
Linda L. Werling, PhD - The George Washington University Medical Center
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1225 Werling revised v2.pdf
Implementing Your Academic Mission
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1305 BUTTERFIELD v2.pdf
Obtaining a Faculty Position and Planning for Tenure
Anil Shanker, PhD - Meharry Medical College/Vanderbilt-Ingram Cancer Center
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1320 Shanker v2.pdf
Keys to a Successful Career in Industry: Building on Early Career Achievements
Leisha A. Emens, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1345 Emens revised v2.pdf
Keys to a Successful Career in Industry: Establishing Yourself and Advancing within the Company
Christian H. Poehlein, MD - Bayer Healthcare Oncology
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1400 Poehlein revised v2.pdf
Navigating a Career in Government: Obtaining Tenure and Beyond
Daniel W. McVicar, PhD - National Institutes of Health/National Cancer Institute
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1425 McVicar revised v2.pdf
Navigating a Career in Government: Obtaining a Position and Preparing for Tenure
Luca Gattinoni, MD - National Cancer Institute
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1440 Gattinoni revised v2.pdf
The SITC-EMD Serono Cancer Immunotherapy Clinical Fellowship Experience
Marco Ruella, MD - University of Pennsylvania
www.sitcancer.org/meetings/pds14/presentations/index.php?filename=1505 Ruella revised v2.pdf

2014 Sidra Symposium

Role of Inflammation in Cancer
Giorgio Trinchieri, MD - National Cancer Institute, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 0805 Trinchieri revised.pdf
Dendritic Cell and Adenovirus-based Cancer Vaccines
Lisa H. Butterfield, PhD - University of Pittsburgh Cancer Institute, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 900 Butterfield.pdf
Cancer Immunotherapies Based on the Immunobiology of the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1000 Gajewski.pdf
Radiation and Immunotherapy
Sandra Demaria, MD - New York University School of Medicine, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1045 Demaria.pdf
Highlights of the Society for Immunotherapy of Cancer Annual Meeting
Lisa H. Butterfield, PhD - University of Pittsburgh Cancer Institute, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1130 Butterfield SITC AM.pdf
Combination Therapies
Paolo Antonio Ascierto, MD - Nazionale Tumori-Fondazione 'G. Pascale', Italy
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1510 Ascierto.pdf
Combination Therapies
Samir N. Khleif, MD - Georgia Regents University Cancer Center, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1510 Ascierto.pdf
WT1 Peptide Analogue WT1-126Y Enhances Leukemia Lysis
Ghofran Alqudaihi, PhD - King Faisal Specialist Hospital and Research Center, KSA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1625 Ghofran revised.pdf
Small G-protein Rnd3/RhoE is Expressed in Brain Cancer and Affects Glioma Morphology, Motility and Invasion
Abdelhamid Liacini, PhD - King Fahad Specialist Hospital Dammam, KSA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1655 Liacini.pdf
Therapy by Resuscitating Notch Immune Surveillance
Anil Shanker, PhD - Meharry Medical College/Vanderbilt-Ingram Comprehensive Cancer Center, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1655 Liacini.pdf
Highlights of the Workshop on Personalized Cancer Immunotherapy
Willem W. Overwijk, PhD - MD Anderson Cancer Center, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 0805 Overwijk.pdf
Scientific and Regulatory Challenges in the Evaluation of Cancer Vaccines and Immunotherapy Products and How to Overcome Them
Raj K. Puri, MD, PhD - U.S. Food and Drug Administration, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 0920 Puri.pdf
Immunomodulation in Cancer with Special Reference to Regulatory T Cells
Said Dermime, PhD - King Fahad Specialist Hospital Dammam, KSA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 1105 Dermime.pdf
Quality Controls and Immunoscore Update from France
Franck Pages, MD, PhD - HEGP Hospital - INSERM, France
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 1455 Pages.pdf
Immunoscore Update from Germany
Arndt Hartmann, MD - University of Erlangen, Germany
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 1525 Hartmann.pdf
Quality Controls and Immunoscore Update from France
Franck Pages, MD, PhD - HEGP Hospital - INSERM, France
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 1455 Pages.pdf
Immunoscore Update from Germany
Arndt Hartmann, MD - University of Erlangen, Germany
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 1525 Hartmann.pdf
Immunoscore Update from Germany
Arndt Hartmann, MD - University of Erlangen, Germany
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 1525 Hartmann.pdf
Immunoscore Update from Switzerland
Viktor H. Kölzer, MD - Institute of Pathology – University of Bern, Switzerland
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-23 1540 Koelzer revised.pdf
Engineered T Cells for Cancer Therapy
Carl H. June, MD - University of Pennsylvania, USA
www.sitcancer.org/meetings/aci14sidra/presentations/index.php?filename=1-22 1315 June revised.pdf

2015 Annual Meeting

Targeting Immune Checkpoints in Cancer Therapy:  New Insights, Opportunities and Prospects for a Cure
James P. Allison, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0750 Allison-SECURE.pdf
Targeting Immune Checkpoints in Cancer Therapy:  New Insights, Opportunities and Prospects for a Cure
James P. Allison, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=aba745e6bd0b4c1aa128a41108f970891d
From Immune Surveillance to Personalized Cancer Vaccines
Robert Schreiber, PhD - Washington University School of Medicine
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0820 Schreiber-SECURE.pdf
From Immune Surveillance to Personalized Cancer Vaccines
Robert Schreiber, PhD - Washington University School of Medicine
www.sitcancer.org/meetings/am15/presentations/index.php?filename=018d0cb914a8424eaaecbbac9c89d8aa1d
Curative Potential of Cell Transfer Therapy for Cancer
Steven A. Rosenberg, MD, PhD - National Cancer Institute, National Institutes of Health
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0920 Rosenberg-SECURE.pdf
Curative Potential of Cell Transfer Therapy for Cancer
Steven A. Rosenberg, MD, PhD - National Cancer Institute, National Institutes of Health
www.sitcancer.org/meetings/am15/presentations/index.php?filename=93d12162509e4d62a23d3941582e80001d
Building Curative Anti-tumor T cells
Nicholas P. Restifo, MD - National Cancer Institute
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1020 Restifo-SECURE.pdf
Building Curative Anti-tumor T cells
Nicholas P. Restifo, MD - National Cancer Institute
www.sitcancer.org/meetings/am15/presentations/index.php?filename=c1d67b341bdb48e781e5b1f783608d941d
Tissue Resident Memory T Cells
David Masopust, PhD - University of Minnesota
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1040 Masopust-SECURE.pdf
Tissue Resident Memory T Cells
David Masopust, PhD - University of Minnesota
www.sitcancer.org/meetings/am15/presentations/index.php?filename=ab7c6d5f50934441a31a93dbe62d14e51d
T Cell Exhaustion
Rafi Ahmed, PhD - Emory University
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1100 Ahmed Rafi-SECURE.pdf
New Insights into CD8 Function and Regulation
Pamela S. Ohashi, PhD - Princess Margaret Cancer Centre
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1120 Ohashi-SECURE.pdf
Preliminary Results from a PhaseI/II Study of Epacadostat (incb024360) in Combination with Pembrolizumab in Patients with Selected Advanced Cancers
Tara C. Gangadhar, MD - Abramson Cancer Center of the University of Pennsylvania
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1200 Gangadhar-SECURE.pdf
Preliminary Results from a PhaseI/II Study of Epacadostat (incb024360) in Combination with Pembrolizumab in Patients with Selected Advanced Cancers
Tara C. Gangadhar, MD - Abramson Cancer Center of the University of Pennsylvania
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1a7eda3118a44d8ab49710b3b1b594d31d
The PTEN Pathway in Tregs Fuctions as a Critical Driver of the Immunosuppressive Tumor Microenvironment and Tolerance to Apoptotic Cells
David H. Munn, MD - Georgia Regents University Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1215 Munn-SECURE.pdf
The PTEN Pathway in Tregs Fuctions as a Critical Driver of the Immunosuppressive Tumor Microenvironment and Tolerance to Apoptotic Cells
David H. Munn, MD - Georgia Regents University Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=043d8ecde40d4decae74f8f6485cdfc81d
Tumor Response from Durvalumab (MED14736) + Tremelimumab Treatment in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) is Observed Regardless of PD-L1 Status
Naiyer A. Rizvi, MD - Columbia University Medical Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1230 Rizvi Naiyer-scaled-SECURE.pdf
Tumor Response from Durvalumab (MED14736) + Tremelimumab Treatment in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) is Observed Regardless of PD-L1 Status
Naiyer A. Rizvi, MD - Columbia University Medical Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=2e9bf4875cae48028a887f338a00de221d
Smalley Keynote Presentation
Tasuku Honjo, MD, PhD - Deparment of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1405 Honjo-SECURE.pdf
Smalley Keynote Presentation
Tasuku Honjo, MD, PhD - Deparment of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University
www.sitcancer.org/meetings/am15/presentations/index.php?filename=4e1cd85b1c2143ae90428157c6794cea1d
Durable Complete Response in a Patient with Metastatic Melanoma Following Adoptive Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Todd Prickett, PhDNational Cancer Institute/National Institutes of Health
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1535 Pricket-SECURE.pdf
Durable Complete Response in a Patient with Metastatic Melanoma Following Adoptive Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Todd Prickett, PhDNational Cancer Institute/National Institutes of Health
www.sitcancer.org/meetings/am15/presentations/index.php?filename=90349cf13f5e4633bd764b1013ef2eba1d
A Bispecific Chimeric Antigen Receptor Molecule Enhances T Cell Activation Through Dual Immunological Synapse Formation and Offsets Antigen Escape in Glioblastoma
Nabil Ahmed, MD - Baylor College of Medicine
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1550 Ahmed-SECURE.pdf
A Bispecific Chimeric Antigen Receptor Molecule Enhances T Cell Activation Through Dual Immunological Synapse Formation and Offsets Antigen Escape in Glioblastoma
Nabil Ahmed, MD - Baylor College of Medicine
www.sitcancer.org/meetings/am15/presentations/index.php?filename=aceb0cbe82994686a1fb5afd2c0410891d
Understanding the CD8T Cell Response to Melanoma Using Transnuclear Mouse Models
Stephanie Dougan, PhD - Dana-Farber Cancer Institute
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1725 Dougan-SECURE.pdf
Understanding the CD8T Cell Response to Melanoma Using Transnuclear Mouse Models
Stephanie Dougan, PhD - Dana-Farber Cancer Institute
www.sitcancer.org/meetings/am15/presentations/index.php?filename=5dee1712741b42cbba1df216a7ee8bf41d
From Immunogenetic Polymorphism to Functional Antitumor Lymphocyte Mitochondrial Dynamics
Anil Shanker, PhD - Meharry Medical College School of Medicine/Vanderbilt-Ingram Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1755 Shanker-SECURE.pdf
Radiotherapy as Adjuvant to Immunotherapy: Clincal Translation
Silvia Formenti, MD - New York Presbyterian/Weill Cornell Medical Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1735 Formenti-SECURE.pdf
Radiotherapy as Adjuvant to Immunotherapy: Clincal Translation
Silvia Formenti, MD - New York Presbyterian/Weill Cornell Medical Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=392e1b122aef467a9b6d8b08ab43b2be1d
Autologous HER2 CMV Bispecific CAR T Cells are Safe and Demonstrate Clincal Benefit for Glioblastoma in a Phase I Trial
Nabil Ahmed, MD - Baylor College of Medicine
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1755 Ahmed-SECURE.pdf
Autologous HER2 CMV Bispecific CAR T Cells are Safe and Demonstrate Clincal Benefit for Glioblastoma in a Phase I Trial
Nabil Ahmed, MD - Baylor College of Medicine
www.sitcancer.org/meetings/am15/presentations/index.php?filename=c51d1700491e42f3af2cbd94e68326d21d
Introduction
Andrew D. Weinberg, PhD - Earle A. Chiles Research Institute, Providence Medical Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0835 Weinberg-SECURE.pdf
Combined Coinhibition in the Clinic
Jedd D. Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0840 Wolchok-SECURE.pdf
Combined Coinhibition in the Clinic
Jedd D. Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0840 Wolchok-SECURE.pdf
Combined Coinhibition in the Clinic
Jedd D. Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=07003d1f2cdd46bc8910452fd8104d731d
Preclinical/Costimulation within Tumor Immunotherapy
Isabelle Le Mercier, PhD – Geisel School of Medicine at Dartmouth
www.sitcancer.org/meetings/am15/presentations/index.php?filename=c1e13671a3414a32be545899c3a23c0e1d
OX40 Agonist Agents in Pre-clinical Models
Daniel Hirschhorn-Cymerman, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0930 Hirschhorn-SECURE.pdf
OX40 Agonist Agents in Pre-clinical Models
Daniel Hirschhorn-Cymerman, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=90d69ead512e429b9299cc318348e8961d
PD-1 Blockade Upregulate Tim-3 Expression as a Compensatory Regulation of Immune Check Point Receptors in HNSCC TIL
Gulidana Shayan - University of Pittsburgh
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1005 Shayan-SECURE.pdf
Understanding Responses to Therapy: the Tissue is the Issue
Jennifer A. Wargo, MD, MMSc - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=8e4e810098f6461ab3967dc4a935bdfd1d
Interim Results of an Ongoing Phase I, Dose Escalation Study of MGA271 (Fc-Optimized Humanized Anti-B7-H3 Monoclonal Antibody) in Patients with Refractory B7-H-3-Expressing Neoplasms or Neoplasms whose Vasculature Expresses B7-H3
John D. Powderly II, MD, CD1 - Carolina BioOncology Institute, PLLC
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1200 Powderly-SECURE.pdf
Interim Results of an Ongoing Phase I, Dose Escalation Study of MGA271 (Fc-Optimized Humanized Anti-B7-H3 Monoclonal Antibody) in Patients with Refractory B7-H-3-Expressing Neoplasms or Neoplasms whose Vasculature Expresses B7-H3
John D. Powderly II, MD, CD1 - Carolina BioOncology Institute, PLLC
www.sitcancer.org/meetings/am15/presentations/index.php?filename=2a07ba80b81a40378a4b0e22faeab8b61d
Efficacy of Anti-ICOS Agonist Monoclonal Antibodies in Preclinical Tumor Models Provides a Rationale for Clinical Development as Cancer Immunotherapeutics
Michael J. Briskin, PhD - Jounce Therapeutics
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1230 Briskin-SECURE.pdf
Inhibition of the T-Cell Oxygen Sensing Machinery Promotes Anti-Tumor Efficacy
David Clever - National Cancer Institute/National Institute of Health – Surgery Branch
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1405 Clever-SECURE.pdf
Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Despite High PD-1 Expression
Dan Erkes - Thomas Jefferson University
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1435 Erkes Dan-SECURE.pdf
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Amir Al-Khami, PhD - Louisiana State University Health Sciences Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1450 Al-Khami-SECURE.pdf
SITC Biomarkers Task Force Update
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1520 Butterfield-SECURE.pdf
SITC Biomarkers Task Force Update
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am15/presentations/index.php?filename=956c8fa1867041e7a12a0b03865752341d
Introduction
Holden T. Maecker, PhD - Stanford Univeristy 
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1605 Maecker-SECURE.pdf
Pre-existing Immunity and Treatment Outcome with Anti-PD1 Therapy in Melanoma
Paul Tumeh, MD - University of California Los Angeles
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1610 Tumeh-SECURE.pdf
Pre-existing Immunity and Treatment Outcome with Anti-PD1 Therapy in Melanoma
Paul Tumeh, MD - University of California Los Angeles
www.sitcancer.org/meetings/am15/presentations/index.php?filename=8f58a69eda1f48b2a292fd0b29e19d6b1d
PD-1 Blockade in Mismatch Repair Deficient Tumors
Luis A. Diaz, MD - Johns Hopkins Sidney Kimmel Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1655 Diaz-SECURE.pdf
PD-1 Blockade in Mismatch Repair Deficient Tumors
Luis A. Diaz, MD - Johns Hopkins Sidney Kimmel Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=04d46a97a89f494abefe8e48558270011d
PTX3 as an Extrinsic Oncosuppressor Regulating Complement and Macrophage Driven Inflammation
Mantovani Alberto, MD - Humanitas University
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1610 Mantovani-SECURE.pdf
PTX3 as an Extrinsic Oncosuppressor Regulating Complement and Macrophage Driven Inflammation
Mantovani Alberto, MD - Humanitas University
www.sitcancer.org/meetings/am15/presentations/index.php?filename=9f60350700b64e00bc2c329dfd03e5131d
Chimeric Endocrine Receptor-Expressing T cells Influenced by the Microbiodata Delay Ovarian Cancer Progression by Boosting Pre-Existing Anti-Tumor Immunity
Jose R. Conejo-Garcia, MD, PhD - The Wistar Institute
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1635 Conejo-SECURE.pdf
Chimeric Endocrine Receptor-Expressing T cells Influenced by the Microbiodata Delay Ovarian Cancer Progression by Boosting Pre-Existing Anti-Tumor Immunity
Jose R. Conejo-Garcia, MD, PhD - The Wistar Institute
www.sitcancer.org/meetings/am15/presentations/index.php?filename=a107fc7f655f48038e3b7ae7d7ffa5a41d
Local Immunotherapy with ONCOS-102 Shapes Harmful Tumor Associated CD68+ Macrophages to Become Beneficial Cells that Correlate with Increased Overall Survival
Dmitriy Zamarin, MD, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1715 Zamarin-SECURE.pdf
Local Immunotherapy with ONCOS-102 Shapes Harmful Tumor Associated CD68+ Macrophages to Become Beneficial Cells that Correlate with Increased Overall Survival
Dmitriy Zamarin, MD, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15/presentations/index.php?filename=d124f6a69f864cc98b80e1dd354a44b11d
Perspective Biomarkers
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0750 Butterfield-SECURE.pdf
Perspective Biomarkers
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am15/presentations/index.php?filename=106d75f48e974029b7b8a6d692c719db1d
Value: "Real World" Points
William McGivney, PhD -
www.sitcancer.org/meetings/am15/presentations/index.php?filename=2d2659cb1c324d6da1fdb8d7abd588691d
Perspective: Analytics/Immunotherapy
Kimberly A Shafer-Weaver, PhD – AstraZeneca
www.sitcancer.org/meetings/am15/presentations/index.php?filename=6282c09c336c402f83b9818ad8c4386f1d
Perspective: Industry
Kevin Trapp - Bristol-Myers Squibb
www.sitcancer.org/meetings/am15/presentations/index.php?filename=1f5d9e14bb70464881d3c90536f5ad6b1d
Perspective: Patient Support
Gwen Darien - Cancer Support Community
www.sitcancer.org/meetings/am15/presentations/index.php?filename=0825 Darien-SECURE.pdf
Perspective: Patient Support
Gwen Darien - Cancer Support Community
www.sitcancer.org/meetings/am15/presentations/index.php?filename=f98d9ccf76cc48fc9295a89e345174041d

2014 Annual Meeting

Presidential Welcome
Francesco M. Marincola, MD - Sidra Medical and Research Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0800 Marincola-v3.pdf
Presidential Welcome
Francesco M. Marincola, MD - Sidra Medical and Research Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=e048fe9fdd554b2886f90e4a2c62e64b1d
Update Session: U.S. Food and Drug Administration
Raj K. Puri, MD, PhD - U.S. Food and Drug Administration
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0805 Puri-v2.pdf
Update Session: National Cancer Institute
William D. Merritt, PhD - National Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0820 Merritt revised-v2.pdf
Introduction
Francesco M. Marincola, MD - Sidra Medical and Research Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=694cd92f05a348cba4f263210d38c6001d
Cancer as a Disease of the Metaorganism
Giorgio Trinchieri, MD - National Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0840 Trinchieri revised-v2.pdf
Session Overview
William J. Murphy, PhD - University of California-Davis
www.sitcancer.org/meetings/am14/presentations/index.php?filename=424158dbe96c46eba8da52f38ffa519c1d
Natural Killer Cell Subsets in Immune Regulation and Tumor Immunity
William J. Murphy, PhD - University of California-Davis
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0930 Murphy-v2.pdf
Natural Killer Cell Subsets in Immune Regulation and Tumor Immunity
William J. Murphy, PhD - University of California-Davis
www.sitcancer.org/meetings/am14/presentations/index.php?filename=aecb4168c73f43d9ae0f92c5e67ad91a1d
Natural Killer Cells and Innate Lymphoid Cells in Inflammation and Cancer
Marco Colonna, MD - Washington University
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0955 Colonna-v2.pdf
Natural Killer Cells and Innate Lymphoid Cells in Inflammation and Cancer
Marco Colonna, MD - Washington University
www.sitcancer.org/meetings/am14/presentations/index.php?filename=b3c1c1b2ecc046b781e464d83ba6eb2e1d
The Role of the Intestinal Microbiome on GVHD
Marcel R.M. van den Brink, MD, PhD - Memorial Sloan-Kettering
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1110 van den Brink-v2.pdf
TCR Repertoire Divergence Reflects Microenvironmental Immune Phenotypes in Glioma
Jennifer Sims, PhD - Columbia University
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1200 Sims-v2.pdf
Personalized Immunotherapy for Non-Small Cell Lung Cancer
Roy S. Herbst, MD, PhD - Yale Cancer Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1430 Herbst-v2.pdf
Personalized Immunotherapy for Non-Small Cell Lung Cancer
Roy S. Herbst, MD, PhD - Yale Cancer Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=d22d1523a8294ae891b5ffc9cdbc68bb1d
TG4010 Immunotherapy Combined with First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase IIb Results of the TIME Study
John Nemunaitis, MD - Mary Crowley Medical Research Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1455 Nemunaitis-v2.pdf
TG4010 Immunotherapy Combined with First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase IIb Results of the TIME Study
John Nemunaitis, MD - Mary Crowley Medical Research Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=a0ccb8df39c24a8e8fb5f2a7053d79e91d
PD-1 Immune Checkpoint Blockade: Patient Characteristics and Biomarkers Associated with Response
Julie R. Brahmer, MD - Sidney Kimmel Comprehensive Cancer
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1550 Brahmer-v2.pdf
PD-1 Immune Checkpoint Blockade: Patient Characteristics and Biomarkers Associated with Response
Julie R. Brahmer, MD - Sidney Kimmel Comprehensive Cancer
www.sitcancer.org/meetings/am14/presentations/index.php?filename=3fa584f5ce6e462a8379f806601dc4761d
Integrating Immunoregulatory and Vascular Signaling Programs Through Lectin-Glycan Interactions
Gabriel A. Rabinovich, PhD - Instituto de Biología y Medicina
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1710 RABINOVICH revised-v2.pdf
Immune Impact on Cancer Stemness
Weiping Zou, MD, PhD - University of Michigan
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1735 Zou-v2.pdf
Immune Impact on Cancer Stemness
Weiping Zou, MD, PhD - University of Michigan
www.sitcancer.org/meetings/am14/presentations/index.php?filename=01097958acfb4b2381a2236e12ca07291d
FcgRIIIA (CD16)-Expressing Monocytes Mediate the Depletion of Tumor-Infiltrating Tregs Via Ipilimumab-Dependent ADCC in Melanoma Patients
Emanuela Romano, MD, PhD - University Hospital of Lausanne
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1755 Romano-v2.pdf
Session Overview
Susan Knox, MD, PhD - Stanford University
www.sitcancer.org/meetings/am14/presentations/index.php?filename=4ca088d21c634e688e48bc334165f35c1d
Radiotherapy with TGF-β Blockade Jump-Starts Tumor-Specific T Cells and Immune Checkpoint Inhibitors Keep Them Going
Sandra Demaria, MD - New York University
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1715 Demaria revised-v2.pdf
Radiotherapy with TGF-β Blockade Jump-Starts Tumor-Specific T Cells and Immune Checkpoint Inhibitors Keep Them Going
Sandra Demaria, MD - New York University
www.sitcancer.org/meetings/am14/presentations/index.php?filename=c516411d3e4941f39ca81fdb884fca691d
The Anti-Tumor Immune Response Generated by Radiation Therapy May be Limited by Tumor Cell Adaptive Resistance and can be Circumvented by PD-L1 Blockade
Simon Dovedi, PhD, MSc, BSC - University of Manchester
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1740 Dovedi revised-v2.pdf
The Anti-Tumor Immune Response Generated by Radiation Therapy May be Limited by Tumor Cell Adaptive Resistance and can be Circumvented by PD-L1 Blockade
Simon Dovedi, PhD, MSc, BSC - University of Manchester
www.sitcancer.org/meetings/am14/presentations/index.php?filename=97559e84f49f4ce996b7fdc72126145f1d
CD47 Limits Cooperation between Adaptive Tumor Immunity and Radiation Therapy
David D. Roberts, PhD - National Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1755 Roberts-v2.pdf
CD47 Limits Cooperation between Adaptive Tumor Immunity and Radiation Therapy
David D. Roberts, PhD - National Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=b19e9153fcc6473b909932158cf99c6f1d
Welcome and Overview
Kim A. Margolin, MD - Stanford University
www.sitcancer.org/meetings/am14/presentations/index.php?filename=f5d28286f8a94bfe8253d3a7adcd66671d
Update Session: SITC Biomarkers Task Force
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0805 BUTTERFIELD-v2.pdf
Update Session: SITC Biomarkers Task Force
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am14/presentations/index.php?filename=c3dc7856d15444b8973bf5bde914fb6f1d
Session Overview
Daniel E. Speiser, MD - Ludwig Center for Cancer Research of the
www.sitcancer.org/meetings/am14/presentations/index.php?filename=af58cec622474bea8d3416b73fa18e5e1d
Antigen-Specific T Cell Responses to Breast Cancer
Jill E. Slansky, PhD - University of Colorado
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1005 Slansky revised-v2.pdf
Vaccine Targeting HIF1A in Triple Negative Breast Cancer
Mary L. Disis, MD, FACP - University of Washington
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1100 Disis revised-v2.pdf
Vaccine Targeting HIF1A in Triple Negative Breast Cancer
Mary L. Disis, MD, FACP - University of Washington
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0b3d00d6483345d6a2ff98d84b8648561d
Local, Regional, and Systemic Effects of TLR Agonists and IFA as Adjuvants for Peptide Vaccines
Craig L. Slingluff, Jr., MD - University of Virginia
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1115 Slingluff revised-v2.pdf
The Use of Peptides in the Therapeutic Vaccination of Cancer
Hans-Georg Rammensee, PhD - Universitäet Tüebingen
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1135 Rammensee-v2.pdf
The Use of Peptides in the Therapeutic Vaccination of Cancer
Hans-Georg Rammensee, PhD - Universitäet Tüebingen
www.sitcancer.org/meetings/am14/presentations/index.php?filename=096237133445436ea3a9668cb02a0ee31d
Closing Remarks
Daniel E. Speiser, MD - Ludwig Center for Cancer Research of the
www.sitcancer.org/meetings/am14/presentations/index.php?filename=e9b6d6a705364ca58c534409f44c8ab11d
OX40 Agonist Immunotherapy Expands Tumor Reactive CD8 T Cells with a Unique T Cell Receptor Repertoire and Synergizes with PDL1 Blockade to Promote Tumor Regression
Amy E. Moran, PhD - Earle A. Chiles Cancer Research Institute,
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1215 Moran revised-v2.pdf
Introduction
Francesco M. Marincola, MD - Sidra Medical and Research Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=91f121d1664f4b939365e6937b43378e1d
Tumor Derived Stress Triggers C/EBPβ Homologous Protein (CHOP) Expression in Myeloid Derived Suppressor Cells (MDSC) and Mediates Immunosuppressive Activity
Paul Thevenot, PhD - Stanley S. Scott Cancer Center, Louisiana State U
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1405 Thevenot revised-v2.pdf
Immunoscore Update
Bernard A. Fox, PhD - Earle A. Chiles Cancer Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1505 Fox-v2.pdf
Immunoscore Update
Bernard A. Fox, PhD - Earle A. Chiles Cancer Research Institute,
Providence Cancer Center

www.sitcancer.org/meetings/am14/presentations/index.php?filename=3de2cf11a71845319a091b338f956ad21d
Session Overview
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute,
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0e76c1da6c6e44a58edb9490e5aaa1061d
OX40 Immunotherapy in Cancer Patients: Immunological Observations and Implications for T Cell Immunotherapy
Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1605 Curti-v2.pdf
OX40 Immunotherapy in Cancer Patients: Immunological Observations and Implications for T Cell Immunotherapy
Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence
www.sitcancer.org/meetings/am14/presentations/index.php?filename=29148e70a5dd44bab1d9194f3df9e31c1d
CD40 Agonists in Cancer Immunotherapy
Robert H. Vonderheide, MD, DPhil - University of Pennsylvania
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1700 Vonderheide-v2.pdf
CD40 Agonists in Cancer Immunotherapy
Robert H. Vonderheide, MD, DPhil - University of Pennsylvania
www.sitcancer.org/meetings/am14/presentations/index.php?filename=deb4c020c8534e9bbf7fcf8e338cd5c91d
Session Overview
Katherine L. Nathanson, MD - University of Pennsylvania
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1600 Nathanson-v2.pdf
Session Overview
Katherine L. Nathanson, MD - University of Pennsylvania
www.sitcancer.org/meetings/am14/presentations/index.php?filename=968969da28bc42b08ce47ef59e3bf8a71d
Use of High Throughput Sequencing to Identify Mutated Tumor Antigens
Paul F. Robbins, PhD - National Institutes of Health/National Cancer
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1605 Robbins-v2.pdf
Use of High Throughput Sequencing to Identify Mutated Tumor Antigens
Paul F. Robbins, PhD - National Institutes of Health/National Cancer
www.sitcancer.org/meetings/am14/presentations/index.php?filename=bcc3903c2e2a4c68ad48f5c5dfe5ff591d
Single Cell Functional Analysis Provides Insights into Cancer Patient Responses, including the Development of Resistance, to Cell-Based and Combination Immunotherapies
James R. Heath, PhD - California Institute of Technology
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1650 Heath-v2.pdf
Single Cell Functional Analysis Provides Insights into Cancer Patient Responses, including the Development of Resistance, to Cell-Based and Combination Immunotherapies
James R. Heath, PhD - California Institute of Technology
www.sitcancer.org/meetings/am14/presentations/index.php?filename=c134530fc4de42418c638b132764e73e1d
T Cell Receptor Diversity Evaluation to Predict Patient Response to Ipilimumab in Metastatic Melanoma
Michael Postow, MD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=1710 Postow revised-v2.pdf
T Cell Receptor Diversity Evaluation to Predict Patient Response to Ipilimumab in Metastatic Melanoma
Michael Postow, MD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=57aa83035fa24311b797d5a046e0f2751d
Session Overview
Helen E. Heslop, MD - Baylor College of Medicine
www.sitcancer.org/meetings/am14/presentations/index.php?filename=5c5be1dc1ba444ca9399e3ac8cdb18801d
Moving Tumor Infiltrating Lymphocytes and Biomarkers Forward
Patrick Hwu, MD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0805 Hwu-v2.pdf
Moving Tumor Infiltrating Lymphocytes and Biomarkers Forward
Patrick Hwu, MD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=aa17481dda5b4b96bff077bd7bb986db1d
Melanoma Therapy using Adoptive Transfer of Expanded Tumor Infiltrating T cells; Prospects and Pitfalls
Per thor Straten, PhD - Centre for Cancer Immune Therapy (CCIT)
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0830 thor Straten-v2.pdf
Melanoma Therapy using Adoptive Transfer of Expanded Tumor Infiltrating T cells; Prospects and Pitfalls
Per thor Straten, PhD - Centre for Cancer Immune Therapy (CCIT)
www.sitcancer.org/meetings/am14/presentations/index.php?filename=c3850ae1adeb4f2ea8cdbf0f968e32af1d
Toward Cell Transfer Immunotherapy Against Patient-Specific Mutations in Gastrointestinal Cancers
Eric Tran, PhD - National Insitutes of Health/National Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0855 Tran-v2.pdf
Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer
Madhusudhanan Sukumar, PhD - National Cancer Institute
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=0910 Sukumar approved-v2.pdf
Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer
Madhusudhanan Sukumar, PhD - National Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=d45e9a0d9b1e4cd8a7621b017addeea71d
Enhancing the IQ of CAR T Cells
Michael C.V. Jensen, MD - University of Washington
www.sitcancer.org/meetings/am14/presentations/index.php?filename=0925 Jensen approved-v2.pdf
Enhancing the IQ of CAR T Cells
Michael C.V. Jensen, MD - University of Washington
www.sitcancer.org/meetings/am14/presentations/index.php?filename=dc8195f5ff3f490bb030b25f837825ee1d

2015 Workshop

Use of Whole Exome and RNAseq Analysis to Identify Mutated Tumor Neo-Antigens
Elaine Mardis, PhD - The Genome Institute
www.sitcancer.org/meetings/am15ws/presentations/index.php?filename=0805 Mardis-SECURE.pdf
Use of MHC Multimers to Identify Tumor Reactive T Cells
John Haanen, PhD - Netherlands Cancer Institute
www.sitcancer.org/meetings/am15ws/presentations/index.php?filename=1035 Haanen-SECURE.pdf
Identification of Antigens Targeted by Tumor Infiltrating Lymphocytes to Enhance Adoptive Immunotherapy
Eric Tran, PhD - National Institutes of Health/National Institute of Health- Surgery Branch
www.sitcancer.org/meetings/am15ws/presentations/index.php?filename=1105 Tran-SECURE.pdf
Targeting the Mutanome for Individualized Cancer Immunotherapy
Ugur Sahin, MD - University Medical Center of the Johannes Gutenberg University Mainz
www.sitcancer.org/meetings/am15ws/presentations/index.php?filename=1335 Sahin-SECURE.pdf
Antigens Targeted by Checkpoint Blockade
Alexandra Snyder Charen, MD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15ws/presentations/index.php?filename=1405 Charen-SECURE.pdf
Antigens Targeted by Checkpoint Blockade
Alexandra Snyder Charen, MD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15ws/presentations/index.php?filename=879580dc98ab4665bc40ee46cee173581d
Control of Tumor Immunity in Humans
Catherine Wu, MD - Dana-Farber Cancer Institute
www.sitcancer.org/meetings/am15ws/presentations/index.php?filename=1435 WU-SECURE.pdf

2014 Workshop

Immune-Tumor Interactions to Guide Combination Therapies
Antoni Ribas, MD, PhD - University of California Los Angeles
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=0835 Ribas-v2.pdf
Immune-Tumor Interactions to Guide Combination Therapies
Antoni Ribas, MD, PhD - University of California Los Angeles
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=a33232c89a39448cb9d9d07e580044eb1d
PD-L1 IHC in Clinical Decision-Making for Immune Checkpoint Blockade
Suzanne L. Topalian, MD - Johns Hopkins University
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=0855 Topalian revised-v2.pdf
Targeting Tregs in Tumors
Dario A. A. Vignali, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=1300 Vignali revised-v2.pdf
Effects of Immunotherapy on the Tumor Microenvironment
Susan M. Kaech, PhD - Yale University
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=1340 Kaech-v2.pdf
Effects of Immunotherapy on the Tumor Microenvironment
Susan M. Kaech, PhD - Yale University
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=f91c8d9d39a444aaaf440f3484befa721d
Molecular Mechanisms of T Cell Exhaustion
E. John Wherry, PhD - University of Pennsylvania
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=1400 Wherry-v2.pdf
Molecular Mechanisms of T Cell Exhaustion
E. John Wherry, PhD - University of Pennsylvania
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=5963a931d30a4328a0a3ee5f62e989591d
Imprecision Medicine: Combination Immunotherapy
Mario Sznol, MD - Yale University
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=1540 Sznol-v2.pdf
Imprecision Medicine: Combination Immunotherapy
Mario Sznol, MD - Yale University
www.sitcancer.org/meetings/am14ws/presentations/index.php?filename=f6660a06f9b94a6f89a002b02bb7cade1d

2015 Primer

Introduction to Innate Immunity
Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=0810 Overwijk-SECURE.pdf
Introduction to Innate Immunity
Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=a1edbe4c9ea345ab8c97c7763506ea4d1d
Overview of Adaptive Immunity
Jonathon Powell, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=0920 Powell-SECURE.pdf
Overview of Adaptive Immunity
Jonathon Powell, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=90e7e27b9d56495c82ebe04ed196abf91d
Adoptive T Cell Therapy
Michel Sadelain, MD, PhD - Memorial Sloan Kettering Cancer Center
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=1030 Sadelain Edited-SECURE.pdf
Anti-Tumor Antibodies
Charles G. Drake, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=1105 Drake-SECURE.pdf
Dendritic Cells: Basic Biology and Therapeutic Use
A. Karolina Palucka, MD, PhD - The Jackson Laboratory for Genomic Medicine
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=1140 Palucka-SECURE.pdf
Cancer Vaccines
Patrick Ott, MD, PhD - Dana-Farber Cancer Institute/Harvard Medical School
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=1335 Ott-SECURE.pdf
Cancer Vaccines
Patrick Ott, MD, PhD - Dana-Farber Cancer Institute/Harvard Medical School
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=ca9ff6e66d82457e8e76d193cfa33b091d
Targeting Immune Checkpoints in Cancer Therapy: New Insights and Opportunities
Suzanne L. Topalian, MD - Johns Hopkins University
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=1410 Topalian-SECURE.pdf
Monitoring of Cellular and Humoral Immune Responses in Tumor Immunotherapy
Sacha Gnjatic, PhD - Icahn School of Medicine at Mount Sinai
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=1520 Gnjatic modified-SECURE.pdf
Pre-Surgical Clinical Trial Design for Immune Monitoring
Sumit Subudhi, MD, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=1555 Subudhi-SECURE.pdf
Pre-Surgical Clinical Trial Design for Immune Monitoring
Sumit Subudhi, MD, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am15pr/presentations/index.php?filename=a777916be6674cd58b88d77e673d4d2d1d

2014 Primer

Welcome and Overview
Willem W. Overwijk, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=2ddbe183b25e4747b2bd9eaa5de1b71d1d
Introduction to Innate Immunity
Vincenzo Bronte, MD - University of Verona
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=0810 Bronte revised-v2.pdf
Dendritic Cells: Basic Biology and Therapeutic Use
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=0845 BUTTERFIELD-v2.pdf
Dendritic Cells: Basic Biology and Therapeutic Use
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=0c2f2c5543614d52acb5eb12d766df081d
Overview of Adaptive Immunity
Jonathan Powell, MD, PhD - Johns Hopkins Hospital
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=0920 Powell-v2.pdf
Overview of Adaptive Immunity
Jonathan Powell, MD, PhD - Johns Hopkins Hospital
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=a11ed283ceaf49e29516cc4a4c0b26f51d
Session II Introduction
Willem W. Overwijk, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=75ca05ab1c4646b9a5a8c1652572111e1d
Adoptive T Cell Therapy
Carl H. June, MD - University of Pittsburgh
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=1030 June revised-v2.pdf
Anti-Tumor Antibodies
Sattva S. Neelapu, MD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=1105 Neelapu-v2.pdf
Anti-Tumor Antibodies
Sattva S. Neelapu, MD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=afa08ff9bffd4cbdb15953d2e48658431d
Obstacles to Driving an Immune Response
Margaret K. Callahan, MD, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=1140 Callahan approved-v2.pdf
Cancer Vaccines
Willem W. Overwijk, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=1335 Overwijk-v2.pdf
Cancer Vaccines
Willem W. Overwijk, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=6399e0e7f31d40a082dba2022870bdc21d
Targeting Immune Checkpoints in Cancer Therapy: New Insights and Opportunities
James P. Allison, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=1410 Allison-v2.pdf
Targeting Immune Checkpoints in Cancer Therapy: New Insights and Opportunities
James P. Allison, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=a6afa4b2b46c45c0ab43e401abee3f161d
Pre-Surgical Clinical Trial Design for Immune Monitoring
Padmanee Sharma, MD, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am14pr/presentations/index.php?filename=1555 Sharma revised-v2.pdf

2014 Hot Topic Symposium I

T Cell Costimulation in Cancer Immunotherapy through Agonist Agents: OX40
Andrew D. Weinberg, PhD - Earle A. Chiles Research Institute, Providence Portland Medical Center
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1030 Weinberg-v2.pdf
T Cell Costimulation in Cancer Immunotherapy through Agonist Agents: OX40
Andrew D. Weinberg, PhD - Earle A. Chiles Research Institute, Providence Portland Medical Center
www.sitcancer.org/meetings/am14/presentations/index.php?filename=5437ade6c8f14932a2fec885507fa3231d
4-1BB: Enhancing Innate and Adaptive Immunity
Holbrook E. Kohrt, MD, PhD - Stanford Cancer Institute
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1055 Kohrt-v2.pdf
4-1BB: Enhancing Innate and Adaptive Immunity
Holbrook E. Kohrt, MD, PhD - Stanford Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=c16623a0efbf46e987112e7d577e0e0f1d
Anti-CD40 Agonist Antibody - The Ideal Combination Partner for Cancer Immunotherapy
Hy Levitsky, MD - Roche Glycart AG
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1120 Levitsky revised-v2.pdf
Oligonucleotide Aptamers: A Novel Drug and Drug Delivery Platform for Cancer Immunotherapy
Eli Gilboa, PhD - University of Miami
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1145 Gilboa-2.pdf
Oligonucleotide Aptamers: A Novel Drug and Drug Delivery Platform for Cancer Immunotherapy
Eli Gilboa, PhD - University of Miami
www.sitcancer.org/meetings/am14/presentations/index.php?filename=a07d5ed67c5c495991f8cd86063179911d

2014 Hot Topic Symposium II

Welcome and Overview
Kristen M. Hege, MD - Celgene Corporation and University of California, San Francisco
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1030 Hege-v2.pdf
Welcome and Overview
Kristen M. Hege, MD - Celgene Corporation and University of California, San Francisco
www.sitcancer.org/meetings/am14/presentations/index.php?filename=d9e366d95b984f88a69a7698a65093141d
FDA – History of Immune-Related Adverse Effects from the Regulatory Perspective
Bindu George, MD - U.S. Food and Drug Administration
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1035 George approved-v2.pdf
Toxicity and Management after CTL019 Therapy: Update from University of Pennsylvania
David L. Porter, MD - University of Pennsylvania
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1045 Porter revised-v2.pdf
Anti-CD19 CAR T Cells: The Balance of Efficacy and Toxicity
James N. Kochenderfer, MD - National Cancer Institute
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1055 Kochenderfer approved-v2.pdf
Anti-CD19 CAR T Cells: The Balance of Efficacy and Toxicity
James N. Kochenderfer, MD - National Cancer Institute
www.sitcancer.org/meetings/am14/presentations/index.php?filename=417a198732be454f9ba52d20f910c4a91d
Fred Hutchinson Cancer Research Center Experience
Michael C.V. Jensen, MD - University of Washington
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1115 Jensen approved-v2.pdf
Fred Hutchinson Cancer Research Center Experience
Michael C.V. Jensen, MD - University of Washington
www.sitcancer.org/meetings/am14/presentations/index.php?filename=21860cc4360a4e2991930be97a04a6761d
Cytokine Storm in T Cell Studies - An Update from Baylor University
Helen E. Heslop, MD - Baylor College of Medicine
www.sitcancer.org/meetings/am14ht/presentations/index.php?filename=1125 Heslop-v2.pdf
Cytokine Storm in T Cell Studies - An Update from Baylor University
Helen E. Heslop, MD - Baylor College of Medicine
www.sitcancer.org/meetings/am14/presentations/index.php?filename=7dc0fd6d14754102b7f1d40643c166641d

2013 ACI

Pittsburgh, PA

Immunology for the Non-immunologist: Measuring Immune Response
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=8aa3b9c549e345c0965f826d94071a981d
Cytokines
Michael T. Lotze, MD - University of Pittsburgh
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=86f06602236b41f5925ab1a63c5e670a1d
Microenvironment and Immune Suppression
Hassane M. Zarour, MD - University of Pittsburgh
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=zarour.pdf
Vaccines
Hideho Okada, MD, PhD - University of Pittsburgh
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=Okada.pdf
Adoptive Transfer
Patrick Hwu, MD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=e8e3c941aa0343b9b1576e1d2e8c97ba1d
Therapy of Cancer with PD-1 Antibody and Combination
Jedd D. Wolchok, MD, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=13cbbddc0c2c487d9c3b873818ca255b1d
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors
Jedd D. Wolchok, MD, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=625084ae7fd24a1782bcbebf817b97d21d
Immunotherapy Combinations with Small Molecules, Surgery and Radiation
David Bartlett, MD - University of Pittsburgh
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=a750a58fc7804a409f7fc47112b0010a1d
Tumor Antigen Targeted Monoclonal Antibodies and Combinations in the Clinic
Robert L. Ferris, MD, PhD, FACS - University of Pittsburgh
www.sitcancer.org/meetings/aci13pa/presentations/index.php?filename=Ferris.pdf

Tampa, FL

Immunology 101 for the Non-Immunologist
Kenneth L. Wright, PhD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=0810 Wright.pdf
Interferon: Indications and Clinical Management in Melanoma
Vernon K. Sondak, MD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=8.35 Sondak.pdf
Interleukin-2 and Related Cytokines: Indications and Clinical Management
Geoffrey T. Gibney, MD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=6085f6a87b674879a0224a854a3585c21d
Ipilimumab in Melanoma: Indications and Clinical Management
Ragini Kudchadkar, MD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=bc1a54fc48df4d289ff1a6b1a50e235d1d
Vaccines and Other Forms of Immunotherapy for Breast Cancer
Keith L. Knutson, PhD - Vaccine & Gene Therapy Institute of Florida
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=c1aed25d6dc3402e841abeebfa0141881d
The PD-1/PD-L1 Pathway as a Target in Tumor Immunotherapy
Jeffrey S. Weber, MD, PhD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=110fd2fd29c74b8e9740b01bed5363471d
The Emerging Role of Combination Tumor Immunotherapy
Gregory K. Pennock, MD - MD Anderson Cancer Center Orlando
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=ebb2e102d9ba408188efa61ba444d6471d
New Tumor Immunotherapy Strategies on the Horizon
Amod A. Sarnaik, MD - Moffitt Cancer Center
www.sitcancer.org/meetings/aci13fl/presentations/index.php?filename=1.55 - 2.30 Amod Sarnaik.pdf

San Francisco, CA

Immunology 101 for the Practicing Oncologist
Aaron Logan, MD, PhD - University of California San Francisco
www.sitcancer.org/meetings/aci13ca/presentations/index.php?filename=fcf4362e138d4381ac839a3bfc4ec9d31d
Ipilimumab: Indications and Clinical Management
Alain Algazi, MD - University of California San Francisco
www.sitcancer.org/meetings/aci13ca/presentations/index.php?filename=6c13937baabd4606b3cf06f7959ee9d01d
Anti-PD-1 and Anti-PD-L1 Therapy
Antoni Ribas, MD, PhD - University of California Los Angeles
www.sitcancer.org/meetings/aci13ca/presentations/index.php?filename=78048d498ab64ff1853c06ce5d17fb8d1d
The Emerging Role of Combination Tumor Immunotherapy
Holbrook E. Kohrt, MD, PhD - Stanford Cancer Institute
www.sitcancer.org/meetings/aci13ca/presentations/index.php?filename=1125 Kohrt.ACI.CA.Combination.Immunotherapy.pdf
Adoptive T-cell Transfer as an Anti-tumor Approach
Antoni Ribas, MD, PhD - University of California Los Angeles
www.sitcancer.org/meetings/aci13ca/presentations/index.php?filename=05f3755d7af945cb941c7132a328304d1d
Keynote: Normal and Neoplastic Stem Cells
Irving L. Weissman, MD - Stanford University
www.sitcancer.org/meetings/aci13ca/presentations/index.php?filename=f9ec78cbfd10407488bae7535a14dc061d

Seattle, WA

Immunology 101 for the Non-Immunologist
Andrew D. Weinberg, PhD - Earle A. Chiles Research Institute, Providence Portland Medical Center
www.sitcancer.org/meetings/aci13wa/presentations/index.php?filename=08.10 Weinberg.pdf
Interleukin-2 and Related Cytokines: Indications and Clinical Management
Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci13wa/presentations/index.php?filename=6da94093427749aea9946679a45787921d
Ipilimumab: Indications and Clinical Management
Shailender Bhatia, MD - University of Washington
www.sitcancer.org/meetings/aci13wa/presentations/index.php?filename=7b0396390e6248148b8227fac22a95bd1d
The PD-1/PD-L1 Pathway as a Target in Tumor Immunotherapy
Scott S. Tykodi, MD, PhD - University of Washington and Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/aci13wa/presentations/index.php?filename=95bba6a02131482d9c60d941614c478a1d
Prediction: Cancer Immunotherapy in 10 Years **Non-CME**
Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/aci13wa/presentations/index.php?filename=12.20 For Distribution Final Cheever SITC Talk Dec 14 2013 Compatibility Mode.pdf
Immunoconjugate Principles and Application
Marka R. Crittenden, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer Center
www.sitcancer.org/meetings/aci13wa/presentations/index.php?filename=1.20 - 1.55 Crittenden revised.pdf
The Emerging Role of Combination Tumor Immunotherapy with Radiation
Hannah M. Linden, MD, FACP - University of Washington
www.sitcancer.org/meetings/aci13wa/presentations/index.php?filename=0e846b392e03478889f1b69d5fd4df741d

Chicago, IL

Basic Immunology
Justin P. Kline, MD - University of Chicago
www.sitcancer.org/meetings/aci13/presentations/index.php?filename=0805-Basic-Immunology_Kline.pdf
Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/aci13/presentations/index.php?filename=0840-tumor-microenvironment_Gajewski.pdf
Immune Potentiating Cytokines
Howard L. Kaufman, MD - Rush University Medical Center
www.sitcancer.org/meetings/aci13/presentations/index.php?filename=Immune-Potentiating-Cytokines_Kaufman.pdf
Therapeutic Cancer Vaccines
Douglas G. McNeel, MD, PhD - University of Wisconsin
www.sitcancer.org/meetings/aci13/presentations/index.php?filename=130504-Therapeutic-Cancer-Vaccines_Ncneel.pdf
Adoptive T Cell Transfer
Patrick Hwu, MD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13/presentations/index.php?filename=1055-AdoptiveTCellTranser_Hwu.pdf
Checkpoint Blockade
Julie Brahmer, MD - Johns Hopkins University
www.sitcancer.org/meetings/aci13/presentations/index.php?filename=1130-CheckPoint Blockade_Brahmer.pdf
Immune System Role For Traditional Cancer Therapies
Sandra Demaria, MD - New York University School of Medicine
www.sitcancer.org/meetings/aci13/presentations/index.php?filename=1205-Immune-Systems-Role_Demaria.pdf

Houston, TX

Basic Immunology
Kimberly S. Schluns, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13tx/presentations/index.php?filename=Basic-Immunology_SCHLUNS.pdf
Innate Immunity
Willem W. Overwijk, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13tx/presentations/index.php?filename=Innate-Immunity_Overwijk.pdf
Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/aci13tx/presentations/index.php?filename=Tumor-Microenvironment_Gajewski.pdf
Therapeutic Cancer Vaccines & Cytokines
Elizabeth A. Mittendorf, MD, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13tx/presentations/index.php?filename=Therapeutic-Cancer-Vaccines-and-Cytokines_Mittendorf.pdf
Adoptive T Cell Transfer
Patrick Hwu, MD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13tx/presentations/index.php?filename=Adoptive-T-Cell-Transfer_HWU.pdf
Checkpoint Blockade
James P. Allison, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13tx/presentations/index.php?filename=Checkpoint-Blockade_Allison.pdf
Combination Therapies
Michael A. Curran, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/aci13tx/presentations/index.php?filename=Combination-Therapies_Curran.pdf

Cleveland, OH

Immunology 101 for the Practicing Oncologist
Charles Tannenbaum, PhD - Cleveland Clinic
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=0810_TANNENBAUM.pdf
What You Need to Know about Innate Immunity
Jennifer S. Ko, MD, PhD - Cleveland Clinic
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=0835_KO.pdf
Tumor Microenvironment: Hijacking the Immune System
James H. Finke, PhD - Cleveland Clinic
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=0900_FINKE_Tumor_Microenvironment_Hijacking_the_Immune_System.pdf
Cytokine Therapy: Lessons Learned and Novel Agents
Pierre L. Triozzi, MD - Cleveland Clinic
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=0940_TRIOZZI.pdf
Therapeutic Cancer Vaccines: Successes and Failures in the Clinic
Joseph Baar, MD, PhD - Seidman Cancer Center
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=1015_BAAR_REVISED_and_APPROVED.pdf
Adoptive T cell Transfer as an Anti-tumor Approach
Gregory E. Plautz, MD - Cleveland Clinic
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=1050_PLAUTZ.pdf
Therapeutic Checkpoint Blockade
Brian I. Rini, MD - Cleveland Clinic
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=1245_RINI.pdf
Rationale for Combining Immunotherapy with Chemotherapy or Targeted Therapy
Qing Yi, MD, PhD - Cleveland Clinic
www.sitcancer.org/meetings/aci13oh/presentations/index.php?filename=1320_YI.pdf

2013 Early Career Scientists Professional Development Session

Academia: How to Navigate the Postdoc to PI Transition and Survive in Academia
Sharon Milgram, PhD - National Institutes of Health Office of Intramural Training & Education
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1225 Milgram-secure.pdf
Working for the NCI (Government)
Daniel W. McVicar, PhD - National Cancer Institute-Frederick
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1310 McVicar revised version-secure.pdf
Medical Writing to Enhance Your Career
Helen K. Angell, PhD - INSERM
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1325 Angell-secure.pdf
Obtaining an Individual Postdoctoral Fellowship Award
William L. Redmond, PhD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1355 Redmond-secure.pdf
Preparing for Your First RO1 Grant
Justin P. Kline, MD - University of Chicago
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1415 Kline-secure.pdf
Alternative Sources of Support: Identifying & Securing Funding from Private Charitable Organizations, Donors, Foundations, and Industry
Shari Pilon-Thomas, PhD - H. Lee Moffitt Cancer Center & Research Institute
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1435 Pilon-Thomas revised version-secure.pdf

2013 Annual Meeting

Update Session: Cancer Immunotherapy Trials Network
Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=0820 Cheever Final-secure.pdf
Update Session: Immunoscore
Bernard A. Fox, MD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am13/presentations/index.php?filename=560ec16680ac4d97998666f02ae2260d1d
Keynote
Giorgio Trinchieri, MD - National Cancer Institute
www.sitcancer.org/meetings/am13/presentations/index.php?filename=0850 Trinchieri revised-secure.pdf
Ambivalent Effects of 5-Flouorouracil on Anticancer Immune Responses
Lionel Apetoh, PhD - INSERM
www.sitcancer.org/meetings/am13/presentations/index.php?filename=c1837d51471f40c9accf904e8874b6eb1d
Modulating Tumor Microenvironment Responses to Genotoxic Cancer Therapy
Peter S. Nelson, MD - Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=c8f4f8974b3b44d0b98ff5a2045eb4201d
Listeria Monocytogenes (Lm)-LLO Immunotherapies Reduce the Immunosuppressive Activity of Myeloid-derived Suppressor Cells and Regulatory T Cells in the Tumor Microenvironment
Anu Wallecha, PhD - Advaxis Inc
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1120 Wallecha-secure.pdf
Cross-talks of Tumor and Myeloid Cells Regulate the Therapeutic Responses to Chemotherapy by Modulating Innate Immune Responses
Masahisa Jinushi, MD, PhD - Hokkaido University
www.sitcancer.org/meetings/am13/presentations/index.php?filename=fa21855dadf64ffc9b82983a42d1bad51d
Update Session: U.S. Food and Drug Administration
Raj K. Puri, MD, PhD - U.S. Food and Drug Administration, CBER
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1215 Puri-secure.pdf
In Vivo ADCC to Treat Neuroblastoma
Paul M. Sondel, MD, PhD - University of Wisconsin
www.sitcancer.org/meetings/am13/presentations/index.php?filename=51231bff59bf4215bf71dafe00019cc31d
In Vivo Persistence of Adoptively Transferred TCR Gene-transduced Lymphocytes with Anti-tumor Reactivity in Patients with MAGE-A4 Expressing Esophageal Cancer
Hiroaki Ikeda, MD, PhD - Mie University Graduate School of Medicine
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1755 Ikeda revised-secure.pdf
Intratumoral Characteristics of Tumor and Immune Cells at Baseline and On-treatment Correlated with Clinical Responses to MPDL3280A, an Engineered Antibody Against PD-L1
Holbrook Kohrt, MD, PhD - Stanford Cancer Institute
www.sitcancer.org/meetings/am13/presentations/index.php?filename=0d4cd1e2f3764cc3b88d5c22cf2c9aac1d
Update Session
William D. Merritt, PhD - National Cancer Institute
www.sitcancer.org/meetings/am13/presentations/index.php?filename=0830 Meritt revised version-secure.pdf
Modified STING-Activating Cyclic Dinucleotide Derivatives Significantly Enhance the Anti-tumor Activity of Therapeutic Vaccines
Thomas W. Dubensky, Jr., PhD - Aduro BioTech, Inc.
www.sitcancer.org/meetings/am13/presentations/index.php?filename=3a80b27bc60643fe97d2473ad5f89f761d
The Abscopal Effect: Efficacy of Radiotherapy in Patients on Progression After Treatment with Ipilimumab 3 mg/kg
Antonio M. Grimaldi, MD - Istituto Nazionale Tumori Fondazione 'G. Pascale'
www.sitcancer.org/meetings/am13/presentations/index.php?filename=e304dfc7b17b4dfea6f490ac3e9ac6671d
Transgenic Expression of Notch-1 Intracellular Active Domain (N1IC) in T Cells: A Potential Therapy to Overcome Suppression Induced by Tumors
Paulo C. Rodriguez, PhD - SUHSC - Stanley S. Scott Cancer Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1405 Rodriguez revised version-secure.pdf
TLR2/6 Agonists and IFN? Synergize to Induce Melanoma Cells to Produce T-cell Recruiting Chemokines
Ileana S. Mauldin, PhD - University of Virginia
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1445 Mauldin revised version-secure.pdf
Uncovering a Novel Function of BTLA on Tumor-Infiltrating CD8+ T Cells
Cara Haymaker, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1505 Haymaker approved-secure.pdf
Dissection of Genomic Networks for Immunosurveillance in Resectable Stage II/III Melanoma
Yvonne Saenger, MD - Mount Sinai School of Medicine
www.sitcancer.org/meetings/am13/presentations/index.php?filename=4dc1ecac0b244444a5b567b9454fdef41d
Combinations of Anti-cancer Immune Therapies Built on Checkpoint Inhibition
Mario Sznol, MD - Yale University School of Medicine
www.sitcancer.org/meetings/am13/presentations/index.php?filename=805 Sznol revised-secure.pdf
Therapeutic Activity of a Combination of Immunostimulatory Monoclonal Antibodies (anti-B7-H1, CD137 and OX40) on a C-myc-driven Spontaneous Transgenic Model of Hepatocellular Carcinoma
Aizea Morales-Kastresana - Center for Applied Medical Research (CIMA)
www.sitcancer.org/meetings/am13/presentations/index.php?filename=0910 Morales-Kastresana revised-secure.pdf
Localized Oncolytic Virotherapy Inflames Distant Tumors and Synergizes with Immune Checkpoint Blockade Leading to Systemic Tumor Rejection
Dmitriy Zamarin, MD, PhD - Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=d495aab015244fc3b16f0188e1b1f5d41d
Targeting Tumor to Generate Systemic Immunity
Yang-Xin Fu, MD, PhD - University of Chicago
www.sitcancer.org/meetings/am13/presentations/index.php?filename=0940 Fu revised-secure.pdf

2013 Workshop

Welcome and Introductions
Nicholas P. Restifo, MD - National Cancer Institute
www.sitcancer.org/meetings/am13/presentations/index.php?filename=64a4a4e3000c4d1e82127fe88d568a5b1d
New Sequencing Technology/Validation of Mutation Data/Bioinformatics
Hans-Georg Rammensee, PhD - Universitaet Tuebingen
www.sitcancer.org/meetings/am13/presentations/index.php?filename=0bbda0d4ade94ece892733007c4fcce11d
T Cell Receptor Affinity and Avidity Defines Antitumor Response and Autoimmunity in T Cell Immunotherapy
Michelle Krogsgaard, PhD - NYU School of Medicine
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1015 Krogsgaard revised version-secure.pdf
CD8 T Cell Epitope Peptide Vaccines: Composition, Not Size It's What Matters
Esteban Celis, MD, PhD - H. Lee Moffitt Cancer Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1030 Celis revised version-secure.pdf
Serial Immune Monitoring: Essential to Resolve Immune Dynamics for Improving Clinical Effectiveness of Immunotherapy
Brendon J. Coventry, MD, PhD - University of Adelaide
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1045 Coventry revised version-secure.pdf
What to do with the Epitope Once You Have It
Willem W. Overwijk, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=ae1b73173b5a49c2a24d8b3854c563631d
Immunologic Implications of Data
Patrick Hwu, MD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=d1aa02d8e689427094f28317211866091d
Immunologic Implications of Data
Paul F. Robbins, PhD - National Cancer Institute, National Institutes of Health
www.sitcancer.org/meetings/am13/presentations/index.php?filename=34f9e3a5211a4a83853dc603981a0f211d
Single Cell Network Profiling (SCNP)
Alessandra Cesano, MD, PhD - Nodality, Inc
www.sitcancer.org/meetings/am13/presentations/index.php?filename=df98b346eb86438fa1d3c3a4a522498e1d

2013 Primer

Introduction to Dendritic Cells
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
www.sitcancer.org/meetings/am13/presentations/index.php?filename=cd7a3333a88a484f90a0856ed737b3f31d
Adoptive T Cell Therapy
Cassian Yee, MD - Johns Hopkins University
www.sitcancer.org/meetings/am13/presentations/index.php?filename=SITC primer 2013 YEE.pdf
Overview of Adaptive Immunity
Jonathan Powell, MD - Johns Hopkins Hospital
www.sitcancer.org/meetings/am13/presentations/index.php?filename=55a5fb294adb465b84edd3a6ed1bf4d01d
Anti-Tumor Antibodies
Charles G. Drake, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1115 Drake modified-secure.pdf
Obstacles to Driving an Immune Response
Jedd D. Wolchok, MD, PhD - Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am13/presentations/index.php?filename=2b864330e55e4673a8285ed9425169071d
Monitoring T and B Cell Responses
Sacha Gnjatic, PhD - Tisch Cancer Institute at Hess Center Mount Sinai School of Medicine
www.sitcancer.org/meetings/am13/presentations/index.php?filename=1545 Gnjatic modified-secure.pdf

2012 Annual Meeting

Richard V. Smalley, MD Memorial Lectureship
Theresa L. Whiteside, PhD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-8.00am - Whiteside_The Immune Escape Game 2012.pdf
Adoptive T Cell Therapy: Faster, Higher, Stronger
Cassian Yee, MD - Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-915 am YEE2.pdf
Memory CD8+ T Cells Induce Precocious Effector Differentiation of Naïve CD8+ T Cells in a Fasl-Fas Dependent Manner: a New Mode of T-T Lymphocyte Interaction and Cross Talk
Christopher A. Klebanoff, MD - National Institutes of Health
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-10.45am - Klebanoff SITC2012 Precosious differentiation presentation 10-25-12 version 3.pdf
Treatment of Non-Hodgkin Lymphoma with CAR-Transduced CD19-Specific Central Memory Derived T Cells
Stephen J. Forman, MD - City of Hope
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-11.45am - SJF for SITC 102312.pdf
Promoting the Effectiveness of Synthetic Cancer Vaccines
Cornelis J.M. Melief, MD, PhD - Leiden University Medical Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-1.30pm - Melief_SITC Bethesda Melief 26 Oct. 2012.pdf
A Novel Dendritic Cell-based Vaccine for Her-2-Positive Early Breast Cancer
Brian Czerniecki, MD, PhD - University of Pennsylvania
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-2.08pm - Czerniecki SITC 2012.pdf
Optimization of DC-based Cancer Therapies
Pawel Kalinski, MD, PhD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-2.34 pm KALINSKI SITC Oct 26 2012 PUBLIC NOV 6.pdf
IDO and Immune Suppression
David H. Munn, MD - Georgia Health Sciences University
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-1.30pm - (Munn) session slides 10-19-12.pdf
The Tumor Microenvironment Can Vary with Anatomical Site to Affect Responses to Therapy
Michael H. Kershaw, PhD - Peter MacCallum Cancer Centre
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-2.30pm - Kershaw SITC 2012.pdf
Tropism of Oncolytic Vaccinia Virus Constructs for HumanMononuclear Cell Subsets
Boris Minev, MD - Genelux Corporation
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-3.15 pm Boris Minev SITC_2012.pdf
Oncolytic Virotherapy as Cancer Immunotherapy
Richard Vile, PhD - Mayo Clinic
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-3.45pm - Vile_SITC Formatd Oct 24 2012 FINAL.pdf
Modulating the Tumor Microenvironment to Enhance Antitumor Immunity in Preclinical and Clinical Settings: Antigen Encoding Poxvirus Vectors Overcome Immune Escape
Edmund C. Lattime, PhD - The Cancer Institute of New Jersey
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-4.15 pm E Lattime SITC Presentation.pdf
US Food and Drug Administration (FDA) Update
Raj K. Puri, MD, PhD - US Food and Drug Administration, CBER
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-5.30pm - Puri SITC FDA Updates talk 10-2012.pdf
National Cancer Institute (NCI) Update
William Merritt, PhD - National Cancer Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-FRI-Merritt NCI update SITC 2012.pdf
Using Genomics To Understand Cancer Immunoediting And Guide Immunotherapy
Robert D. Schreiber, PhD - Washington University St. Louis
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-8.00am - Schreiber SITC Keynote 2012 PC.pdf
Combining Immunotherapy and Targeted Therapy for Melanoma
Antoni Ribas, MD - UCLA Medical Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-8.45am - Ribas_Combo immunother and targeted tx_Ribas.pdf
PD-1/PD-L1 Blockade after Transient Lymphodepletion to Treat Myeloma
Bryon D. Johnson, PhD - Medical College of Wisconsin
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-9.15am - Johnson_ SITC Talk 2012.pdf
ADXS11-001 Lm-LLO Immunotherapy Targeting HPV-E7: Preliminary Safety and Survival Data From A Phase 2 Study in Indian Women With Recurrent/Refractory Cervical Cancer
Robert Petit, PhD - Advaxis
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-9.45am - Petit_1 SITC Final Oral Presentation 102712 (no notes).pdf
Critical Issues for Early Trial Design in Immunotherapy
Osama Rahma, MD - National Cancer Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-11.45am - Khleif_Rahma Sitc.pdf
Design Issues in the Immunotherapy Combinatorial Trials
Antoni Ribas, MD - UCLA Medical Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-12.00pm - Ribas_Clinical Trials Session_Ribas.pdf
TIL Adoptive Cell Therapy for Melanoma: Trials and Tribulations in the Quest for FDA Approval
Laszlo G. Radvanyi, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-SITC Talk - Radvanyi FINAL 27Oct12.pdf
Developing Commercially Relevant T Cell Therapy Manufacturing Processes
Robert Keefe, PhD - Lonza Walkersville, Inc.
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-2.30pm - SITC2012_KEEFE_Lonza.pdf
Artificial Antigen Presenting Cells as a Standardized Platform for TIL Expansion
Daniel J. Powell, Jr., PhD - University of Pennsylvania
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-3.00pm Powell SITC T cell manufacturing.pdf
A Single Cell Network Profiling (SCNP) View of the Immune System
Alessandra Cesano, MD, PhD - Nodality, Inc.
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-2.00pm - Cesano_SITC presentation 2012 Final.pdf
Dissection of Anti-CTLA4-induced Cytotoxic T Cell Responses in Melanoma
Pia Kvistborg, MD - Netherlands Cancer Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-2.30pm - kvistborgSITC.pdf
A Shape for Cancer and Immunity at the Single Cell Level
Garry P. Nolan, PhD - Stanford School of Medicine
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-Nolan-slides.pdf
CARs For Childhood Cancer: Development and Comparison of Permanently and Transiently-Modified T-cells Targeting All and Neuroblastoma
Nathan Singh - University of Pennsylvania
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SAT-4.20pm - Singh Nathan SITC 10.27.12.pdf
Adoptive Immunotherapy of Cancer
Steven A. Rosenberg, MD, PhD - National Cancer Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SUN-8.00am - Rosenberg Speaker 1.pdf
Building a Better T Cell for Targeting Tumors
Philip D. Greenberg, MD - University of Washington
www.sitcancer.org/meetings/am12/presentations/index.php?filename=AM-SUN-SITC-10_12 Greenberg.pdf

2012 Primer

Session 250: Innate Immunity
Willem W. Overwijk, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PR-8.05am - Overwijk_Innate Immunity and Inflammation_ISBTc primer 2012.pdf
Session 251: Dendritic Cells
Madhav Dhodapkar, MD - Yale University
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PR-DhodapkarFxSITC2080712pdfFx.pdf
Session 252: Immunology of Antibodies as Therapy
Helen Chen, MD - National Cancer Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PR-SITC 2012 MAb Chen 10-25-2012.pdf
Session 253: T Cell Differentiation: From Naïve to Effector Cells
Susan M. Kaech, PhD - Yale University
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PR-Kaech - 2012 Primer.pdf
Session 254: Immunobiology of the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PR-11.40am - SITC tumor microenvironment primer 092312 edited 102512.pdf
Session 256: Tumor Antigen, Tumor Immunogenicy and Immunization
Pedro J. Romero, MD - University of Lausanne
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PR-Romero SITC Primer 2012.pdf
Session 258: Adoptive Immunotherapy
Cassian Yee, MD - Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PR-Yee - SITC primer 2012c 11.02.2012.pdf

2012 Workshop

Immune Suppression by Stromal Cells
David H. Munn, MD - Georgia Health Sciences University
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-11.30am - (Munn) workshop slides 10-23-12.pdf
Innate and Adaptive Immunity Regulated Within the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-Gajewski 11.27.2012.pdf
Oncogene Inactivation and CD4+ T Cells
Dean W. Felsher, MD, PhD - Stanford University School of Medicine
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-felsher_slides.pdf
Immune Impact on Cancer Stemness and Metastasis
Weiping Zou, MD, PhD - University of Michigan
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-9.15am - Weiping Zou.pdf
Microenvironment Immunogenetics Biomarkers in CombinationImmunotherapy
Samir N. Khleif, MD - Georgia Health Sciences University
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-10.30am - Samir Khleif SITC 2012.pdf
Epigenetic Immune Cell Markers - Enabling Novel Clinical Trials with Robust Results from Frozen Whole Blood or Tissue
Thomas O. Kleen, PhD - Epiontis GmbH
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-Day 2 11.30 - Kleen_SITC 2012 CMI monitoring.pdf
Immune Response Signatures and Patient Survival
Mary L. Disis, MD - University of Washington
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-Redact_SITC_30 min_Disis 11.05.2012.pdf
Combination Immunotherapies Designed to Target the TumorMicroenvironment
Leisha A. Emens, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-emens_slides.pdf
Clinical Trials: Provoking Immunity in the Tumor Microenvironment
Antoni Ribas, MD - UCLA Medical Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-2.50pm - Ribas_SITC workshop talk.pdf
Sunitinib and Immunity
Brian I. Rini, MD - Cleveland Clinic Taussig Cancer Center
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-3.10pm - Rini_SITC 2012 sunitinib immunomodulation.pdf
A Strategic View of the Immunoscore
Bernard A. Fox, PhD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-fox_slides.pdf
Immune System and Cancer: Importance of the Immunoscore
Francesco Marincola, MD - National Institutes of Health
www.sitcancer.org/meetings/am12/presentations/index.php?filename=WK-4.30pm - Marincola Tum Micr 2012.pdf

2012 Early Career Scientists Professional Development Session

Getting a K99/R00 Award from the National Institutes of Health
Shari Pilon-Thomas, PhD - H. Lee Moffitt Cancer Center and Research Institute
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PDS-Pilon-ThomasSITC2012rev.pdf
Getting a K Award from the National Institutes of Health
Christopher Gamper, MD, PhD - Johns Hopkins University School of Medicine
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PDS-2.00pm - Gamper Applying for a K08.pdf
The Business of Research
Lisa Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PDS-3.05pm - Butterfield_SITCeducational2012.pdf
Academia
Ana Anderson, PhD - Harvard Medical School
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PDS-3.45pm - Andersen_SITC2012.pdf
Government
Raj K. Puri, MD, PhD - US Food and Drug Administration, CBER
www.sitcancer.org/meetings/am12/presentations/index.php?filename=PDS-Puri-slides.pdf

2011 Annual Meeting

Optimizing T Cell Immunity with Prime-Boost Immunization Using Viral and Protein/Adjuvant Based Vaccines
Robert A. Seder, MD - NIAID, NIH
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-8.45am%20-%20Seder_SITC%20Meeting-S.pdf
Adenovirus-Engineered Human Dendritic Cell Vaccine Induces Natural Killer Cell Chemotaxis via CXCL8/IL-8 and CXCL10/IP-10 Chemokines
Lazar Vujanovic, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-10.45am%20-%20Vujanovic%20SITC%20seminar%202011%20Final%205-S.pdf
Phase I Study of Intravenous Recombinant Human Interleukin-15 (RH IL-15) in Adults with Metastatic Malignant Melanoma and Renal Cell Carcinoma
Kevin C. Conlon, MD, MS - National Cancer Institute, NIH
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-11.30am - ConlonSITC slides NCI IL-15 Phase I trial-S.pdf
IL-12 Triggers an Inflammatory Gene Signature that Reverses Dysfunctional Antigen-presentation by Myeloid-Derived Cells Residing within Tumors
Sid Kerkar, MD - National Cancer Institute, Center for Cancer Research, NIH
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-2.15pm%20-%20Kline_SITC%202011%20FINAL-S.pdf
Acute Myeloid Leukemia Promotes Immune Evasion through Induction of Antigen-Specific T Cell Deletion
Justin P. Kline, MD - University of Chicago
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-2.15pm - Kline_SITC 2011 FINAL-S.pdf
Genetically Engineered Receptors in Adoptive Cell Therapies
Laurence J.N. Cooper, MD, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-3.15pm-11-04-2011 Cooper final-S.pdf
Selection of Allo-Restricted Peptide-Specific TCRs for Adoptive T Cell Therapy
Dolores J. Schendel, PhD - Helmholtz Zentrum Muenchen - German Research Center for Environmental Health Institute of Molecular Immunology
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-3.45 _Schendel final online.pdf
Differential Gene Expression Associated with Immune Down Regulation in TCR Gene-engineered T Cells Administered to Patients
Daniel Abate-Daga, PhD - National Cancer Institute
www.sitcancer.org/meetings/am11/presentations/index.php?filename=FRI-4.15pm - SITC2011 Abate-Daga.pdf
Active STAT5 Promotes Long-Lived Cytotoxic CD8 T Cells that Induce Regression of Autochthonous Mouse Melanoma
Gregory Verdeil, PhD - Centre d'Immunologie de Marseille-Luminy, CIML
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-FRI-4.30pm - Verdeil SITC 2011-S.pdf
DC Vaccination Concurrently Reduces Treg and Enhances Activated CTL in Tumor Biopsies from Immunoresponsive Patients with Advanced Melanoma
Massimo Guidoboni, MD - Immunology & Somatic Cell Therapy Lab
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-9.15am - Guidoboni SITC 2011-S.pdf
Contrasted Prognostic Impact of Tumor Infiltration by Various Subsets of Immune Cells
Wolf Hervé Fridman, MD, PhD - INSERM
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-9.30 - Fridman.pdf
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Breast Cancer Skin Metastases
Sylvia Adams, MD - NYU Cancer Institute
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-10.00am - Adams Nov 5 SITC IMQ in breast cancer-S.pdf
Serial Imaging of Inflammation and Therapeutic Response with Clinically Translational 19F MRI
Amy K. Wesa, PhD - Celsense, Inc
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-10.45 Wesa.pdf
Frequency of Strong Antibody Responses Following Combination Immunotherapy Correlates with Increased PSA Doubling Time in Men with Androgen-Independent Prostate Cancer
Sachin Puri, PhD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-11.30am - Sachin Puri, SITC 2011, 11052011-S.pdf
IDO1 Activity Correlates with Hepatocyte Growth Factor Levels and Immune System Impairment in Multiple Myeloma
Sergio Rutella, MD, PhD - IRCCS Bambino Gesù Children's Hospital
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-11.45am - Rutella_SITC Bethesda 2011-Revised-S.pdf
Intracranial Administration of Human Activated NK Cells in a Xenogeneic Model of Orthotopic Glioblastoma
William J. Murphy, PhD - University of California-Davis
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-2.15pm - Murphy_SITC20011talk-S.pdf
Immunological Correlates of Long-Term Survival in Melanoma Patients
Graham Pawelec, PhD - University of Tuebingen
www.sitcancer.org/meetings/am11/presentations/index.php?filename=2.00pm - Pawelec SITC 051111.pdf
Immunotransplant for Mantle Cell Lymphoma: a Phase I/II Study Demonstrating Amplification of Tumor-Reactive T Cells
Joshua Brody, MD - Stanford University Medical Center
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-3.30pm%20-%20Brody-J%20SITC%2011-11-S.pdf
IRF5 Gene Polymorphism in Melanoma
Lorenzo Uccellini, PhD - National Institutes of Health, CC, DTM
www.sitcancer.org/meetings/am11/presentations/index.php?filename=3.50%20-%20%20Lorenzo%20Uccellini.pdf
Dysfunctional Tumor-Infiltrating T Cells Express the Anergy-Associated Molecules Lymphocyte-Activation Gene 3 (LAG3) and Class-I-MHC Restricted T Cell Associated Molecules (CRTAM)
Yan Zheng, PhD - University of Chicago
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-4.30pm%20-%20Yan%20SITC%20Revised%2020111027%20TG%20102811-S.pdf
Clinical Immunotherapy Guidelines Update
Howard L. Kaufman, MD - Rush University Medical Center
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-4.50pm%20-%20Kaufman_CIG%20Update%20for%20SITC%2011.11-S.pdf
National Cancer Institute, NIH Update
William Merritt, PhD - National Cancer Institute
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SAT-5.20pm%20-%20Merritt_Updade%20on%20NCI%20to%20SITC%202011%20Final-S.pdf
Repetitive DNA Vaccination Elicits PAP Antigen-Specific T Cell Immune Responses in Patients with Castrate-Resistant Prostate Cancer
Douglas G. McNeel, MD, PhD - University of Wisconsin
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SUN-830.pdf
Lymphoid and Myeloid Biomarkers for Clinical Outcome of Ipilimumab and Prostate GVAX Treatment: Tumor-related CTLA-4 Expression by CD4+ T Cells as a Dominant Predictor of Survival
Tanja D. De Gruijl, PhD - VU University Medical Center
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SUN-9.15_de%20Gruijl.pdf
Combining Vaccines with Other Therapeutics: A Strategy to Accelerate Proof of Concept Studies
James L. Gulley, MD, PhD, FACP - National Cancer Institute
www.sitcancer.org/meetings/am11/presentations/index.php?filename=AM-SUN-9.45am%20-%20Gulley2011%2011%2006%20SITC%20Comb%20tx-S.pdf

2011 Primer

Innate Immunity
Willem W. Overwijk, PhD - UT MD Anderson Cancer Center
www.sitcancer.org/meetings/am11/presentations/index.php?filename=PR-8.05am - Overwijk_Innate Immunity and Inflammation_ISBTc primer 2011-S.pdf
Immunobiology of the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/am11/presentations/index.php?filename=PR-11.40am%20-%20Gajewski_SITC%20tumor%20microenvironment%20primer%20092611-S.pdf
Adoptive Immunotherapy
Mark E. Dudley, PhD - National Cancer Institute, NIH
www.sitcancer.org/meetings/am11/presentations/index.php?filename=Dudley%20Primer%20revised%20slides-S.pdf
Immune Monitoring
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am11/presentations/index.php?filename=PR-4.10pm%20-%20Butterfield_ImmMonitor_Nov2011rev-S.pdf

2011 Workshop

Differential Responses to Immunotherapy of Orthotopic Tumors Compared to Subcutaneous Tumors
Michael H. Kershaw, PhD - Peter MacCallum Cancer Centre
www.sitcancer.org/meetings/am11/presentations/index.php?filename=WK-8.40am%20-%20Kershaw%20SITC-S.pdf
Session Introduction
Hideho Okada, MD, PhD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am11/presentations/index.php?filename=WK-10.40am%20-%20Okada_Session%202%20Introduction-S.pdf
PresentationTranslational Development of Therapeutic Vaccines for Lymphoma
Larry W. Kwak, MD, PhD, MD - Anderson Cancer Center
www.sitcancer.org/meetings/am11/presentations/index.php?filename=WS-11.05%20-%20rev%20KWAK.pdf
Cancer Vaccine Combinations with Conventional Therapies
Philip M. Arlen, MD - National Cancer Institute, NIH
www.sitcancer.org/meetings/am11/presentations/index.php?filename=WK-11.25am%20-%20Arlen_STIC%20NOV%202011-S.pdf
Developing Immunotherapy Combinations - Logistical Issues/Legal Matters
David T. Bonk, JD - Bristol-Myers Squibb Company
www.sitcancer.org/meetings/am11/presentations/index.php?filename=WK-1.40pm%20-%20Bonk%20Immunotherapy%20Pres-S.pdf

2011 Hot Topic Symposium

Tim-3 as a Target for Anti-Tumor Immunotherapy
Ana C. Anderson, PhD - Harvard Medical School
www.sitcancer.org/meetings/am11/presentations/index.php?filename=SITC-Anderson_public-S.pdf
Selective IDO1 Inhibition: Pharmacodynamic & Antitumor Activity
Holly K. Koblish, PhD - Incyte Corporation
www.sitcancer.org/meetings/am11/presentations/index.php?filename=HT-11.20%20-%20Koblish.pdf
VISTA, a Novel Immune Checkpoint Protein that Negatively Regulates T Cell Responses & Suppresses Anti-tumor Immunity
Li Wang, PhD - Dartmouth Medical School
www.sitcancer.org/meetings/am11/presentations/index.php?filename=HT-11.40am%20-%20Wang_SITC%20NOV.%202011%20-%20revised-S.pdf
New Methods of Expanding T Cells
Mark E. Dudley, PhD - National Cancer Institute, NIH
www.sitcancer.org/meetings/am11/presentations/index.php?filename=SM-Dudley%2011-1-S.pdf

2010 Annual Meeting

Immune Checkpoint Blockade in Cancer Therapy: New Insights and Opportunities
James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Allison_AM10_secure.pdf
Therapeutic Vaccination with Autologous mRNA Electroporated Dendritic Cells in Patients
Bart Neyns, MD, PhD - Universitair Ziekenhuis Brussel
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Neyns_AM10_secure.pdf
Resistance to the Proapoptotic Effects of IFN-? on Melanoma Cells Used in Patient-Specific Dendritic Cell Immunotherapy is Associated with Improved Overall Survival
Andrew N. Cornforth, PhD - Hoag Memorial Hospital Cancer Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Conforth_AM10_secure.pdf
IFN-gamma is Central to Both Immunogenic and Tolerogenic Properties of Dendritic Cells After IL-12 and GM-CSF Microsphere Treatment
Jamie L. Harden - State University of New York, University at Buffalo
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Harden_AM10_secure.pdf
The High-Dose Aldesleukin (IL-2) Select Trail in Patients with Metastatic Renal Cell Carcinoma
Kim A. Margolin, MD - Seattle Cancer Care Alliance
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Margolin_AM10_secure.pdf
The Role of Invariant NKT Cells at the Interface of Innate and Adaptive Immunity
Vincenzo Cerundolo, MD, PhD - University of Oxford - Institute of Molecular Medicine
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Cerundolo_AM10_secure.pdf
T-Regulatory Cells in Colon Cancer: Friend or Foe?
Khashayarsha Khazaie, PhD, DSc - Northwestern University, Robert Lurie Comprehensive Cancer Ctr.
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Khazaie_AM10_secure.pdf
Decoding the Tower of Babel
Vernon K. Sondak, MD - H. Lee Moffitt Cancer & Research Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Sondak_AM10_secure.pdf
Defining Response in Prostate Cancer Immunotherapy
Lawrence Fong, MD - University of California - San Francisco
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Fong_AM10_secure.pdf
Clinical Immunotherapy Guidelines: A New iSBTc Initiative
Howard L. Kaufman, MD - Rush University Medical Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Kaufman_AM10_secure.pdf
Therapeutic vaccination against HPV16-induced disease
Cornelius J.M. Melief, MD, PhD - Leiden University Medical Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Melief_AM10_secure.pdf
Induction of CD8+ T Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations with beta-Type-1-Polarized Dendritic Cells and Poly-ICLC in Patients with Recurrent Malignant Glioma
Hideho Okada, MD, PhD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Okada_AM10_secure.pdf
Endogenous and Exogenous Vaccination in the Context of Immunologic Checkpoint Blockade
Jedd D. Wolchok, MD, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Wolchok_AM10_secure.pdf
Vaccine Sites as Sinks and Graveyards for Tumor-specific T Cells
Willem W. Overwijk, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Overwiik_AM10_secure.pdf
Final Efficacy Results of A3671009, a Phase III Study of Tremelimumab vs Chemotherapy (Dacarbazine or Temozolomide) in First-line Patients With Unresectable Melanoma
Antoni Ribas, MD - University of California, Los Angeles
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Ribas_AM10_secure.pdf
The Multikinase Inhibitor Sorafenib Reverses the Suppression of IL-12 and Enhancement of IL-10 by PGE2 in Murine Macrophages
Leisha A. Emens, MD, PhD - Johns Hopkins University School of Medicine
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Emens_AM10_secure.pdf
Loss of HLA-DR Expression on CD14+ Cells: A Common Marker of Immunosuppression in Cancer Patients
Michael P. Gustafson, PhD - Mayo Clinic
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Gustafson_AM10_secure.pdf
Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Gajewski_AM10_secure.pdf
Update: 2009 iSBTc-FDA-NCI Workshop on Prognostic and Predictive Immunologic Biomarkers in Cancer
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Butterfield_AM10_secure.pdf
Cancer Immunotherapy Trials Network Update
William Merritt PhD - National Cancer Institute
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Merritt_AM10_secure.pdf
Cancer Immunotherapy Trials Network Update
Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Cheever_AM10_secure.pdf
Improving the Efficacy and Safety of G-M Virus-Specific T cells for Solid Tumors
Malcolm K. Brenner, MD, PhD - Baylor College of Medicine
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Brenner_AM10_secure.pdf
Functional Reprogramming of the Tumor Stroma by IL-12 Engineered T Cells is Required for Anti-Tumor Immunity
Sid Kerkar, MD - National Cancer institute, Center for Cancer Research, NIH
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Kerkar_AM10_secure.pdf
Noninvasive Positron Emission Tomography (PET) Imaging of Sleeping Beauty (SB) Modified CD19-Specific T Cells Expressing Herpes Simplex Virus1-Thymidine Kinase
Pallavi Raja Manuri, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Manuri_AM10_secure.pdf
Dissection of Therapy-Induced Melanoma-Reactive Cytotoxic T Cell Responses
Ton N. Schumacher, PhD - Netherlands Cancer Institute
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Schumacher_AM10_secure.pdf
Therapeutic Cell Engineering Using Surface-Conjugated Synthetic Nanoparticles
Matthias Stephen, MD, PhD - Massachusetts Institute of Technology
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Stephan_AM10_secure.pdf

2010 Primer

Innate Immunity and Inflammation
Willem W. Overwijk, PhD - University of Texas MD Anderson Cancer Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Overwijk-Primer-secure.pdf
Will Dendritic Cells Help Us Address the Challenge of Cancer Vaccines?
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Palucka-Primer-secure.pdf
Immunotherapeutic Barriers at the Level of the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Gajewski-Primer-secure.pdf
Regulatory Immune Cells
James H. Finke, PhD - Cleveland Clinic Foundation
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Finke_Primer_secure.pdf
Immune Monitoring
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Butterfield-Primer-secure.pdf
Cytokines in Cancer Immunotherapy
Kim A. Margolin, MD - Seattle Cancer Center Alliance
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Margolin-Primer-secure.pdf
Presentation SlidesCancer Vaccines
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Urba-Primer-secure.pdf

2010 Workshop

Welcome & Overview: Monoclonal Antibodies in Cancer
George J. Weiner, MD - University of Iowa
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Weiner-G_Intro_WS-secure.pdf
Monoclonal Antibody Immunotherapy
Louis M. Weiner, MD - Georgetown University Medical Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Weiner-L_WS-secure.pdf
Presentaton SlidesCombining Tumor-Reactive mAbs with Cytokines to Induce ADCC in Patients
Paul M. Sondel, MD, PhD - University of Wisconsin, Madison
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Sondel-WS-secure.pdf
Antibody-Targeted Vaccines
Tibor Keler, PhD - Celldex Therapeutics, Inc.
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Keler-WS-secure.pdf
Two-in-One Antibody: From Proof-of-Concept to Therapeutic Candidate
Germaine Fuh - Genentech, Inc.
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Fuh-WS-secure.pdf
Engineered Anti-Cancer Antibodies with Enhanced Effector Functions
Pablo Umaña, PhD - Roche Glycart AG
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Umana_WS_secure.pdf
T Cell-Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle, PhD - Micromet, Inc.
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Baeuerle-WS-secure.pdf

2010 Other

Combination opportunities in immunotherapy with immunostimulatory mAb
Ignacio Melero, MD, PhD - University of Navarra
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Melero_Hot_Topics-secure.pdf
Exploring Therapeutic Combinations with Anti-CLTA-4 Antibody
Padmanee Sharma, MD, PhD - University of Texas, MD Anderson Cancer Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Sharma_Hot_Topics-secure.pdf
Defining the Critical Hurdles in Cancer Immunotherapy
Bernard A. Fox, PhD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Fox-BM10_secure.pdf
Recommendations from the iSBTc/FDA/NCI Workshop on Immunotherapy Biomarkers
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Butterfield_BM10_secure.pdf
CTL on ELISPOT Standardization, Story of Successful Standardization
Paul V. Lehmann, MD, PhD - Cellular Technology Limited
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Lehmann_BM10_secure.pdf
Harmonization of Immunologic Monitoring Across Institutions
Cedrik M. Britten, MD - Association for Cancer Immunotherapy (CIMT)
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Britten_BM10_secure.pdf
Regulatory and Scientific Considerations for Potency Testing and Immune Monitoring
Raj K. Puri, MD, PhD - U.S. Food and Drug Administration (CBER)
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Puri_BM10_secure.pdf
Immunologic Biomarkers as Correlates for Clinical Response
Mary L. (Nora) Disis, MD - University of Washington
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Disis_BM10_secure.pdf
Measuring the Potency of Dendritic Cell Preparations Using Transcriptional Analysis
David Stroncek, MD - National Institutes of Health
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Stroncek_BM10_secure.pdf
Sipuleucel-T Immune Parameters and Correlation with Overall Survival
Mark W. Frohlich, MD - Dendreon Corporation
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Frohlich_BM10_secure.pdf
Genetic Variants in IL28B (IFN-Gamma): Major Predictors of Response to IFN-alfa Therapy for Chronic Hepatitis C
Thomas R. O'Brien, MD - National Cancer Institute, Division of Cancer Epidemiology and Genetics
www.sitcancer.org/meetings/am10/presentations/index.php?filename=OBrien_BM10_secure.pdf
Immune Changes in Tumor-Draining Lymph Nodes as Novel Biomarkers
Peter P. Lee, MD - Stanford University
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Lee_BM10_secure.pdf
Single Cell Network Profiling Technology and Applications in Immunological Monitoring
Diane Longo, PhD - Nodality Inc.
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Longo_BM10_secure.pdf
Biostatistical Considerations: Biologics and Biomarkers in Oncology
Daniel Normolle, PhD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Normolle_BM10_secure.pdf
Prospects for New Clinical Flow Cytometry Assays
Holden T. Maecker, PhD - Stanford University Medical Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Maecker_BM10_secure.pdf
Predictive Biomarkers for Tumor Immunotherapy: Are We Ready for Clinical Implementation?
Howard L. Kaufman, MD, FACS - Rush University Medical Center
www.sitcancer.org/meetings/am10/presentations/index.php?filename=Kaufma_BM10_secure.pdf

2009 Annual Meeting

The Biology and Therapy of Brain Metastasis
Isaiah J. Fidler, DVM, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am09/presentations/thurs/Fidler.pdf
Identification of Colon Cancer Associated Antigens which would be Key Therapeutic Targets in the Prevention of Disease Relapse or Progression
Elizabeth K. Broussard, MD - University of Washington Tumor Vaccine Group
www.sitcancer.org/meetings/am09/presentations/thurs/Broussard_915am.pdf
Identification of a Novel CD8+CD57+ T Cell Subset in Human Melanoma Exhibiting an Incompletely Differentiated CTL Phenotype
Richard Wu, BS - MD Anderson Cancer Center
www.sitcancer.org/meetings/am09/presentations/thurs/Wu1000am.pdf
A Data Analysis Method for Identifying Autoantibody Biomarkers in Cancer Patients Following Immunotherapy
Janet Siebert, MD - CytoAnalytics
www.sitcancer.org/meetings/am09/presentations/thurs/Siebert_1045am.pdf
gamma-8 T Cells-Agents of Tissue and Tumour Immune Surveillance
Adrian Hayday, PhD - King's College London
www.sitcancer.org/meetings/am09/presentations/thurs/Hayday.pdf
Enhancing Cancer Vaccines as Monotherapy and in Combination Therapies
Jeffrey Schlom, PhD - National Cancer Institute, NIH
www.sitcancer.org/meetings/am09/presentations/thurs/Schlom.pdf
Defining the Role of TKIs in Reducing Immune Suppression While Improving T Cell Responsiveness and Efficacy of Immunotherapy for the Treatment of Tumors
James H. Finke, PhD - Cleveland Clinic Foundation
www.sitcancer.org/meetings/am09/presentations/thurs/Finke.pdf
Type-1 Dendritic Cell Vaccines in Combination With Poly-ICLC - Association Between Positive Tetramer Response and 6-Month Progression-Free Survival
Hideho Okada, MD, PhD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am09/presentations/thurs/Okada.pdf
IL-17 Secreting CD8 T Cells - Functional Plasticity and Potential Role in Tumor Immunity
Charles G. Drake, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am09/presentations/thurs/Drake_355pm.pdf
Interleukin-1 Role in Human TH17 Responses, Dendritic Cell Activation, and Epithelial Cell Transformation
Giorgio Trinchieri, MD - National Cancer Institute
www.sitcancer.org/meetings/am09/presentations/thurs/Trinchieri_420pm.pdf
FcγR Mediated Regulation of Adaptive Immunity: Implications for Antibody Therapies
Madhav Dhodapkar, MD - Yale University
www.sitcancer.org/meetings/am09/presentations/thurs/Dhodapkar.pdf
Synergy of Radiation and Immune Therapy in Tumor Eradication
Maria Grazia Ruocco, PhD - NYU - School of Medicine, Skirball Institute
www.sitcancer.org/meetings/am09/presentations/thurs/Ruocco_335pm.pdf
Current and Future Preventive HPV Vaccines
Douglas R. Lowy, MD - National Cancer Institute, CCR
www.sitcancer.org/meetings/am09/presentations/fri/Lowy_845am.pdf
Therapeutic Strategies for Human Papillomavirus-Associated Cancers
Karl Munger, PhD - Brigham & Women's Hospital, Harvard Medical School
www.sitcancer.org/meetings/am09/presentations/fri/Munger_915am.pdf
Definition of the Immunological Properties of Cancer Stem Cells Isolated from Human Glioblastoma
Cristina Maccalli, PhD - San Raffaele Foundation Scientific Institute
www.sitcancer.org/meetings/am09/presentations/fri/Maccalli_1045am.pdf
T-Cell Delivery of Interleukin-12 to the Tumor Microenvironment Triggers Potent Endogenous Anti-Tumor Responses
Sid Kerkar, MD - National Cancer Institute, Center for Cancer Research
www.sitcancer.org/meetings/am09/presentations/fri/Kerkar_100pm.pdf
Eradication of Established CD19-Postive Leukemia Using a Single Injection of Chimeric Immunoreceptor Modified Lentiviral Transduced T Cells in a Xenograft Nog Mouse Model
David M. Barrett, MD, PhD - Children's Hospital of Philadelphia
www.sitcancer.org/meetings/am09/presentations/fri/Barrett_200pm.pdf
Cellular and Molecular Requirements for Rejection of B16 Melanoma in the Setting of Regulatory T Cell Depletion and Homeostatic Proliferation
Presented by Thomas F. Gajeski, MD, PhD - on behalf of Justin P. Kline, MD- University of Chicago
www.sitcancer.org/meetings/am09/presentations/fri/Kline.pdf
Checkpoint Blockade in Tumor Immunotherapy: New Insights and Opportunities
James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am09/presentations/fri/Allison_245pm.pdf
Manipulation of the Tumor Microenvironment by CTLA-4 Blockade
Padmanee Sharma, MD, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am09/presentations/fri/Sharma_315pm.pdf
Eosinophilic Granulocytes Modulate Tumor Microenvironment by Oxidizing Damage Associated Molecular Pattern Molecules Derived from Necrotic Tumor Cells
Ramin Lotfi, MD - University of Ulm, Institute for Transfusion Medicine
www.sitcancer.org/meetings/am09/presentations/fri/Lotfi_400pm.pdf
Small-Molecule Inhibitors of the IDO Pathway as Immune Modulators
David H. Munn, MD - Medical College of Georgia
www.sitcancer.org/meetings/am09/presentations/fri/Munn.pdf
Soluble, High Affinity T Cell Receptors as Cancer Therapeutics
Bent Jakobsen - Immunocore Ltd.
www.sitcancer.org/meetings/am09/presentations/fri/Jakobsen.pdf
Small Molecule Curcumin Analogs Induce Apoptosis in Human Melanoma Cells via STAT3 Inhibition but do not Alter the Cellular Response to Immunotherapeutic Cytokines
Gregory B. Lesinski, PhD - The Ohio State University
www.sitcancer.org/meetings/am09/presentations/fri/Lesinski400pm.pdf
Update: 2008 Workshop on Cancer & Inflammation: Promise for Biological Therapy
Michael T. Lotze, MD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am09/presentations/fri/Lotze430pm.pdf
Cell Transfer Therapy for Patients with Metastatic Cancer
Steven A. Rosenberg, MD, PhD - National Cancer Institute
www.sitcancer.org/meetings/am09/presentations/sat/rosenberg.pdf
What are the Functional and Phenotypic Qualities of Therapeutically Successful Anti-Tumor Cells?
Nicholas P. Restifo, MD - National Cancer Institute
www.sitcancer.org/meetings/am09/presentations/sat/Restifo.pdf
Programming Tumor-Reactive Effector Memory CD8+ T Cells In Vitro Obivates the Requirement for In Vivo Vaccination
Christopher A. Klebanoff, MD - National Institutes of Health, Center for Cancer Research
www.sitcancer.org/meetings/am09/presentations/sat/Klebanoff900am.pdf
Adoptive Transfer of T Cells Genetically Modified Using the Sleeping Beauty System
Laurence J.N. Cooper, MD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am09/presentations/sat/Cooper.pdf

2009 Workshop

FDA Perspective on Biomarkers
Steven Kozlowski, MD - Food and Drug Administration, Office of Biotechnology Products
www.sitcancer.org/meetings/am09/workshop09/presentations/Kozlowski_800am.pdf
The Biomarkers Consortium: A Public-Private Partnership to Advance Biomarker Research
Shawnmarie Mayrand-Chung, PhD, JD - National Institutes of Health - Office of the Director, OPSA Public-Private Partnerships Program
www.sitcancer.org/meetings/am09/workshop09/presentations/Mayrand_Chung_835am.pdf
Standardization of Immune Biomarkers: Lessons from the HIV Field
Alan L. Landay, PhD - Rush University Medical Center
www.sitcancer.org/meetings/am09/workshop09/presentations/Landay_845am.pdf
Immune Monitoring Consortium Experience
Mary (Nora) Disis, MD - University of Washington
www.sitcancer.org/meetings/am09/workshop09/presentations/Disis_915am.pdf
Multi-Institution Trials and the Eastern Cooperative Oncology Group
Lisa H. Butterfield, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am09/workshop09/presentations/Butterfield.pdf
Discussion
Sylvia Janetzki, MD - ZellNet Consulting
www.sitcancer.org/meetings/am09/workshop09/presentations/Janetzki_945am.pdf
Discussion
Cedrik Britten, MD - Johannes Gutenberg University
www.sitcancer.org/meetings/am09/workshop09/presentations/Britten.pdf
Discussion
Dominic Eisinger, PhD - Rules Based Medicine, Inc.
www.sitcancer.org/meetings/am09/workshop09/presentations/Eisenger_945am_RBM.pdf
Assessing Dendritic Cell Vaccines
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
www.sitcancer.org/meetings/am09/workshop09/presentations/Palucka_iSBTc_Oct2009.pdf
Use of Molecular Assays to Assess Cellular Therapies
David Stroncek, MD - Cell Processing, DTM, CC, National Institutes of Health
www.sitcancer.org/meetings/am09/workshop09/presentations/Stroncek.pdf
Discussion
Moderator: Licia Rivoltini, MD - Fondazione IRCCS Istituto Nazionale dei Tumori
www.sitcancer.org/meetings/am09/workshop09/presentations/Discuss2.pdf
Discussion
Edwin Walker, PhD - Providence Cancer Center
www.sitcancer.org/meetings/am09/workshop09/presentations/Walker_1150.pdf
T Cell Response Signatures in Breast Cancer vs. Chronic Infection
Holden T. Maecker, PhD - Stanford University Medical Center
www.sitcancer.org/meetings/am09/workshop09/presentations/Maecker120pm.pdf
Summary of the US-Japan Workshop on Immunotherapy Markers in Oncology
Hideaki Tahara, MD, PhD - University of Tokyo
www.sitcancer.org/meetings/am09/workshop09/presentations/TAHARA_200pm.pdf
Discussion
Moderator: Lupe G. Salazar, MD
Keith Bahjat, PhD - University of Washington
Earle A. Chiles Research Institute

www.sitcancer.org/meetings/am09/workshop09/presentations/Discuss3.pdf
Immunologic Monitoring of Cancer Vaccine Trials - What to Measure, How and Why?
Anatoli M. Malyguine, MD, PhD - SAIC-Frederick, NCI-Frederick
www.sitcancer.org/meetings/am09/workshop09/presentations/Malyguine345pm.pdf
System Biology Approaches
Rafick-Pierre Sékaly, PhD - University of Montreal, VGTI Florida
www.sitcancer.org/meetings/am09/workshop09/presentations/Sekaly_355pm.pdf
Some Statistical Issues in the Design and Analysis of Vaccine Clinical Trials in Cancer Patients
Douglas M. Potter, PhD - University of Pittsburgh
www.sitcancer.org/meetings/am09/workshop09/presentations/Potter_425pm.pdf
High Throughput Technology and Predictive Immune Monitoring
Peter P. Lee, MD - Stanford University
www.sitcancer.org/meetings/am09/workshop09/presentations/Lee445pm.pdf
Systems Immunology at the Bedside
Damien Chaussabel, PhD - Baylor Institute for Immunology Research
www.sitcancer.org/meetings/am09/workshop09/presentations/Chaussabel5pm.pdf
Trans-NIH Center for Human Immunology: Goals and Progress
Giorgio Trinchieri, MD - National Cancer Institute
www.sitcancer.org/meetings/am09/workshop09/presentations/Trinchieri_520pm.pdf
Application of Proteomics to Biomarker Discovery: New Challenges, New Technology
Lance Liotta, MD, PhD - George Mason University
www.sitcancer.org/meetings/am09/workshop09/presentations/Liotta.pdf

2009 Other

A Phase III Multi-Institutional Randomized Study of Immunization with the gp 100:209-217 (210M) Peptide Followed by High Dose IL-2 vs. High Dose IL-2 Alone in Patients with Metastatic Melanoma
Doug J. Schwartzentruber, MD, FACS - Goshen Center for Cancer Care
www.sitcancer.org/meetings/am09/presentations/sat/Schwartzentruber_1045.pdf
Development History of Sipuleucel-T: Progress of an Active Immunotherapy for Prostate Cancer
David L. Urdal, PhD - Dendreon Corporation
www.sitcancer.org/meetings/am09/presentations/sat/Urdal.pdf
NY-ESO-1 Specific Responses in Patients with Advanced Prostate Cancer Treated wtih Ipilimumab
Jianda Yuan, MD, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am09/presentations/sat/Yuan.pdf
Circulating Regulatory T Cell Function and Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Poxviral-based Vaccine
Matteo Vergati, MD - National Cancer Institute, Center for Cancer Research
www.sitcancer.org/meetings/am09/presentations/sat/VERGATI.pdf

2008 Annual Meeting

Different Tumor Antigens in the Immunotherapy of Cancer: Are we Selecting the Right Target?
Giorgio Parmiani, MD - San Raffaele Foundation
www.sitcancer.org/meetings/am08/presentations/giorgio_parmiani.pdf
T Cell Receptor-Dependent and Independent Pathways Control PD-1 Expression on CD8+ T cells Generated upon Intra Lymph Node Immunization
Adrian Bot, MD, PhD - MannKind Corporation
www.sitcancer.org/meetings/am08/presentations/adrian_bot.pdf
Cellular Immunotherapy and Immune Regulation in Ovarian Cancer
Martin J. Cannon, PhD - University of Arkansas for Medical Sciences
www.sitcancer.org/meetings/am08/presentations/martin_cannon.pdf
Three Ways to Enhance the Destructive Power of Tumor-Specific T Cells
Nicholas P. Restifo, MD - National Cancer Institute
www.sitcancer.org/meetings/am08/presentations/nicholas_restfio.pdf
Engineering GVL by T-Cell Genetic Modification
Michael C.V. Jensen, MD - City of Hope / Beckman Research Institute
www.sitcancer.org/meetings/am08/presentations/michael_jensen.pdf
IL-23 Promotes Tumor Associated Inflammation and Subverts Immune Surveillance
Martin Oft, MD - Schering-Plough Biopharma (formerly DNAX)
www.sitcancer.org/meetings/am08/presentations/martin_oft.pdf
Potent Anti-Tumor Immunity and Both TH-1 and TH-17 Promotion Associated with IL-23 Administration
Hideaki Tahara, MD, PhD - University of Tokyo
www.sitcancer.org/meetings/am08/presentations/hideaki_tahara.pdf
Overall Survival and New Patterns of Response in Patients with Advanced Melanoma Treated with Ipilimumab
Steven J. O'Day, MD - The Angeles Clinic and Research Institute
www.sitcancer.org/meetings/am08/presentations/steven_oday.pdf
Endpoints for Biologic Therapeutics in Oncology
Peter Bross, MD - FDA - Office of Cellular, Tissue, and Gene Therapies
www.sitcancer.org/meetings/am08/presentations/peter_bross.pdf
Keynote Address
Cancer Immunoediting: Distinct Roles for Innate and Adaptive Immunity in Cancer Control and Promotion

Robert D. Schreiber, PhD - Washington University in St. Louis
www.sitcancer.org/meetings/am08/presentations/robert_schreiber.pdf
Innate Immune Signals that Mediate Host Awareness of Tumor and Promote Adaptive Immune Responses Against Tumor Antigens
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/images/icn_video.gif
Inhibitory B7 Family Members (B7-H1 and B7-H4) in the Tumor Microenvironment
Weiping Zou, MD, PhD - University of Michigan
www.sitcancer.org/meetings/am08/presentations/weiping_zou.pdf
Evidence for Selection of a Resistant Tumor Microenvironment Following Successful Clinical Response to a Multi-Peptide + IL-12 Melanoma Vaccine
Yuanyuan Zha, PhD - Human Immunologic Monitoring Facility, University of Chicago
www.sitcancer.org/meetings/am08/presentations/yuanyuan_zha.pdf
CCL28 a New Link Between Hypoxia Angiogenesis and Tumor Immune Evasion
Andrea Facciabene, PhD - University of Pennsylvania
www.sitcancer.org/meetings/am08/presentations/andrea_facciabene.pdf
Cytotoxic T Lymphocyte-associated Antigen 4 Blockade Enhances Polyfunctional NY-ESO-1 Specific T Cell Responses in Metastatic Melanoma Patients with Tumor Regression
Jianda Yuan, MD, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am08/presentations/jianda_yuan.pdf
Radiofrequency Ablation with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect Against Murine Colon Adenocarcinoma
Erik Johnson, MD - University of Wisconsin-Madison
www.sitcancer.org/meetings/am08/presentations/erik_johnson.pdf
Antibody and Small Moldular Immune Pharmaceutical Therapies for Patients with Chronic Lymphocytic Leukemia: A Major Step Forward
John C. Byrd, MD - The Ohio State University
www.sitcancer.org/meetings/am08/presentations/john_byrd.pdf
Phase I/II Study of CR011-vcMMAE, an Antibody-Drug Conjugate Targeting GPNMB, for the Treatment of Patients with Advanced Melanoma
Patrick Hwu, MD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am08/presentations/patrick_hwu.pdf
Optimizing Engagement of the Immune System by Anti-Tumor Antibodies
John R. Desjarlais, PhD - Xencor, Inc.
www.sitcancer.org/meetings/am08/presentations/john_desjarlais.pdf
Role of NKG2D in Tumor Surveillance
David Raulet, PhD - University of California, Berkeley
www.sitcancer.org/meetings/am08/presentations/david_raulet.pdf
Innate Immunity Can Contribute to the Shaping of Tumor Immunogenicity in the Absence of Adaptive Immunity
Jack D. Bui, MD, PhD - University of California, San Diego
www.sitcancer.org/meetings/am08/presentations/jack_bui.pdf
Update: 2007 Workshop on Future Opportunities for Combination Biological Therapy of Cancer
Jon M. Wigginton, MD - Merck & Co., Inc.
www.sitcancer.org/meetings/am08/presentations/jon_wigginton.pdf
Regulation of Breast Cancer Stem Cells by the Microenvironment
Max Wicha, MD - University of Michigan
www.sitcancer.org/meetings/am08/presentations/max_wicha.pdf
Characterization of the Immune Profile of Cancer Stem Cells Isolated from Human Glioblastoma
Cristina Maccalli, PhD - San Raffaele Foundation Scientific Institute
www.sitcancer.org/meetings/am08/presentations/christina_maccalli.pdf

2008 Primer

End Stage: Immune Killing of Tumors
William J. Murphy, PhD - University of California Davis, School of Medicine
www.sitcancer.org/meetings/am08/primer08/presentations/william_murphy.pdf
Blocking T Cell Checkpoints
James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am08/primer08/presentations/james_allison.pdf
Approach to Identification and Therapeutic Exploitation of Tumor Antigens
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am08/primer08/presentations/walter_urba.pdf
T Reg Cells
Shimon Sakaguchi, MD, PhD - Kyoto University, Japan
www.sitcancer.org/meetings/am08/primer08/presentations/shimon_sakaguchi.pdf
Immune Monitoring of Cancer Immunotherapy
Michael D. Kalos, PhD - City of Hope
www.sitcancer.org/meetings/am08/primer08/presentations/michael_kalos.pdf
Immune Adjuvants
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
www.sitcancer.org/meetings/am08/primer08/presentations/palucka_adjuvants.pdf

2009 Workshop

Defining Inflammation
Sandra Demaria, MD - New York University
www.sitcancer.org/meetings/am08/workshop08/presentations/sandra_demaria.pdf
Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer
Yen-Ching Karen Chen, ScD, SM - National Taiwan University
www.sitcancer.org/meetings/am08/workshop08/presentations/karen_chen.pdf
Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer
Emad M. El-Omar, MB ChB, MD - University of Aberdeen
www.sitcancer.org/meetings/am08/workshop08/presentations/emad_elomar_b.pdf
Current Clinical Evidence for Targeting Inflammation to Prevent Cancer
Eva Szabo, MD - National Cancer Institute, NIH
www.sitcancer.org/meetings/am08/workshop08/presentations/eva_szabo.pdf
Novel Therapeutics and Clinical Trial Development to Treat Cancer
Arthur M. Krieg, MD - Pfizer
www.sitcancer.org/meetings/am08/workshop08/presentations/arthur_krieg.pdf
Recombinant Interleukin-21 Plus Sorafenib for Metastatic Renal Cell Carcinoma (MRCC): A Phase 1 Dose Escalation Study
Shailender Bhatia, MD - University of Washington
www.sitcancer.org/meetings/am08/workshop08/presentations/shailender_bhatia.pdf
RLIP76: A Target for Kidney cancer Therapy
Sanjay Awasthi, MD - University of North Texas Health Sciences Center
www.sitcancer.org/meetings/am08/workshop08/presentations/sanjay_awasthi.pdf
April Produced by Neutrophils Promotes Diffuse Large B-Cell Lymphoma Development
Bertrand Huard, PhD - Medical University Center
www.sitcancer.org/meetings/am08/workshop08/presentations/bertrand_huard.pdf
Plenary Session: Industry Perspectives on Anti-inflammatory Therapy
Robert T. Abraham, PhD - Wyeth
www.sitcancer.org/meetings/am08/workshop08/presentations/robert_abraham.pdf
Breakout 1 Report: Defining Inflammation
Michele Carbone, MD, PhD - Cancer Research Center of Hawaii
www.sitcancer.org/meetings/am08/workshop08/presentations/michele_carbone.pdf
Breakout 2 Report: Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer
Emad M. El-Omar, MB ChB, MD - University of Aberdeen
www.sitcancer.org/meetings/am08/workshop08/presentations/emad_elomar.pdf
Breakout 3 Report: Animal Models of Cancer and Inflammation.
Lisa M. Coussens, PhD - University of California, San Francisco
www.sitcancer.org/meetings/am08/workshop08/presentations/lisa_coussens.pdf
Breakout 4 Report: Causes and Molecular Targets in Cancer and Inflammation
Giorgio Trinchieri, MD - National Cancer Institute
www.sitcancer.org/meetings/am08/workshop08/presentations/giorgio_trinchieri.pdf
Breakout 5 Report: Current Clinical Evidence for Targeting Inflammation to Prevent Cancer
Steven Dubnielt, MD - University of california, Los Angeles
www.sitcancer.org/meetings/am08/workshop08/presentations/steven_dubnielt.pdf
Breakout 6 Report: Novel Therapeutics and Clinical Trial Development to Treat Cancer
George J. Weiner, MD - University of Iowa
www.sitcancer.org/meetings/am08/workshop08/presentations/george_weiner.pdf

2008 Other

Introduction
Ulrich Keilholz, MD - Charité CBF
www.sitcancer.org/meetings/am08/symposium/presentations/ulrich_keilholz.pdf
Review of Ipilmumab Development Program and Data
Jeffrey S. Weber, MD, PhD - H. Lee Moffitt Cancer Center and Research Institute
www.sitcancer.org/meetings/am08/symposium/presentations/jeffrey_weber.pdf
Review of Tremilmumab Development Program and Data
Antoni Ribas, MD - UCLA Medical Center
www.sitcancer.org/meetings/am08/symposium/presentations/antoni_ribas.pdf
Comparison of Development Plans of IL2 and CTLA4 Abs
Mario Sznol, MD - Yale University School of Medicine
www.sitcancer.org/meetings/am08/symposium/presentations/mario_sznol.pdf
Evaluation of IL2/Anti-CTLA4 Type Activity Data
Steven Hirschfeld, MD, PhD - National Institute of Child Health and Human Development
www.sitcancer.org/meetings/am08/symposium/presentations/steven_hirschfeld.pdf
Keynote Address
Regulatory Overview of Oncology Biologics Product Development from Bench to First-in-Man

Raj Puri, MD, PhD - Food and Drug Administration, CBER
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/1_puri.pdf
Cell and Gene Therapy Products for Cancer Treatment
Ying Huang, PhD - Food and Drug Administration, CBER
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/2_%20huang.pdf
Biological Therapeutics for Cancer Treatment
Andrew J. McDougal, PhD, DABT - Food and Drug Administration, CDER
www.sitcancer.orghttp://www.sitcancer.org/meetings/am08/primer08_oncology/presentations/3_mcdougal.pdf
Session 2: Clinical Development
Phase I Design Issues: Surrogate Markers/Selecting Pts/Special Inclusion-Exclusion Criteria

Susan Jerian, MD - OncoRD, Inc.
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/6_jerian.pdf
Session 2: Clinical Development
Phase II and Beyond Issues

John M. Kirkwood, MD - University of Pittsburgh
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/7_kirkwood.pdf
Session 2: Clinical Development
Good Clinical Research Practice - Working in the World of Regulated Research

Marta Fields - Amgen Inc.
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/8_fields.pdf
Session 3: Case Studies in Protein Therapeutics
Cytokines: Lessons From Double Digit Cytokines IL12, IL18 and Counting

Michael T. Lotze, MD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/10_lotze.pdf
Session 3: Case Studies in Protein Therapeutics
Antibodies: CD40 Agonist Development for Cancer

Robert H. Vonderheide, MD, D.Phil - University of Pennsylvania, Abramson Family Cancer Rsch. Inst.
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/12_vonderheide.pdf
Session 4: Industry and Academic Relationships in Biologic Development
Academic Drug Development: Bench to First-in-Man without Industry

Elizabeth M. Jaffee, MD - Johns Hopkins University
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/13_jaffee.pdf
Session 4: Industry and Academic Relationships in Biologic Development
Industry Perspective: What Industry Expects from Academic Partnerships

David Parkinson, MD - Nodality, Inc.
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/14_parkinson.pdf
Session 4: Industry and Academic Relationships in Biologic Development
Academic Perspective: Role of Tech Transfer in Academia and Common Out-Licensing Criteria

Christopher Moulding - USC Stevens Institute for Innovation
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/15_moulding.pdf
Session 5: Regulatory Strategies in the Global Arena
EU Perspective on Regulatory Issues for Biologics

Robert Charnas, PhD - Amgen
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/16_charnas.pdf
Session 5: Regulatory Strategies in the Global Arena
Japan Perspective on Regulatory Issues for Biologics

Click to view presentationKen Takeshita, MD - Celgene
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/17_takeshita.pdf
Session 6: Case Studies in Vaccines
Dendritic Cell Based Vaccines

Lothar H. Finke, MD - ARGOS Therapeutics
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/19_finke.pdf
Session 6: Case Studies in Vaccines
Nucleic Acid Based Vaccines

Laurence Elias, MD - Geron Corporation
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/21_elias.pdf
Session 7: Case Studies in Cellular Therapeutics
NK Cell Therapeutics for Cancer

Jeffrey Miller, MD - University of Minnesota
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/23_miller.pdf
Session 7: Case Studies in Cellular Therapeutics
Adoptive T Cell Transfer of Regulatory T Cells for GVHD

Carl H. June, MD - University of Pennsylvania
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/24_june.pdf
Session 7: Case Studies in Cellular Therapeutics
Mesenchymal Stem Cell Therapy with ProchymalTM

C. Randal Mills, PhD - Osiris Therapeutics, Inc.
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/25_mills.pdf
Session 8: Case Studies in Gene Therapies
Oncolytic Viruses: Reovirus

Matt Coffey, PhD - Oncolytics Biotech, Inc.
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/26_coffey.pdf
Session 8: Case Studies in Gene Therapies
Adenovirus Vectors

Sunil Chada, PhD - Introgen Therapeutics, Inc.
www.sitcancer.org/meetings/am08/primer08_oncology/presentations/28_chada.pdf

2007 Annual Meeting

Richard V. Smalley Memorial Lectureship
Interferons (IFNs) for Cancer: Defining Biological Response Modification and Full Therapeutic Potential

Ernest C. Borden, MD - Cleveland Clinic Foundation
www.sitcancer.org/meetings/am07/presentations/friday/bordens.pdf
Adoptive Cellular Therapy: Sustained Regression of Large Tumor Burdens with In Vitro Expanded T-Cells
James C. Yang, MD - National Cancer Institute
www.sitcancer.org/meetings/am07/presentations/friday/iSBTc.pdf
Targeting Tumors with Genetically Enhanced T Lymphocytes
Michel Sadelain, MD, PhD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am07/presentations/friday/Sadelain.pdf
Engineering Cytolytic Effector Cells for Glioma Immunotherapy Using Gene Insertion and Zinc Finger Nuclease Genomic Editing
Click to view presentationMichael C.V. Jensen, MD - City of Hope / Beckman Research Institute
www.sitcancer.org/meetings/am07/presentations/friday/945_jensen.pdf
T-Cell Therapy for the Control of EBV-Related Nasopharyngeal Carcinoma
Paulo Pedrazzoli, MD - Ospedale Niguarda Cao Granda
www.sitcancer.org/meetings/am07/presentations/friday/pedrazzoli.pdf
Stat3 Mediates a Crosstalk Between Tumor Cells and Immune Cells in the Tumor Microenvironment
Hua Yu, PhD - City of Hope National Medical Center
www.sitcancer.org/meetings/am07/presentations/friday/Yu.pdf
Antibody Immunity to a Panel of Oncogenic Proteins May Predict Presence of Colon Cancer and Stage of Disease
Vivian Goodell, MPH - University of Washington
www.sitcancer.org/meetings/am07/presentations/friday/2_Goodell.pdf
A Possible Role for Regulatory T-Cells in Survival Differences Between Helicobacter Pylori Posititve and Negative Gastric Cancer Patients After Curative Tumor Resection
Hauke Winter, MD - Klinikum Grosshadern, Ludwig-Maximilians University of Munich
www.sitcancer.org/meetings/am07/presentations/friday/215_Winter.pdf
Immunophenotypic Analysis of Melanoma Metastases: A New Approach for Prognostication in Stage IV Melanoma
Alicia M. Terando, MD - John Wayne Cancer Institute
www.sitcancer.org/meetings/am07/presentations/friday/230_Terando.pdf
A Cell-Based Vaccine for Neuroblastoma Induces VLA-2 (CD49b) on CD8+ T Effector/Memory Cells Via CD137
Rimas J. Orentas, PhD - Medical College of Wisconsin
www.sitcancer.org/meetings/am07/presentations/friday/245_Orentas.pdf
Interleukin 1 Family Members Regulate Tumor Immunity in Response to Damage Associated Molecular Pattern Molecules (DAMPs)
Michael T. Lotze, MD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am07/presentations/friday/345_Lotze.pdf
IL-24 and Its Role in Wound Healing
Nancy J. Poindexter, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am07/presentations/friday/415_Poindexter.pdf
Intra-Tumoral IL-12 Promotes CD8 + T-Effector/Memory Cell- Mediated IFN-Gamma and FASL-Dependent Elimination of CD4+ CD25+ FOX3+ T-Suppressor Cells from Tumors
Mehmet O. Kilinc, PhD - University at Buffalo / SUNY
www.sitcancer.org/meetings/am07/presentations/friday/kilinc.pdf
Impaired Angiogenesis in Aminopeptidase N-Null Mice
Roberto Rangel, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am07/presentations/friday/5_Rangel.pdf
Saturday Keynote Address
Adoptive T Cell Therapy: Grand Challenges and Opportunities

Carl H. June, MD - University of Pennsylvania
www.sitcancer.org/meetings/am07/presentations/saturday/June.pdf
Different Flavors of Regulatory T-Cell (Treg) Subsets in Patients with Cancer and Their Role in Tumor Escape
Christoph Bergmann, MD, PhD - University of Duisburg-Essen
www.sitcancer.org/meetings/am07/presentations/saturday/bergmann.pdf
Foxp3 is Expressed by Tumor Cells, Virally Transformed B Cells, and Germ Cells
Weisan Chen, PhD - Ludwig Institute for Cancer Research
www.sitcancer.org/meetings/am07/presentations/saturday/Chen.pdf
Adoptive Immunotherapy of Malignancies with Gene Modified, EBV-Specific, Cytotoxic T-Cell Lines
Malcolm K. Brenner, MD, PhD - Baylor College of Medicine
www.sitcancer.org/meetings/am07/presentations/saturday/Brenner2.pdf
Therapeutically Accessible Molecules That Regulate the Regulators
Drew M. Pardoll, MD, PhD - Johns Hopkins University School of Medicine
www.sitcancer.org/meetings/am07/presentations/saturday/2_Pardoll.pdf
Tumor-Derived Macrophage Migration Inhibitory Factor (MIF) Inhibits Immune Reactivity to Neuroblastoma In Vivo
Bryon D. Johnson, PhD - Medical College of Wisconsin
www.sitcancer.org/meetings/am07/presentations/saturday/230_Johnson.pdf
5-aza-2?- Deoxycytidine Treatment Increases Expression of Tumor Associated Antigens in Human Melanoma
Timothy Haggerty, PhD - CytoCure LLC
www.sitcancer.org/meetings/am07/presentations/saturday/24_Haggerty.pdf
A Phase II Study of Tremelimumab (CP-675,206), an Anti-CTLA4 Monoclonal Antibody, in Patients with Refractory Metastatic Colorectoal Cancer
Ki Y. Chung, MD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am07/presentations/saturday/145_Chung.pdf
EGFRVIII Vaccine (CDX-110) Alone and with Simultaneous Temozolomide in Patients with Newly Diagnosed, Resected, EGFRVIII Positive GBM
John Sampson, MD, PhD - Duke University Medical Center
www.sitcancer.org/meetings/am07/presentations/saturday/Sampson.pdf
Novel Agents in Renal Cell Carcinoma: Challenges and Opportunities in Capitalizing on Active Therapy
Brian I. Rini, MD - Cleveland Clinic Taussig Cancer Center
www.sitcancer.org/meetings/am07/presentations/saturday/230_Rini.pdf
Retrospective Analysis of Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma Who had Received Prior Antiangiogenic Therapy
Talya Schwarzberg, MD - Beth Israel Deaconess Medical Center
www.sitcancer.org/meetings/am07/presentations/saturday/405_Schwarzberg.pdf
CD4+CD25highFoxp3+ T Regulatory Cells Kill Autologous CD8(+) and CD4(+) T Cells Using GranzymeB and Fas/FasL-Mediated Pathways
Laura Strauss, PhD - San Raffaele Telethon Institute for Gene Therapy
www.sitcancer.org/meetings/am07/presentations/saturday/strauss.pdf
Update: 2006 Mini-Symposium Update
Michael B. Atkins, MD - Beth Israel Deaconess Medical Center
www.sitcancer.org/meetings/am07/presentations/sunday/Atkins.pdf
Update: National Cancer Institute Immunotherapy Agent Workshop
Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center
www.sitcancer.org/meetings/am07/presentations/sunday/cheever.pdf
The Development of Provenge (Sipuleucel-T) an Active Cellular Immunotherapy for Prostate Cancer
David L. Urdal, PhD - Dendreon Corporation
www.sitcancer.org/meetings/am07/presentations/sunday/845_Urdal.pdf
Long-Term Survival in Patients with Metastatic Melanoma Vaccinated with Melanoma-Antigen Loaded Dendritic Cells
Joseph W. Fay, MD - Baylor University Medical Center
www.sitcancer.org/meetings/am07/presentations/sunday/915_Fay.pdf
IMA901, a Novel Multi-Peptide Vaccine for the Treatment of Renal Cell Carcinoma - Pre-Clinical and Clinical Studies and Implications for Combination with Other Agents
Harpreet Singh, PhD - Immatics Biotechnologies GmbH
www.sitcancer.org/meetings/am07/presentations/sunday/singh.pdf
Insulin like Growth Factor Receptor Family Members: Essential Tumor Antigens in Breast Cancer
Mary L. Disis, MD - University of Washington
www.sitcancer.org/meetings/am07/presentations/sunday/disis.pdf
Hot Topic Sessions: Vaccines / Dendritic Cells
Brent A. Blumenstein, PhD - TriArc Consulting
www.sitcancer.org/meetings/am07/presentations/sunday/1135_Blumenstein.pdf
Hot Topic Sessions: Vaccines / Dendritic Cells
Lee S. Simon, MD - Beth Israel Deaconess Medical Center
www.sitcancer.org/meetings/am07/presentations/sunday/112_Simon.pdf
Hot Topic Sessions: Vaccines / Dendritic Cells
Charles Drake, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am07/presentations/sunday/1150_drake.pdf
Hot Topic Sessions: Vaccines / Dendritic Cells
David L. Urdal, PhD - Dendreon Corporation
www.sitcancer.org/meetings/am07/presentations/sunday/1130_Urdal.pdf

2007 Primer

Cancer Vaccines
Carmen Scheibenbogen, MD - Institut for Med. Immunologie, Charité, Berlin
www.sitcancer.org/meetings/primer07/presentations/3_Scheibenbogen.pdf
T Cell Therapy
Patrick Hwu, MD - MD Anderson Cancer Center
www.sitcancer.org/meetings/primer07/presentations/hwu.pdf
Host-Tumor Interations
Francesco Marincola, MD - National Institutes of Health
www.sitcancer.org/meetings/primer07/presentations/415_Marincola.pdf
Normalization of the Tumor Microenvironment by Antiangiogenic Therapy
Rakesh K. Jain, PhD - Harvard Medical School
www.sitcancer.org/meetings/primer07/presentations/jain.pdf
Angiogenesis as an Organizing Principle in Biology
Judah Folkman, MD - Children's Hospital Boston
www.sitcancer.org/meetings/primer07/presentations/folkman.pdf
Antibody Therapy, Biology, Immunocytokines and Hematologic Malignancy
Paul M. Sondel, MD, PhD - University of Wisconsin
www.sitcancer.org/meetings/primer07/presentations/730_Sondel.pdf
Antibody Therapy of Solid Tumors
Louis M. Weiner, MD - Fox Chase Cancer Center
www.sitcancer.org/meetings/primer07/presentations/weiner.pdf
Immunotoxin Therapy of Cancer: Successes and Challenges
Ira H. Pastan, MD - National Institutes of Health
www.sitcancer.org/meetings/primer07/presentations/pastan.pdf
Cytokines in Malignancy
Kim A. Margolin, MD - City of Hope Cancer Center
www.sitcancer.org/meetings/primer07/presentations/925_Margolin.pdf

2007 Workshop

Welcome and Meeting Introduction
Jon M. Wigginton, MD - Merck & Co., Inc.
www.sitcancer.org/meetings/workshop07/presentations/8_Wigginton.pdf
Immunotherapy and Immunotherapy Combinations
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/workshop07/presentations/815_Gajweski.pdf
Angiogenesis and Immunotherapy Combinations
George Coukos, MD, PhD - University of Pennsylvania Medical Center
www.sitcancer.org/meetings/workshop07/presentations/9_Coukos.pdf
Apoptosis Induction and Immunotherapy
Peter Hersey, MD, PhD - University of Newcastle
www.sitcancer.org/meetings/workshop07/presentations/10_Hersey.pdf
Cytotoxic Chemotherapy and Immunotherapy
Ronald E. Gress, MD - NCI, NIH
www.sitcancer.org/meetings/workshop07/presentations/gress_a.pdf
Treatment of Established Tumors with Peritumoral Injections of CD40 Ligand (CD40L), CpG, poly(I:C), and Extracellular ATP in Murine Models
Richard S. Kornbluth, MD, PhD - University of California San Diego
www.sitcancer.org/meetings/workshop07/presentations/1_Kornbluth.pdf
Plenary Session: Perspectives on Combination Therapy
Regulatory Perspective

Ashok Batra, MD - Food and Drug Administration
www.sitcancer.org/meetings/workshop07/presentations/145_Batra.pdf
Plenary Session: Perspectives on Combination Therapy
Industry Perspective

Geoffrey M. Nichol, MBChB, MBA - Medarex, Inc
www.sitcancer.org/meetings/workshop07/presentations/2_Nichol.pdf
Plenary Session: Perspectives on Combination Therapy
Legal Perspective

Andrew D. Barofsky, JD, MBA - Oregon Biomedical Engineering Institute, Inc.
www.sitcancer.org/meetings/workshop07/presentations/225_Barofsky.pdf
Breakout Session Reports/Panel Discussions
Breakout 1 Report: Immunotherapy and Immunotherapy Combinations

Jon M. Wigginton, MD - Merck & Co., Inc.
www.sitcancer.org/meetings/workshop07/presentations/Wigginton.pdf
Breakout Session Reports/Panel Discussions
Breakout 2 Report: Angiogenesis and Immunotherapy Combinations

Heinz Zwierzina, MD - Innsbruck Medical University
www.sitcancer.org/meetings/workshop07/presentations/Zwierzina.pdf
Breakout Session Reports/Panel Discussions
Breakout 3 Report: Apoptosis Induction and Immunotherapy

James H. Finke, PhD - Cleveland Clinic Foundation
www.sitcancer.org/meetings/workshop07/presentations/finke.pdf
Breakout Session Reports/Panel Discussions
Breakout 4 Report: Cytotoxic Chemotherapy and Immunotherapy

Ronald E. Gress, MD - NCI, NIH
www.sitcancer.org/meetings/workshop07/presentations/gress_b.pdf

2007 Other

Introduction
Robert J. Soiffer, MD - Dana-Farber Cancer Institute
www.sitcancer.org/meetings/dinner07/presentations/730_Soiffer.pdf
NK Cells and Hematopoietic Stem Cell Transplantation
Jeffrey Miller, MD - University of Minnesota
www.sitcancer.org/meetings/dinner07/presentations/miller.pdf
Use of Molecular Targeting to Separate Graft-Versus-Host Disease from Graft-Versus-Tumor Effects
William J. Murphy, PhD - University of Nevada School of Medicine
www.sitcancer.org/meetings/dinner07/presentations/845_Murphy.pdf
Keynote Address
Signaling PAMPs and DAMPSs - role of TLRs, NLRs and RLRs

Gunther Hartmann, MD
www.sitcancer.org/meetings/damp07/doc/gunther_hartmann.pdf
Leaderless Cytokines as DAMP's: Role of REDOX
Anna Rubartelli, MD - National Cancer Research Institute
www.sitcancer.org/meetings/damp07/doc/anna_rubartelli.pdf
Chronic Inflammation and Cancer
Michael Lotze, MD - Professor of Surgery and Bioengineering, University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/damp07/doc/michael_lotze.pdf
Experimental Models Evaluating DAMP's in Trauma and Sepsis
Tim Billiar, MD - Professor, University of Pittsburgh
www.sitcancer.org/meetings/damp07/doc/tim_billiar.pdf
Cellular and Extracellular Endogenous Agonists
Jeffrey Platt, MD - Professor of Surgery, Immunology, and Pediatrics and Head of the Transplantation Biology Program, Mayo Clinic College of Medicine
www.sitcancer.org/meetings/damp07/doc/jeffrey_platt.pdf
Hypoxia-Adenosinergic Regulation of Immune Response and Control of Inflammatory Tissue Damage
Mikael Sitkovsky, PhD - Eleanor M. Black Chair of Immunophysiology and Pharmaceutical Biotechnology, Professor of Pharmaceutical Biotechnology, Northeastern University
www.sitcancer.org/meetings/damp07/doc/michail_sitkovsky.pdf
Accelerated Development of Glomerulonephritis in TNF Receptor 1 and 2 Double-knockout Lupus-mice
Noam Jacob - University of Southern California
www.sitcancer.org/meetings/damp07/doc/noam_jacob.pdf
TLR2-mediated Tumorigenesis
http://www.sitcancer.org/meetings/damp07/doc/sunhwa_kim_2.pdf - University of California, San Diego
www.sitcancer.org/meetings/damp07/doc/sunhwa_kim_2.pdf
Defying Death Defining Cancer
http://www.sitcancer.org/meetings/damp07/doc/wei-xing_zong.pdf - Assistant Professor, Stony Brook University
www.sitcancer.org/meetings/damp07/doc/wei-xing_zong.pdf
Toll-like Receptors and Cancer
Alain Vicari, DVM PhD - Director, Immunology, Coley Pharmaceutical Group
www.sitcancer.org/meetings/damp07/doc/alain_vicari.pdf
Mouse Models of Apoptosis, Autophagy, Necrosis, and Cancer
Eileen White, PhD - Principal Investigator, White Lab, Center for Advanced Biotechnology and Medicine
www.sitcancer.org/meetings/damp07/doc/eileen_white.pdf

2006 Annual Meeting

Targeting Tumor Antigen Delivery to Dendritic Cells In Vivo
Larry Kwak, MD, PhD - MD Anderson Cancer Center
www.sitcancer.org/meetings/am06/presentations/annual_meeting/kwak.pdf
Immunogenicity and Clinical Efficacy of a Hi-8TM PrimeBoost Therapeutic Vaccine in Stage III/IV Melanoma Patients in a Phase I/II Trial
Richard J. Anderson, PhD - Oxxon Therapeutics Limited
www.sitcancer.org/meetings/am06/presentations/annual_meeting/anderson.pdf
A Phase I Trial of a Monoclonal Antibody to OX40 in Patients with Advanced Cancer
Brendan D. Curti, MD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/am06/presentations/annual_meeting/curti.pdf
A Histone Deacetylase Inhibitor (HDACi) Sensitizes B16 Melanoma to Adoptive Transfer (AT) Immunotherapy
Dan Vo - University of California, Los Angeles
www.sitcancer.org/meetings/am06/presentations/annual_meeting/vo.pdf
Preclinical Studies of IL-21 Plus Rituximab Combination Therapy for B-Cell Lymphoma
Wayne Kindsvogel, PhD - ZymoGenetics, Inc.
www.sitcancer.org/meetings/am06/presentations/annual_meeting/kindsvogel.pdf
rhIL7 Administration in Humans Results in Preferential Expansion of Naive, and Memory Subsets of CD4+ & CD8+ T-Cells
Claude Sport's, MD - National Cancer Institute
www.sitcancer.org/meetings/am06/presentations/annual_meeting/sportes.pdf
Evaluation of the Performance of Immunologic Monitoring Assays: Results from the Immunologic Monitoring Consortium
Mary L. Disis, MD - University of Washington
www.sitcancer.org/meetings/am06/presentations/annual_meeting/disis.pdf
The Paradoxical Effect Of High Dose Interleukin-2 (IL-2) On CD4+CD25+ Regulatory T Cells
Howard L. Kaufman, MD - Columbia University
www.sitcancer.org/meetings/am06/presentations/annual_meeting/kaufman.pdf
Maintenance of CD27+ Effector Memory T Cells During Ex Vivo Expansion of Melanoma TIL is Critical for Adoptive T-Cell Therapy
Yufeng Li - MD Anderson Cancer Center
www.sitcancer.org/meetings/am06/presentations/annual_meeting/li.pdf
Induction of Anti-Tumor Immunity by Anti-Tumor Monoclonal Antibodies
Madhav Dhodapkar, MD - The Rockefeller University
www.sitcancer.org/meetings/am06/presentations/annual_meeting/dhodapkar.pdf
Immunotherapy with Antibody Targeted MHC Complexes: Results of InVivo Tumour Cell Killing and Therapeutic Vaccination
Philip M. Savage, PhD, FRCP - Charing Cross Hospital
www.sitcancer.org/meetings/am06/presentations/annual_meeting/savage.pdf
Changes in Intratumoral Immune Cell Infiltrates, Foxp3 and Indoleamine 2, 3-dioxygenase (IDO) Expression with the CTLA4 Blocking mAb CP-675,206
Antoni Ribas, MD - University of California, Los Angeles Medical Center
www.sitcancer.org/meetings/am06/presentations/annual_meeting/ribas.pdf
CD8 T Cell-Mediated Antitumor Effect of Imiquimod in a Mouse Model of Breast Cancer
Hailing Lu, PhD - University of Washington
www.sitcancer.org/meetings/am06/presentations/annual_meeting/lu.pdf
Poster Discussion Session
F. Stephen Hodi, MD - Dana-Farber Cancer Institute
www.sitcancer.org/meetings/am06/presentations/annual_meeting/hodi.pdf
2005 Workshop Update: Early and Late Clinical Vaccine Development
Axel Hoos, MD, PhD - Bristol-Myers Squibb Company
www.sitcancer.org/meetings/am06/presentations/annual_meeting/hoos.pdf

2006 Primer

Clinical Trials of Immunotherapy with T Cells: Vaccines and Adoptive T Cell Therapy
Mary L. Disis, MD - University of Washington
www.sitcancer.org/meetings/am06/presentations/primer/disis.pdf
Biology of Innate Immunity: NK Cells, Macrophage, PMN, PAMP/TLR
Lewis Lanier, PhD - University of California, San Francisco
www.sitcancer.org/meetings/am06/presentations/primer/lanier.pdf
Principles of Antibody Engineering and Therapy
Sherie Morrison, PhD - UCLA
www.sitcancer.org/meetings/am06/presentations/primer/morrison.pdf
Clinical Trials of Antibody Therapy: Solid Tumors
Dennis J. Slamon, MD, PhD - UCLA
www.sitcancer.org/meetings/am06/presentations/primer/slamon.pdf
Cytokines in the (Immuno)Therapy of Malignancy
Kim A. Margolin, MD - City of Hope Cancer Center
www.sitcancer.org/meetings/am06/presentations/primer/margolin.pdf

2006 Other

Welcome/Introduction
Michael B. Atkins, MD - Beth Israel Deaconess Medical Center, Boston, MA
www.sitcancer.org/meetings/am06/presentations/mini-symposium/atkins.pdf
Impact of Chemotherapy on Angiogenesis
George Coukos, MD, PhD - University of Pennsylvania Medical Center, Philadelphia, PA
www.sitcancer.org/meetings/am06/presentations/mini-symposium/coukos.pdf
Impact of the Nature of Cell Death on Immune Function
Michael T. Lotze, MD - University of Pittsburgh, Pittsburgh, PA
www.sitcancer.org/meetings/am06/presentations/mini-symposium/lotze.pdf
Does Antibody Therapy Induce Immune Response?
Madhav Dhodapkar, MD - The Rockefeller University, New York, NY
www.sitcancer.org/meetings/am06/presentations/mini-symposium/dhodapkar.pdf
Effects of Antiagiogenic Therapy on the Immune System
Marc S. Ernstoff, MD - Dartmouth-Hitchcock Medical Center, Lebanon, NH
www.sitcancer.org/meetings/am06/presentations/mini-symposium/ernstoff.pdf
Off Target Biologic Effects on Targeted Therapies
Thomas F. Gajewski, MD, PhD - University of Chicago, Chicago, IL
www.sitcancer.org/meetings/am06/presentations/mini-symposium/gajewski.pdf

2006 Workshop

Leadership Perspectives on Biologic Combinations
Perspectives from NCI

Robert Wiltrout, PhD - National Cancer Institute
www.sitcancer.org/meetings/workshop06/nci_wiltrout.pdf
Leadership Perspectives on Biologic Combinations
Perspectives from FDA

Raj Puri, MD, PhD - Food and Drug Administration
www.sitcancer.org/meetings/workshop06/fda_puri.pdf
Leadership Perspectives on Biologic Combinations
Perspective from EORTC

Alexander Eggermont, MD, PhD - Erasmus University Medical Center
www.sitcancer.org/meetings/workshop06/eortc_eggermont.pdf
Opportunities and Obstacles to Developing Novel Biologic Combinations
Academic Perspective

Michael Atkins, MD - Beth Israel Deaconess Medical Center
www.sitcancer.org/meetings/workshop06/academic_atkins.pdf
Opportunities and Obstacles to Developing Novel Biologic Combinations
Industry Perspective

Geoffrey Nichol, MD, MBA - Medarex, Inc.
www.sitcancer.org/meetings/workshop06/industry_nichol.pdf
Opportunities and Obstacles to Developing Novel Biologic Combinations
Regulatory Perspective

Steven Hirschfeld, MD, PhD - Food and Drug Administration
www.sitcancer.org/meetings/workshop06/regulatory_hirschfeld.pdf
State of the Art 1: Combination Immunotherapy
Thomas Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/workshop06/state_of_the_art_1.pdf
State of the Art 2: Combination Immune-Antiangiogenic Therapy
Kim Margolin, MD - City of Hope
www.sitcancer.org/meetings/workshop06/state_of_the_art_2_margolin.pdf
State of the Art 2: Combination Immune-Antiangiogenic Therapy
George Coukos, MD, PhD - University of Pennsylvania
www.sitcancer.org/meetings/workshop06/state_of_the_art_2_coukos.pdf
State of the Art 2: Combination Immune-Antiangiogenic Therapy
Ralph Reisfeld, PhD - Scripps Research Institute
www.sitcancer.org/meetings/workshop06/state_of_the_art_2_reisfeld.pdf
State of the Art 3: Combination Immune Therapy-Modulator of Apoptosis
Craig Slingluff, Jr., MD - University of Virginia
www.sitcancer.org/meetings/workshop06/state_of_the_art_3.pdf
State of the Art 4: Combination Immune Therapy-Chemotherapy
Elizabeth Jaffee, MD - Johns Hopkins University
www.sitcancer.org/meetings/workshop06/state_of_the_art_4.pdf
State of the Art 4: Combination Immune Therapy-Chemotherapy
John Kirkwood, MD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/workshop06/state_of_the_art_4_kirkwood.pdf
Breakout Session Discussion Reports: Breakout 1
Bernard Fox, PhD - Earle A. Chiles Research Institute
www.sitcancer.org/meetings/workshop06/breakout_1_dinner_report.pdf
Breakout Session Discussion Reports: Breakout 2
Rachel Humphrey, MD - Bristol Myers-Squibb Company
www.sitcancer.org/meetings/workshop06/breakout_2_dinner_report.pdf
Breakout Session Discussion Reports: Breakout 3
Jeffrey Weber, MD, PhD - Norris Cancer Center
www.sitcancer.org/meetings/workshop06/breakout_3_dinner_report.pdf
Breakout Session Discussion Reports: Breakout 4
Edward Berg - Bristol Myers-Squibb Company
www.sitcancer.org/meetings/workshop06/breakout_4_dinner_report.pdf

2005 Annual Meeting

Plenary Session: Overcoming Immunosuppression / Tolerance in Cancer Patients
Thomas F. Gajewski, MD, PhD - University of Chicago
www.sitcancer.org/meetings/am05/presentations/gajewski-jaffey.pdf
How Host Cells Sink Anti-tumor Responses by Competing for Activating Cytokines
Nicholas P. Restifo, MD - National Cancer Institute
www.sitcancer.org/meetings/am05/presentations/restifo.pdf
IL-2 Paradoxically Controls Tolerance and Immunity to a Tumor/Self-antigen
Paul A. Antony, MD - National Cancer Institute - Surgery Branch
www.sitcancer.org/meetings/am05/presentations/antony.pdf
Recruitment of High Avidity Antigen Specific T Cells with T Regulatory Cell Modulation
Elizabeth M. Jaffee, MD - Johns Hopkins University
www.sitcancer.org/meetings/am05/presentations/jaffee.pdf
Identification of a Well-tolerated Outpatient Regimen of Interleukin-21 in Patients with Metastatic Melanoma and Renal Cell Carcinoma
John A. Thompson, MD - University of Washington
www.sitcancer.org/meetings/am05/presentations/thompson.pdf
Induction of Therapeutic Breast Cancer Immunity with an IL-2 Immunotoxin
Keith Knutson, PhD - Mayo Clinic
www.sitcancer.org/meetings/am05/presentations/knutson.pdf
Systematic Analysis of Anti-NY-ESO-1 T Cell Responses Reveals Striking HLA-dependent Immunodominance
Weisan Chen, PhD - Ludwig Institute for Cancer Research
www.sitcancer.org/meetings/am05/presentations/chen.pdf
GM-CSF Can Modulate the Migratory Phenotype of Vaccine-induced T Cells by Enhancing CXCR3 Expression
Il-Kang Na, MD - Charity, Campus Benjamin Franklin
www.sitcancer.org/meetings/am05/presentations/na.pdf
A CWG 3-arm Phase II Trial of GP100 (209-2M) Peptide + High Dose Interleukin-2 in HLA-A2+ Advanced Melanoma Patients
Jeffrey A. Sosman, MD - Vanderbilt University
www.sitcancer.org/meetings/am05/presentations/sosman.pdf
Stepping Stones Toward Cancer Immunotherapy
Alan L. Epstein, MD, PhD - University of Southern California, Keck School of Medicine
www.sitcancer.org/meetings/am05/presentations/epstein.pdf
Phase I Trial of Siplizumab in CD2-positive Lymphoproliferative Disease
John Janik, MD - National Cancer Institute - Metabolism Branch
www.sitcancer.org/meetings/am05/presentations/janik.pdf
A Phase I Trial of Interleukin-12 with Trastuzumab and Paclitaxel for HER2-overexpressing Malignancies
Julie Roda - Ohio State University
www.sitcancer.org/meetings/am05/presentations/roda.pdf
Inflammatory Protein Profile During Systemic High Dose Interleukin-2 Administration
Leonardo Rossi, PhD - National Institutes of Health - Immunogenetics Section
www.sitcancer.org/meetings/am05/presentations/rossi.pdf
A Novel Two-gene Expression Ratio that Predicts Clinical Outcome in Breast Cancer Patients Treated with Tamoxifen
Dennis C. Sgroi, MD - Harvard Medical School
www.sitcancer.org/meetings/am05/presentations/sgroi.pdf
Characterization of Primary and Immune Escape Variant of HER- 2/NEU Overexpressing Mouse Mammary Carcinoma
Masoud H. Manjili, PhD - Virginia Commonwealth University
www.sitcancer.org/meetings/am05/presentations/manjili.pdf
CD4 Cells can be More Efficient at Tumor Rejection than CD8 Cells
Ainhoa Perez-Diez, PhD - National Institutes of Health
www.sitcancer.org/meetings/am05/presentations/perez-diez.pdf
Mechanism of Caspase Independent Activation Induced Cell Death of Human Primary Cytotoxic T Lymphocytes: Implications for Cancer Immunotherapy
Arvind Chhabra, PhD - University of Connecticut Health Center
www.sitcancer.org/meetings/am05/presentations/chhabra.pdf
Treatment of Patients with Metastatic Melanoma by Infusion of Anti-MART-1 TCR-Gene Engineered Lymphocytes
Richard Morgan, PhD - National Cancer Institute - Surgery Branch
www.sitcancer.org/meetings/am05/presentations/morgan.pdf
Ex-vivo Heat Shock Protein 70-Peptide-activated, Autologous Natural Killer Cells Adoptive Therapy: From the Bench to the Clinic
Valeria Milani, MD, PhD - Ludwig Maximilian University
www.sitcancer.org/meetings/am05/presentations/milani.pdf
Isoform-specific Gene Targeting for Cancer Therapy with Small Interfering RNA (siRNA)
Lin Zhang, MD - University of Pennsylvania
www.sitcancer.org/meetings/am05/presentations/zhang.pdf
Molecular Manipulation of the Anti-tumor Immune Response
Drew M. Pardoll, MD, PhD - Johns Hopkins University
www.sitcancer.org/meetings/am05/presentations/pardoll.pdf
Potent Immunity Achieved by Targeted, Sequential Administration of Recombinant DNA Vectors and Anchor-modified Epitope Peptides
Adrian Bot, MD, PhD - MannKind Corporation
www.sitcancer.org/meetings/am05/presentations/bot.pdf
In Situ Targeting of Antigen Presenting Cells within Secondary Lymphoid Organs as a Means to Control Immune Responses
Kent A. Smith, MA - MannKind Corporation
www.sitcancer.org/meetings/am05/presentations/smith.pdf
Making Vaccines Work: Translating Basic and Preclinical Immunology into Human Immunotherapies
Nicholas P. Restifo, MD - National Cancer Institute
www.sitcancer.org/meetings/am05/presentations/restifo_sunday.pdf

2005 Primer

T Cells: Receptors and Biology
Carl June, PhD
www.sitcancer.org/meetings/am05/primer_presentations/june.pdf
B Cells, Antibody Synthesis, Immunoglobulin Genetics, and Antibody Engineering
Stephen Gillies, PhD
www.sitcancer.org/meetings/am05/primer_presentations/gillies.pdf
NK Cells and NKT Cells: Receptors and Biology
Jenny Gumperz, PhD
www.sitcancer.org/meetings/am05/primer_presentations/gumperz.pdf
Macrophages and Dendritic Cells
Giorgio Trinchieri, MD
www.sitcancer.org/meetings/am05/primer_presentations/trinchieri.pdf
Cancer Immunotherapy with T Cells: Vaccines and Adoptive Immunotherapy
Martin Cheever, MD
www.sitcancer.org/meetings/am05/primer_presentations/cheever.pdf
Cancer Immunotherapy with Cytokines: Activation of Endogenous Immune Cells and Combination with other Immunotherapies
William Carson, MD
www.sitcancer.org/meetings/am05/primer_presentations/carson.pdf
Cancer Immunotherapy: Combined Therapies with Antibodies and Antibody Constructs
Dennis J. Slamon, MD, PhD
www.sitcancer.org/meetings/am05/primer_presentations/slamon.pdf

2005 Workshop

Introductory Remarks
Ulrich Keilholz, MD - Charity CBF, Berlin, Germany
www.sitcancer.org/meetings/am05/workshop_presentations/hoos.pdf
Dendritic Cell Based Vaccine Development
Robert Hershberg, MD, PhD - Dendreon Corporation, Seattle, WA
www.sitcancer.org/meetings/am05/workshop_presentations/hershberg.pdf
Multi-Peptide Vaccines
Craig Slingluff, Jr., MD - University of Virginia, Charlottesville, VA
www.sitcancer.org/meetings/am05/workshop_presentations/slingluff.pdf
Workstream 1: Clinical Endpoints to Support Efficacy
Peter Bross, MD - Food and Drug Administration, Rockville, MD
www.sitcancer.org/meetings/am05/workshop_presentations/workstream_1.pdf
Workstream 2: Design Methodologies for Cancer Vaccine Trials
Alexander Eggermont, MD, PhD - Erasmus University Medical Center, Rotterdam, Netherlands
www.sitcancer.org/meetings/am05/workshop_presentations/workstream_2.pdf
Workstream 4: Enabling Technologies and Combinations of Investigational Agents
Ke Liu, PhD - Food and Drug Administration, Rockville, MD
www.sitcancer.org/meetings/am05/workshop_presentations/workstream_4.pdf
Measuring Residual Tumor Burden
Jerald Radich, MD - Fred Hutchinson Cancer Research Center, Seattle, WA
www.sitcancer.org/meetings/am05/workshop_presentations/radich.pdf
Cancer Biometrics - Results of the 2003 iSBTc Workshop
Theresa Whiteside, PhD - University of Pittsburgh Cancer Institute, Pittsburgh, PA
www.sitcancer.org/meetings/am05/workshop_presentations/whiteside.pdf
Bayesian Designs for Early Drug Development Trials
Stephen George, PhD - Duke University, Durham, NC
www.sitcancer.org/meetings/am05/workshop_presentations/george.pdf
FDA Perspective on the Preclinical Development of Cancer Vaccines
Richard McFarland, MD, PhD - Food and Drug Administration, Rockville, MD
www.sitcancer.org/meetings/am05/workshop_presentations/mcfarland.pdf

2004 Annual Meeting

Welcome Address
Steven Hirschfeld, MD, PhD - FDA Office of Cellular, Tissue and Gene Therapies
www.sitcancer.org/meetings/am04/presentations/hirschfeld.pdf
Immunological Adjuvants, the Indispensable Third Component
Philip O. Livingston, MD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am04/presentations/livingston.pdf
nduction of TH1-Type Immunity and Tumor Protection with a Prostate Specific Antigen DNA Vaccine and pIL-18 Adjuvant Therapy
Deborah J. Marshall, PhD - Centocor, Inc.
www.sitcancer.org/meetings/am04/presentations/marshall.pdf
Adoptive Immunotherapy of Cancer with Polyclonal Hyperexpanded CD4 and CD8 T Cells Derived from Tumor-Draining Lymph Nodes
Gregory E. Plautz, MD - Cleveland Clinic Foundation
www.sitcancer.org/meetings/am04/presentations/plautz.pdf
Therapeutic Efficacy of MUC1-Specific Cytotoxic T Lymphocytes and CD137 Co-Stimulation in a Spontaneous Mammary Cancer Model
Pinku Mukherjee, PhD - Mayo Clinic Scottsdale
www.sitcancer.org/meetings/am04/presentations/mukherjee.pdf
Where's the Rub - Really Useful Biomarkers in Cancer
Michael T. Lotze, MD - University of Pittsburgh School of Medicine
www.sitcancer.org/meetings/am04/presentations/lotze.pdf
Bioinformatical Data Reduction Approaches for High Dimensional Data Derived from High Throughput Assays
Yu Shyr, MD - Vanderbilt University School of Medicine
www.sitcancer.org/meetings/am04/presentations/shyr.pdf
Characterizing Complete Responders to IL-2 Using Gene Expression Analysis and Tissue Array Validation in Patients with Metastatic Renal Cell Carcinoma
Allan Pantuck, MD - University of California Los Angeles
www.sitcancer.org/meetings/am04/presentations/pantuck.pdf
Gene Expression Patterns Associated with Renal Cancer (RCC) Response and Resistance to IL-2-Based Therapy
Philip G. Febbo, MD - Duke Institute for Genome Science and Policy
www.sitcancer.org/meetings/am04/presentations/febbo.pdf
Markers from the Tumor Microenvironment. Are They Useful?
George Coukos, MD, PhD - University of Pennsylvania Medical Center
www.sitcancer.org/meetings/am04/presentations/coukos.pdf
Strategies to Augment the Efficacy of Dendritic Cell-Based Vaccines
Johannes Vieweg, MD FACS - Duke University
www.sitcancer.org/meetings/am04/presentations/vieweg.pdf
A Randomized Placebo-Controlled Phase II Study with the Cancer Vaccine IGN101 in Patients with Epithelial Cancers
Marc Salzberg - Pharma Brains, Ltd.
www.sitcancer.org/meetings/am04/presentations/salzberg.pdf
Multipeptide Vaccines for Melanoma: Strategies for Increasing the Breadth of the T Cell Repertoire
Craig L. Slingluff, Jr., MD - University of Virginia
www.sitcancer.org/meetings/am04/presentations/slingluff.pdf
Cross Resistance of Melanoma Cells to Apoptosis Induced by Trail and Chemotherapy
Peter Hersey, MD, PhD - Newcastle Mater Hospital
www.sitcancer.org/meetings/am04/presentations/hersey.pdf
Mechanisms of Resistance to Anti-Tumor Immunity Downstream from Initial T Cell Priming
Thomas Gajewski, MD, PhD - University of Chicago Medical School
www.sitcancer.org/meetings/am04/presentations/gajewski.pdf
Melanoma Gene Expression Profiles To Identify Mechanisms of Tumor Resistance to a Multi-Peptide/IL-12 Vaccine
Helena A. Harlin, PhD - University of Chicago
www.sitcancer.org/meetings/am04/presentations/harlin.pdf
Tumor-Infiltrating Dendritic Cell Precursors Recruited by a ß-Defensin Contribute to Vasculogenesis Under the Influence of VEGF-A in Ovarian Cancer
Jose Ramon Conejo-Garcia, MD, PhD - University of Pennsylvania
www.sitcancer.org/meetings/am04/presentations/conejo-garcia.pdf
Cyclooxygenase-2 Regulates Cytokine Balance and Apoptosis Resistance in Non-Small Cell Lung Cancer
Steven Dubinett, MD - University of California Los Angeles Lung Cancer Research Program
www.sitcancer.org/meetings/am04/presentations/dubinett.pdf
Grade 4 Thrombocytopenia During Treatment with High-Dose Interleukin-2 Is a Predictor of Response in Melanoma But Not in Renal Cell Cancer
Timothy E. Bael, MD - Duke University Medical Center
www.sitcancer.org/meetings/am04/presentations/bael.pdf
Use of DNA Microarray Analysis to Identify Genes and Signaling Pathways Central to the Anti-Melanoma Effect of Interferon-?
Jared A. Gollob, MD - Duke University Medical Center
www.sitcancer.org/meetings/am04/presentations/gollob.pdf
Discussion on Dendritic Cells and Vaccines
Howard L. Kaufman, MD - New York Presbyterian Hospital -Columbia Campus
www.sitcancer.org/meetings/am04/presentations/kaufman.pdf
Discussion on Mechanisms of Escape/Resistance
James W. Mier, MD - Beth Israel Deaconess Medical Center
www.sitcancer.org/meetings/am04/presentations/mier.pdf
Discussion on Adoptive Immunotherapy
James W. Young, MD - Memorial Sloan-Kettering Cancer Center
www.sitcancer.org/meetings/am04/presentations/young.pdf
Discussion on Antibody Therapy
George J. Weiner, MD - University of Iowa
www.sitcancer.org/meetings/am04/presentations/weiner.pdf
Discussion on Natural Killer Cells & Innate Immunity
Theresa L. Whiteside, PhD - University of Pittsburgh Cancer Institute
www.sitcancer.org/meetings/am04/presentations/whiteside.pdf
Threshold of Credibility: A New Approach to Product Development for Metastatic Melanoma Therapy
Steven Hirschfeld, MD, PhD - FDA Office of Cellular, Tissue and Gene Therapies
www.sitcancer.org/meetings/am04/presentations/hirschfeld2.pdf
T-Cell Independent Activity of Talabostat (PT-100) Against Human Tumor Xenografts in Mice
Barry Jones, PhD - Point Therapeutics
www.sitcancer.org/meetings/am04/presentations/jones.pdf
AME-133: A Next-Generation Anti-CD20 Engineered for Enhanced Killer Function
James B. Breitmeyer, MD, PhD - Applied Molecular Evolution, Inc.
www.sitcancer.org/meetings/am04/presentations/breitmeyer.pdf
Therapeutic Efficacy of Gc Protein-Derived Macrophage Activating Factor (GcMAF) for Adenocarcinoma
Nobuto Yamamoto, PhD - Socrates Institute for Therapeutic Immunology
www.sitcancer.org/meetings/am04/presentations/yamamoto.pdf
A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group
Kaci L. Osenga, MD - University of Wisconsin Comprehensive Cancer Center
www.sitcancer.org/meetings/am04/presentations/osenga.pdf

2004 Primer

Tumor Hypoxia and Other Physiological Barriers to Effective Biological Therapy
Mark Dewhirst, DVM, PhD
www.sitcancer.org/meetings/am04/primer_presentations/dewhirst.pdf
Mechanisms and Uses of Monoclonal Antibodies
Paul Sondel, MD
www.sitcancer.org/meetings/am04/primer_presentations/sondel.pdf
Monoclonal Antibodies in Cancer Therapy
Ralph Schwall, PhD
www.sitcancer.org/meetings/am04/primer_presentations/schwall.pdf
Targeting Tumor Antigens by Redirecting T Cells Using Bispecific Antibodies
Lawrence Lum, MD
www.sitcancer.org/meetings/am04/primer_presentations/lum.pdf
Cytokines as Cancer Therapy
Jan Dutcher, MD
www.sitcancer.org/meetings/am04/primer_presentations/dutcher.pdf
Therapeutic Approaches with Immune Cells
Robert Dillman, MD
www.sitcancer.org/meetings/am04/primer_presentations/dillman.pdf
Melanoma - Evolution as a Model for Biological Therapy
Peter Hersey, MD
www.sitcancer.org/meetings/am04/primer_presentations/hersey.pdf
Role of Antigenic Profile Changes in Tumor Escape Mechanisms
Soldano Ferrone, MD, PhD
www.sitcancer.org/meetings/am04/primer_presentations/ferrone.pdf

2004 Workshop

Introductory Remarks
Ulrich Keilholz, MD - Charity CBF, Berlin, Germany
www.sitcancer.org/meetings/am04/workshop_presentations/urba.pdf
Introductory Remarks
Jeffrey Weber for Steven Hirschfeld - FDA Office of Cellular, Tissue, Gene Therapy, Center for Biologics Evaluation & Research, Rockville, MD
www.sitcancer.org/meetings/am04/workshop_presentations/hirschfeld.pdf
Clinical Trial to Assess Vaccine Characteristics
Jeffrey S. Weber, MD, PhD - University of Southern California, Norris Cancer Center, Los Angeles, CA
www.sitcancer.org/meetings/am04/workshop_presentations/weber.pdf
Assay Validation for Vaccine Potency Assessment
Mary L. Disis, MD - University of Washington, Department of Oncology, Seattle, WA
www.sitcancer.org/meetings/am04/workshop_presentations/disis.pdf
Monitoring of Multi-Antigen Vaccines
Craig Slingluff, Jr., MD - University of Virginia, Charlottesville, VA
www.sitcancer.org/meetings/am04/workshop_presentations/slingluff.pdf
Functional Cytometry
Vernon Maino, PhD - BD Biosciences, San Jose, CA
www.sitcancer.org/meetings/am04/workshop_presentations/ulrich.pdf
Migration of Tumor-Specific T Cells
Carmen Scheibenbogen, MD - Med Klinik III, Charity, CBF, Berlin, Germany
www.sitcancer.org/meetings/am04/workshop_presentations/scheibenbogen.pdf
Tumor Escape Mechanisms: Clinical Observations
Cassian Yee, MD
www.sitcancer.org/meetings/am04/workshop_presentations/yee.pdf
Maximizing the Retention of Antigen Specific Lymphocyte Function after Cryopreservation
Corazon dela Rosa - University of Washington, Department of Oncology, Seattle, WA
www.sitcancer.org/meetings/am04/workshop_presentations/delarosa.pdf
MHC Class II Tetramers Quantitatively Detect DP-4 Restricted, Antigen Specific CD4+ T Lymphocytes
Kristine Kuus-Reichel, PhD - Beckman Coulter Inc., San Diego, CA
www.sitcancer.org/meetings/am04/workshop_presentations/kuus-reichel.pdf
Effect of Cryopreservation on Assays of Antigen-Specific T Cells: Comparison of Tetramer, Cytokine Flow Cytometry, and ELISPOT
Holden Maecker, PhD - BD Biosciences, San Jose, CA
www.sitcancer.org/meetings/am04/workshop_presentations/maecker.pdf
CD8d/d+ Melan-A/MART-1 Specific T-Cells in Patients with Melanoma
Isabelle Magalhaes - University of Mainz, Mainz, Germany
www.sitcancer.org/meetings/am04/workshop_presentations/magalhaes.pdf
tandardization of MHC Tetramer and ELISPOT Assays To Quantitate Antigen-Specific T Cell Expansion after CTLA4 Blockade
Antoni Ribas, MD - University of California Los Angeles Medical Center, Los Angeles, CA
www.sitcancer.org/meetings/am04/workshop_presentations/ribas.pdf
Adenovirus Mediated Interferon-gamma Expression in Cutaneous Lymphoma: Monitoring of Local and Systemic Events
Reinhard Dummer, MD - University Hospital of Zurich, Zurich, Switzerland
www.sitcancer.org/meetings/am04/workshop_presentations/dummer.pdf
Genomics and Proteomics in Immunotherapy Trials
Francesco Marincola, MD - National Institutes of Health, Clinical Center, Bethesda, MD
www.sitcancer.org/meetings/am04/workshop_presentations/marincola.pdf
Farewell and Future Plans
Michael B. Atkins, MD
www.sitcancer.org/meetings/am04/workshop_presentations/atkins.pdf

Creative Commons License
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.